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Abstract 
Amine Catalyzed Functionalization of Enolizable Ketones 
 Development of efficient methods for the synthesis of biologically important 
molecules in safe, atom economical, and environmentally friendly ways is a significant goal 
of modern organic chemistry. In this thesis, efficient methods using amines as catalysts for 
functionalization of enolizable ketones and synthesis of potential biofunctional molecules 
have been developed. First, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was indentified to be 
an efficient catalyst for fast regioselective aldol reactions. Molecules containing tertiary 
alcohols were concisely obtained through the aldol reactions. The developed DBU-catalysis 
was applied for the synthesis of spirooxindoles and trifluoromethyl-substituted alcohols. 
Although the DBU-catalyzed aldol reactions are not enantioselective, the enantiomerically 
pure forms of the aldol products derived from -keto esters were obtained by the resolution of 
the enamines of the aldol products with a homochiral amine. Second, deuteration studies were 
carried out to elucidate the mechanism of the regioselective formation of the products in the 
aldol reactions catalyzed by DBU and to understand the relationship between the carbanion 
formation and the bond-formation. Finally, enantioselective oxa-hetero-Diels-Alder reaction 
of enones with aryl trifluoromethyl ketones catalyzed by a novel amine catalyst system was 
developed. Tetrasubstituted carbon centers bearing a trifluoromethyl group were concisely 
constructed with the formation of the tetrahydropyranone ring. The hetero-Diels-Alder 
products were further transformed to various trifluoromethyl-substituted tetrahydropyran 
derivatives. 
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Chapter 1 
Introduction 
 
 The development of efficient synthetic routes and synthesis of functional molecules 
are always the main task of organic chemists since functional molecules are often required for 
drug discovery, creation of biofunctional molecules, biological probes, etc. Particularly, 
introduction of substituents to carbonyl compounds has been one of the most important 
reactions used to synthesize molecules of interest.
1,2,3,4,5,6,7,8 
Ketone and aldehydes can react 
with nucleophiles at the carbonyl carbon. They can also react with electrophiles and 
nucleophiles at the α- and β-positions,1,2,3,4,5 depending on the structure of the ketones and 
aldehydes, reacting partner, and activation reagent and/or catalyst. While simple 
functionalization of γ- and δ- positions is more difficult, some recent advances made the γ- 
and even δ-functionalization possible.6,7,8 These reactions have been of great interest in the 
field of synthetic chemistry (Scheme 1.1).  
 
Scheme 1.1. Introduction of substituents to carbonyl compounds.  
 
Chapter 1                                                                                                                                                                2   
 
 
 A great number of methods about functionalization of carbonyl compounds have been 
reported. Highly reactive bases and metal-based reagents such as lithium diisopropylamide 
(LDA) and related lithium amides have made a great contribution to this area.
9,10,11
 However, 
reactions with excellent results by these bases and reagents often require absolute conditions, 
because they are sensitive to air and moisture. For a simple example, LDA is a widely used 
base for deprotonation of α-position of carbonyl compounds, forming enolates that act as 
nucleophiles. However, the reaction with LDA often needs to be executed at low temperature 
with the use of completely dehydrated solvents and reactants under inert gas such as argon 
and nitrogen. Because LDA is highly reactive, protection of functional groups with highly 
acidic protons, protection of hydroxyl groups for instance, is usually required, leading long 
non-economical synthetic routes. In addition, production and delivery as well as the use in 
laboratories of highly reactive, moisture and oxygen sensitive reagents could possibly pollute 
the environment if handled improperly.  
 Mukaiyama aldol reactions are also great methods for functionalization of carbonyl 
compounds.
4,12
 However, the Mukaiyama methods require formation of silyl enol ether and 
related compounds before the reactions and deprotection of the silyl groups after the 
reactions.
4,12
 
 As a comparison, functionalization of carbonyl compounds can be performed under 
mild conditions at ambient temperature without special care for exposing to air and moisture 
by using organocatalysts.
2,5,13 ,14 ,15 , 16 ,17 ,18 , 19 ,20
 The organocatalytic reactions are safe and 
environmentally friendly. More importantly, most organocatalytic reactions do not affect 
functional groups such as hydroxyl groups, and thus protection of these groups is often not 
necessary. Accordingly, organocatalytic reactions are atom economical and operationally 
simple. As we all know, it is important that target compounds are synthesized in high yields 
and high selectivities, avoiding the production of waste, in safe, resource-efficient, and 
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environmentally friendly ways.
21
  Due to the great advantages of organocatalysis, the field has 
quickly grown all over the world.  
 For functionalization of carbonyl compounds, organocatalytic methods including the 
use of aminocatalysts have brought fruitful results.
22 , 23 , 24
 However, there is still a high 
demand for new and improved organocatalytic methods to synthesize molecules of interest. 
Here, in the thesis study, I concentrated on the development of amine-catalyzed new chemical 
transformation methods for functionalization of carbonyl compounds, particularly unactivated 
enolizable ketones, and on the synthesis of functionalized molecules using the developed 
methods. 
 For functionalization of enolizable ketones and aldehydes, it is important to find 
effective ways for the formation of nucleophiles (i.e. enolates or enamines, etc.) from these 
ketones or aldehydes. Before discussing the results of the thesis study, reported amine-
catalyzed functionalization methods via the formation of enol/enolate and enamine 
nucleophiles in situ are summarized here.
15,25,26,27,28,29
 
 Preformed enamines have been used as efficient reactants for functionalization of 
ketones since 1950s.
30,31
 First enantioselective reactions involving in situ-formed enamine as 
nucleophiles were reported in early 1970s (Scheme 1.2a).
32,33
 The reactions were performed 
using proline and other amino acids as catalysts. The intramolecular reactions were well 
recognized and used for the synthesis of steroids.
34
  In recent years, safe and environmentally 
benign methods are preferred and amino acid-catalyzed intra- and intermolecular reactions via 
in situ-formed enamines have become popular (Scheme 1.2b).
35-48 
Based on experimental 
evidence and theoretical studies, it is suggested that in proline catalysis, both the amine and 
acid functionalities of the proline are responsible for the catalysis and high enantioselectivity 
(Scheme 1.3).
35,36
 The mechanism of proline-catalyzed reaction of acetone and an aldehyde is 
suggested as following:
35,36
 First, the nitrogen atom of proline attacks the carbonyl group of 
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acetone. With the elimination of water, intermediate iminium ion A is formed, further 
evolving to enamine intermediate B. Then, intermediate B as a nucleophile reacts with the 
carbonyl group of the aldehyde, directed by the carboxylic acid group originated from proline 
in the enamine B via the formation of a hydrogen bond. A highly structured Zimmerman-
Traxler type transition state (TS) is suggested for the C-C bond formation step. In the 
transition state, the aldehyde is attacked on the re-face when L-proline is used as a catalyst, by 
placing the R group in the energetically favored pseudoequatorial position. After the C-C 
bond formation, iminium ion C forms. With the hydrolysis of the iminium ion C, the desired 
aldol product is obtained and the proline is turned over to act in another catalytic cycle. 
 
Scheme 1.2. a) L-Proline-catalyzed intramolecular aldol reaction.
32,33
 b) L-Proline-catalyzed 
intermolecular aldol reaction between acetone and aldehydes.
35
 c) L-Proline-catalyzed three-
component Mannich reaction (PMP = p-methoxyphenyl). 
37
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Scheme 1.3. A proposed mechanism for L-proline-catalyzed aldol reaction of acetone and 
aldehydes.
35,36 
 
 For the L-proline-catalyzed Mannich reaction of acetone and in situ-formed imines 
between p-methoxyaniline and aldehydes, the product stereochemistry is different from that 
obtained in the L-proline-catalyzed aldol reactions (Scheme 1.2b vs. Scheme 1.2c).
35,36,37,38,39
 
In the Mannich reaction, the in situ-formed aldimines are attacked on the si-face. In the 
transition state, the (E)-imine forced the substituent R into the pseudoaxial position (Scheme 
1.4). 
 
Scheme 1.4. Reversal of stereochemistry of L-proline-catalyzed aldol and Mannich 
reactions.
35,36,37,38,39 
PMP = p-methoxyphenyl. 
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 Whereas proline is widely used as catalyst in huge numbers of chemical 
transformations involving in situ-formed enamine nucleophiles, limitations of the proline 
catalysis have also been reported. For example, because of the α-substituent on the pyrrolidine 
ring, ketones larger than acetone such as 3-pentanone, are difficult to give desired products in 
proline-catalyzed reactions. To catalyze reactions of bulky ketones, β-proline (II) has been 
used as catalyst. Catalyst II catalyzes Mannich reactions between bulky ketones and imines as 
well as those between aldehydes and imines.
40 , 41 ,42
 The stereochemistry of the Mannich 
products using β-proline as the catalyst is altered compared to that of proline catalysis 
(Scheme 1.5). For the β-proline-catalyzed reactions, both conformations D and E of enamine 
nucleophiles may be present, but only conformation E can take part in the reaction with the 
imine because the reacting carbon atoms can be positioned for the C-C bond formation under 
the interaction between the carboxylic acid and the imine (i.e. proton transfers from the 
carboxylic acid to the imine).
40,41,42, 
In conformation D, the reaction sites are too far apart 
under the carboxylic acid-imine interaction (i.e. no reaction). The formation of the Mannich 
product in the β-proline catalysis has been explained by transition state F. 
 
Scheme 1.5. β-Proline catalyzed anti-Mannich reactions (PMP = p-methoxyphenyl).40,41,42  
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 Product stereochemistry has also been altered by using primary amine-containing 
amino acids from those catalyzed by proline (Scheme 1.6a,b).
43 , 44 , 45
 When α-hydroxyl 
ketones are applied as substrates, 1,2-amino alcohols and 1,2-diols are synthesized through 
Mannich and aldol reactions catalyzed by proline or primary amine-containing amino 
acids.
43,44,46
 In the reactions of hydroxyacetone catalyzed by proline, products are formed via 
a reaction involving an (E)-enamine because of steric interactions in (Z)-enamine.
44,46,47,48 
The 
stereochemistry of the product has been explained by transition state G or H. However, when 
primary amine containing amino acids are used as catalysts, (Z)-enamines are formed 
predominantly because of the hydrogen bonding between the oxygen of the hydroxyl group 
and the amine proton of the enamine. Then, anti-Mannich and syn-aldol products are formed 
via transition states I and J respectively (Scheme 1.6c).
44
  
 Besides aldol and Mannich reactions, conjugate additions involving enamine 
nucleophiles have also been reported. For example, primary amine-thiourea bifunctional 
catalysts have been used for the conjugate additions of acyclic ketones and α,α-disubstituted 
aldehydes to nitroolefins to generate a series of chiral nitroalkanes (Scheme 1.7a,b).
49,50
 It has 
been suggested that the bifunctional catalysts activate the carbonyl group by the formation of 
enamine and the nitroolefins by hydrogen-bonding.
49,50, 51
 Although the thiourea moiety 
possibly interacts with the nitro group, the exact mode of thiourea binding to nitroolefins is 
unknown. Some theoretical studies have been performed and suggested that only one of the 
nitro oxygen is engaged in the interaction with the thiourea.
49,50,51
  
 For ketone cases, the reaction favors formation of anti-diastereomers and it has been 
suggested that (Z)-enamine intermediate K participated in the transition state (Scheme 1.8).
49
 
For the reactions of aldehydes, syn-diastereomers are mainly obtained and this is explained by 
the involvement of (E)-enamine intermediates in the transition state L.
50
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Scheme 1.6. Primary amine-containing amino acid-catalyzed a) Mannich reactions with anti-
selectivity
44
 and b) aldol reactions with syn-selectivity.
43,44
 c) Proposed transition states to 
lead the products in the proline and primary amine-containing amino acid catalysis.
44 
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Scheme 1.7. Enantioselective Michael additions of a) ketones
49
 and b) aldehydes
50
 to 
nitroolefins catalyzed by primary amine and thiourea based bifunctional catalysts. 
 
 
Scheme 1.8. Proposed intermediates in Michael reactions catalyzed by VI and VII.
49,50
  
 
 With the combination of enamine and iminium catalysis,
5
 formation of more than one 
bond to generate products in one pot has also been widely applied. For instance, a triple 
cascade organocatalytic reaction by way of a Michael/Michael/aldol condensation sequence 
has been reported to afford the products with four stereogenic centers (Scheme 1.9).
52
 Firstly, 
catalyst VIII forms enamine with aldehyde M; this enamine reacts as a nucleophile with 
nitroolefin N to afford the Michael adduct O. Then, O acts as a donor for the conjugate 
additions to the iminium ion formed from the enals and catalyst VIII, giving intermediate P. 
In the last step, intermediate P is used for an intramolecular aldol condensation, leading to Q, 
which is hydrolyzed to give tetra-substituted cyclohexene carbaldehyde.  
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Scheme 1.9. A triple cascade reaction and its proposed catalytic cycle.
52
  
 
 
Scheme 1.10. Hetero-Diels-Alder reactions of enones with isatins.
53
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Recently, organocatalytic hetero-Diels-Alder reactions of enones with isatins have 
been reported to afford spirooxindole tetrahydropyranones using amine-based catalyst 
systems composed of the primary amine IX, a chiral acid X, and a thiourea derivative XI 
(Scheme 1.10).
53,54,55 
In this reaction, enamines of enones are involved. 
 In the amine catalysis described above, the amine catalysts form covalent bonds with 
ketones and aldehydes to generate enamines that act as nucleophiles. And during the catalysis, 
hydrogen bonds and/or ion pairs are also involved to form the enamine and to activate and 
direct the electrophiles. Hydrogen bonds and ion pairs alone without formation of covalent 
bonds between reactants and catalysts have also been used for asymmetric 
organocatalysis.
16,20,56
 In these cases, the formation of hydrogen bonds and/or ion pairs are 
usually used to activate electrophiles; formation of nucleophiles from ketones may be 
performed by the use of preformed silyl enol ethers
57,58 
and related compounds or the use of 
relatively reactive ketones such as β-keto esters.59,60  
The use of oganobases as catalysts to form enolates of unactivated ketones has been 
claimed but these reactions were performed with alkali metals.
61
 The alkali metals were 
important for the reactions, indicating that organic molecules alone were not sufficient.
61,62
 In 
addition, organobases such as guanidine-group-containing bases are used in their protonated 
forms as acid catalysts.
60,62  
Asymmetric organocatalyzed aldol reaction of unactivated ketones as donors via 
formation of hydrogen bonds and/or ion pairs is currently difficult. This is probably because 
the acidity of the α-proton in these ketones is low (pKa values are high) to form enol/enolate 
through interaction with organic molecules that provides only hydrogen bondings. Catalysis 
by simple hydrogen bonds and/or ion pairs that activate ketone substrates via enol/enolate 
mechanism for aldol donors is rare but such examples have been reported, for example, 
enantioselective aldol reaction of unactivated ketones with isatins catalyzed by cinchona 
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derived thiourea XII (Scheme 1.11).
63
 Transition state R is proposed in which the ketone is 
deprotonated by the tertiary amine and during the approach of the enolate to isatin, the ionic 
interaction between the enolate and protonated tertiary amine is retained. Simultaneously, it is 
suggested that the thiourea moiety provides dual hydrogen bonds to activate the isatin 
carbonyl groups and direct the reaction face for nucleophilic attack of the enolate. Whereas 
this reaction gave the aldol products in high yields with high enantioselectivities, the reaction 
was slow and took several days.   
 
Scheme 1.11. Cinchona alkaloids based thiourea derivative catalyzed aldol reaction of 
unactivated ketones via enolate intermediate and its possible transition state.
63
  
 
As described above, depending on the structures of catalysts, substrate specificity, 
products, and the product stereochemistries can be altered, indicating that currently difficult 
chemical transformations may be overcome by the use of new designs and appropriate 
catalyst systems and conditions. New chemical transformations should also be able to be 
performed if appropriate development would be made. Whereas many organocatalytic 
reaction methods for functionalization of unactivated enolizable ketones have been reported, 
most of the reactions are relatively slow; the reaction time often ranges from a few hours to 
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several days. Therefore, the development of efficient synthetic methods is necessary to 
synthesize functionalized molecules from these ketones. At the same time, new methods to 
efficiently synthesize functionalized molecules in safe and atom economical ways are 
required.  
In this thesis study, efficient chemical transformation methods involved in 
functionalization unactivated enolizable ketones have been developed and using the methods, 
functionalized molecules that are relevant to the search of biofunctional molecules have been 
synthesized.  
In Chapter 2, the development of efficient and fast aldol reactions with high 
regioselectivities and the application of these aldol reactions to synthesize functionalized 
molecules are described.  
In Chapter 3, deuteration studies of enolizable ketones under aldol reaction catalysis 
conditions are described.  
In Chapter 4, the development of catalytic enantioselective hetero-Diels-Alder 
reactions is described. The use of the hetero-Diels-Alder reactions is demonstrated by the 
synthesis of tetrahydropyranon and tetrahydropyran derivatives.   
In Chapter 5, summary and conclusions are provided.  
In Chapter 6, experimental details and characterization of synthesized compounds are 
provided.  
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Chapter 2  
Development of DBU-Catalyzed Aldol 
Reactions 
 
2.1 Introduction for Chapter 2  
Functionalization of unactivated enolizable ketones is often performed via enamine 
formation using secondary and primary amine-based catalysts as explained in Chapter 1. 
However, the reactions of bulky substrates (i.e. bulky ketones, α-branched aldehydes etc.) 
catalyzed by pyrrolidines with α-substituent, such as proline, usually proceed with slow 
reaction rates and some reactions cannot even be facilitated, probably due to slow formation 
or inability to form the enamine intermediates because of the sterical reasons (Scheme 2.1). 
Pyrrolidines bearing substituent at the β-position and primary amine catalysts have been used 
to effectively functionalize sterically hindered ketones and aldehydes.
40,41,42,43,44,45,64,65
 Use of 
pyrrolidines that do not have substituent at the α-position can lead better formation of 
enamines with bulky ketones and aldehydes than that of pyrrolidines bearing α-
substituent.
40,41,42
 Although primary amines helped to solve the issue of bulky substrates to 
some extent, usually the reaction time needed was still quite long.
43,44,45,64,65 
Accordingly, fast 
reactions yet providing high selectivities (chemo-, regio-, diastereo-, enantio-, etc.) would be 
useful and essential to be developed.   
Because aldol reaction is one of the most important methods for functionalization of 
ketone or aldehyde, affording β-hydroxy ketone or aldehyde, 66 , 67  first, the research was 
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performed to developed efficient aldol reaction methods for unactivated enolizable ketones 
including ketones used in slow reactions.
68,69
 Organocatlytic aldol reactions are often based 
on the use of secondary and primary amine-based catalysts via enamine 
catalysis.
35,36,43,44,45,46, 70
 Reports of tertiary amine-catalyzed aldol reactions of unactivated 
enolizable ketones via enolate intermediate are rare.
28,63,71
 For example, Mlynarski and co-
workers reported the asymmetric aldol reaction of hydroxyacetone to various aldehydes 
catalyzed by quindine while the stereoselectivities were relatively low.
71
 Zhao and co-workers 
reported the quinidine thiourea catalyzed aldol reactions of unactivated ketones to isatins with 
high enantioselectivities, but the reactions were slow and took several days.
63
 Also, DBU had 
been used as aldol reaction catalyst, but the catalytic efficiency for the formation of aldol 
products depended on substrates.
28,72
      
In this chapter, the development of DBU-catalyzed aldol reaction methods and the 
applicationof the aldol reactions to synthesize functionalized molecules are described. 
 
Scheme 2.1. Comparison of α-substituted pyrrolidine, β-substituted pyrrolidine, and primary 
amine in condensation with sterically hindered ketones and aldehydes.                                                                                                                                                                                
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2.2 Development of DBU-Catalyzed Aldol Reactions for the 
Synthesis of Spirooxindoles 
2.2.1 Development of DBU-Catalyzed Aldol Reactions of a Pyruvic 
Aldehyde Derivative 
Pyruvic aldehyde derivative 1 is one of the useful starting materials for the synthesis 
of functional molecules because it has an acetal group, a protected aldehyde group, which can 
be used for further transformations. In spite of the expected usefulness of the aldol reaction of 
1, previously reported aldol reactions of 1 performed under mild conditions are relatively 
slow. For example, the proline-catalyzed aldol reaction of 1 with α,α-disubstituted 
alkylaldehydes reported by Enders took 5 to 10 days at room temperature or at 4 °C to obtain 
the aldol products in up to 53% yield in excellent diastereo- and enantioselectivities.
73
 
Reactions of 1 using primary amine-based catalysis reported by the group of Luo and Cheng 
also required up to 3 days.
74
 The Chimni group also reported the reaction of 1 with isatins 
using cinchona-derived amines with acid additives as catalysts at 25 °C, and the time required 
for completion of these reactions ranged from 16 to 30 h.
75
 
The slow reactions of ketone 1 might be explained as shown in Scheme 2.2 (initial 
hypotheses). Formation of enamine 2 may be more favored than that of enamine 3, because 
the acidity of α-proton at the carbon with the dimethoxy group may be higher than that of the 
protons of the methyl group and because enamine 2 can be stablized by the dimethoxy group. 
In addition, the dimethoxy group may act as sterically hindered group for the formation of the 
enamine. The reactivity of enamine 2 at the carbon with dimethoxy group may be much lower 
than enamine 3 due to the stabilization and the steric hindrance by the dimethoxyl group. This 
is matter is further discussed on Chapter 3.  
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Scheme 2.2. Enamine and enolate formation of ketone 1 (initial hypotheses). 
 
For enolate formation of 1, it is also considered that enolate 4 is more stable than 
enolate 5. Although the stability of the enamine or enolate might be different from the 
reactivity, formation of 2 or 4 would diminish the reaction at the methyl group of 1 to some 
degree. For efficient and fast reactions, formation of 3 or 5 should be enhanced or other 
effective ways should be applied. 
To develop a new method for fast aldol reactions of pyruvic aldehyde derivative 1, 
first, reaction using isatin 6a as an acceptor electrophile to form product 7a was investigated 
(Table 2.1). Isatin 6a was chosen because oxindole derivatives are important as bioactive 
molecules, drug leads, and synthons to synthesize bioactive molecules.
76 , 77
 Synthesis of 
oxindole derivatives is a current topic.
76,77,78,79,80  
 
The goal was to obtain reasonable product yields for the aldol reaction within 30 min 
at room temperature (25 
o
C). When the reaction was performed using pyrrolidine, pyrrolidine-
acetic acid (1:1), or pyrrolidine-Et3N (1:1) as catalyst (20 mol%) in DME, isatin 6a was 
completely consumed in 30 min; but multiple products were formed including a small amount 
of desired aldol product 7a (Table 2.1, entries 1-3). For these catalysts, neither use of a lower 
catalyst loading (10 and 5 mol%) nor a shorter reaction time improved the outcome to obtain 
7a. In contrast, the reaction in the presence of pyrrolidine-DBU (1:1, 20 mol%) in DME gave 
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7a in good yield (entry 4). The reaction using DBU
 
as a sole catalyst in DME also afforded 7a 
in similar yield (entry 5). A screen of a small set of solvents for the reaction in the presence of 
DBU revealed that toluene was the optimal solvent of those tested in terms of cleanness of the 
reaction (less or no by-product formation) and the yield of 7a (entry 7). The regioisomer of 7a, 
in which a new bond was formed at the acetal carbon, was not obtained. Loading of DBU was 
able to be reduced; the reaction in the presence of DBU (10 mol%) in toluene afforded 7a in 
80% yield (entry 8). Further testing of the reaction at 0 °C (entry 9) and of the use of NaOMe, 
DABCO, or DMAP as catalyst (entries 10-12) indicated that the reaction using DBU (20 or 
10 mol%) in toluene was optimal (entries 7 and 8). Note that the DBU-catalyzed aldol 
reaction constructed tetrasubstituted carbon center in short reaction time.  
Table 2.1. Screen of catalysts and conditions for the aldol reaction.
[a] 
 
Entry Catalyst
[b]
 (loading relative to 6a) Solvent Time Yield (%)
[c]
 
1 Pyrrolidine-Et3N (XIII) 1:1 (20 mol%) DME 30 min ND 
2 Pyrrolidine-CH3COOH (XIV) 1:1 (20 mol%) DME 30 min ND 
3 Pyrrolidine (20 mol%) DME 30 min ND 
4 Pyrrolidine-DBU 1:1 (20 mol%) DME 30 min 72 
5 DBU (20 mol%) DME 30 min 74 
6 DBU (10 mol%) dioxane 30 min 56
[d]
 
7 DBU (20 mol%) toluene 30 min 79 
8 DBU (10 mol%) toluene 30 min 80 
9
[e]
 DBU (10 mol%) toluene 30 min 67 
10 NaOMe
[f]
 (20 mol%) toluene 30 min 73 
11 DABCO (XV) (20 mol%) toluene 3 h NR 
12 DMAP (XVI) (20 mol%) toluene 3 h NR 
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13 Et3N (XIII) (20 mol%) toluene 3 h NR 
14
[g]
 DBU (10 mol%) toluene 30 min 67 
[a] Reaction conditions: 1 (5.0 mmol), 6a (0.50 mmol), and catalyst (0.10 mmol or 0.05 mmol as indicated; i.e., 
20 mol% or 10 mol% to 6a) in solvent (1 mL) at rt (25 °C) except noted; DME: dimethoxyethane. [b] DBU: 1,8-
diazabicyclo[5.4.0]undec-7-ene; DABCO: 1,4-diazabicyclo[2.2.2]octane; DMAP: 4-(dimethylamino)pyridine. 
[c] Isolated yield of 7a. ND = not determined because of formation of by-products, see text. NR = no reaction. 
[d] Yield was determined by 
1
H NMR spectroscopy of the crude mixture. [e] Reaction at 0 °C for 10 min then rt 
for 20 min. [f] NaOMe 5 M solution in MeOH was used. [g] 1 (2.5 mmol) was used. 
 
Whereas pyrrolidine with or without acetic acid or Et3N may form an enamine with 1 
as a nucleophile for the aldol reaction, the reaction using DBU as catalyst may proceed via an 
enolate. Enamine and enolate generated by the deprotonation at the dimethoxy-substituted 
carbon of 1 may be less reactive than those generated by deprotonation at the methyl group of 
1 because of electronic and steric reasons as described above. As a strong base, DBU was an 
efficient catalyst for the reaction; possibility of the formation of the dianion
81
 of 1 is discussed 
in Chapter 3. 
 With the best conditions identified to form 7a, a series of aldol products were 
synthesized from substituted isatins (Table 2.2). Reactions utilizing chloro-, bromo-, and 
methyl- substituted isatin derivatives afforded corresponding aldol products 7b-7f in good to 
high yields (70-89%). The methoxy and the nitro substituted isatins were less soluble in 
toluene. Based on this solubility feature, these reactions were performed in DME to increase 
yields of products 7g and 7h (Table 2.2, 62-63% in DME versus 45-47% in toluene; entry 8 
versus entry 9; entry 10 versus entries 11 and 12).  
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Table 2.2. Aldol reactions of 1 and 6.
[a]
 
 
Entry R 7 DBU (mol%)
[b]
 Time (min) Yield (%) 
1 4-Cl 7b 10 30 70 
2 4-Cl 7b 20 15 78 
3 4-Br 7c 10 15 83 
4 6-Cl 7d 10 15 89 
5 5-Br 7e 10 30
[c]
 54 
6 5-Br 7e 20 15 70 
7 5-Me 7f 10 30 88 
8 5-OMe 7g 10 15 45 
9
[d]
 5-OMe 7g 10 15 63 
10 5-NO2 7h 10 15 47 
11
[d]
 5-NO2 7h 20 15
[c]
 <10
[e]
 
12
[d]
 5-NO2 7h 30 15 62 
[a] Reaction conditions: 1 (5.0 mmol), 6 (0.50 mmol), and catalyst (0.10 mmol or 0.05 mmol as indicated; i.e., 
20 mol% or 10 mol% to 6) in toluene (1 mL) at rt (25 °C) except noted. [b] DBU loading amount relative to 6. 
[c] Reaction was stopped at the indicated time without complete consumption of 6. [d] Reaction in DME. DME: 
dimethoxyethane. [e] Estimated by TLC analysis. 
 
2.2.2 Synthesis of Furanose Spirooxindoles from the Aldol Products 
 Spirooxindoles are common in many natural products and bioactive molecules.
76,77  
Thus, to discover therapeutic leads and biofunctional molecules, there is a high demand for 
new types of spirooxindoles and for the development of efficient, concise synthetic methods 
to access spirooxindole frameworks.
76,77 
 
 As 5-membered-ring sugars, furanose units, are present in DNA and RNA, hence 
spirooxindoles with furanose units will likely be biofunctional molecules.
82,83,84 
The DBU-
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catalyzed aldol reaction of a pyruvic aldehyde derivative (1) with isatins (6) described in 
section 2.2.1 was applied to synthesize a furanose-oxindole-spirosystem. The design to 
synthesize the furanose spirooxindoles was the aldol reaction followed by reduction of the 
ketone carbonyl group and an acidic workup as shown in Scheme 2.3.  
 
Scheme 2.3. A route to furanose-spirooxindoles.   
 
 The aldol product 7a was first reduced using NaBH4 in MeOH at 0 °C; diol 8a was 
obtained as a mixture of the two diastereomers (dr 1.6:1) (Scheme 2.4). In contrast, reduction 
of 7a using NaBH(OAc)3 in CH2Cl2 at -10 °C afforded mostly a single diastereomer of 8a (dr 
20:1) in high yield. This single diastereomer of 8a was converted to 9a (dr 1:1 at the anomeric 
center) by an acid treatment (Scheme 2.4). When 8a (dr 1.6:1) was treated under the same 
acidic conditions, it seemed that all four possible diastereomers of 9a were formed by TLC 
analysis. Although 18 h reaction time for the reduction was significantly more time than the 
aldol reaction step, reduction using NaBH(OAc)3 at -10 °C was chosen to combine with an 
acidic workup to obtain a set of furanose-spirooxindoles. 
 The major diastereomer of 8a obtained by the reduction with NaBH(OAc)3 was the 
same as the major diastereomer of 8a obtained by the reduction using NaBH4. The relative 
stereochemistry of the major diastereomer of 8a was deduced from 9a (see Table 6.1 and 
Figure 6.1 in Chapter 6.2.1). 
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Scheme 2.4. Reduction of 7a and transformation of diol 8a to furanose-spirooxindole 9a.  
 
 The acid treatment of 7a did not afford the corresponding five-membered ring product 
(Scheme 2.5). The acetal group of 7a, located next to the carbonyl group, was also not 
deprotected under typical acidic conditions used for the deprotection of dimethyl acetals. We 
attribute this to the formation of a stable dimethoxy-substituted enol/enolate. Once the ketone 
group was reduced, formation of the five-membered ring proceeded smoothly. 
 
Scheme 2.5. Features of 7a under acidic conditions. 
 
 Results of the formation of 9 by the reduction of 7 using NaBH(OAc)3 followed by an 
acidic workup are shown in Scheme 2.6. Furanose-spirooxindoles 9a-h were obtained in good 
to high yields from the corresponding aldol products 7a-h. The transformation of aldol 
products 7 with substitudent at the 4-position gave corresponding spirooxindoles 9 with good 
diastereomer selectivities (9b and 9c). 
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 The relative stereochemistry of 9a was determined by the coupling constants in 
1
H 
NMR and by NOESY experiments (see Table 6.1 and Figure 6.1 in Chapter 6.2.1). 
 
Scheme 2.6. Conversion of aldol products 7 to furanose-spirooxindoles 9.
 
Diastereomers of 9 
were generated at the acetal carbon. 
 
   
2.3 Development of DBU-Catalyzed Regioselective Aldol 
Reactions for Concise Access to Aryl- and Trifluoromethyl 
Substituted Tertiary Alcohols 
2.3.1 Development of DBU-Catalyzed Aldol Reactions of Ketone Donors 
with Aryl Trifluoromethyl Ketone Acceptors 
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 Molecules bearing aryl- and trifluoromethyl-substituted tertiary alcohol moieties are 
often found in pharmaceuticals, biological probes, enantiomer-discriminating reagents, and 
synthons and building blocks of these molecules.
85,86,87,88
 Accordingly, the development of the 
methods to efficiently synthesize these molecules is of interest.
74,85,86,87,88,89,90,91,92,93,94,95,96,97
 
Based on the results of the DBU-catalyzed reactions described in section 2.2.1, investigation 
was performed to apply DBU-catalysis to aldol and vinylogous aldol reactions of aryl 
trifluoromethyl ketones as acceptors that provide molecules bearing tertiary alcohols with aryl 
and trifluoromethyl groups (Scheme 2.7).
69 
 
Scheme 2.7. Aldol and vinylogous aldol reactions performed using DBU as catalyst. 
 
 First, DBU catalysis conditions were evaluated to obtain the aldol product in the 
reaction of phenyl trifluoromethyl ketone (10a) with pyruvic aldehyde derivative 1, which 
was used for previous DBU-catalyzed reactions with isatins. The results are shown in Table 
2.3. Similar to previous results, the DBU catalysis in toluene afforded aldol product 11a at 
room temperature (25°C) (entry 1). But, the reaction rate was not fast; a 6 h-reaction yielded 3 
in 52% (entry 1). When reactions were performed in neat conditions, the aldol product was 
obtained in high yields (83–94%) after 1.5 h (entries 2-5). Use of 0.1 equiv of DBU was 
sufficient to give 3a in high yields (entries 4 and 5). The conditions used for entries 4 and 5 
(10a, 1 equiv; 2, 5 equiv; DBU 0.1 equiv; 25 °C) were the best of those conditions tested. 
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Note that other amine bases such as Et3N, DMAP, and DABCO did not act as catalyst for this 
aldol reaction (entries 6-8).  
Table 2.3. Reaction of 10a with 1 to give 11a.
[a]
 
 
Entry Catalyst (equiv) Time (h) Conversion
[b]
 (%) Yield
[c]
 (%) 
1
[d]
 DBU (0.2) 6 ND 52 
2 DBU (0.2) 1.5 >95 83 
3
[e]
 DBU (0.2) 1.5 >95 ND 
4
[e]
 DBU (0.1) 1.5 >95 84 
5
[e,f]
 DBU (0.1) 1.5 >95 94 
6 Et3N (XIII) (0.2) 6 0 - 
7 DABCO (XV) (0.2) 6 0 - 
8 DMAP (XVI) (0.2) 6 0 - 
[a]
 Conditions: Ketone 10a (0.5 mmol, 1 equiv), 1 (10 equiv), and catalyst (0.2 or 0.1 equiv as indicated) were 
stirred at 25 °C except where noted. DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene; DMAP = 4-
(dimethylamino)pyridine; DABCO = 1,4-diazabicyclo[2.2.2]octane. ND = not determined. 
[b] 
Conversion of 10a 
was determined by 
1
H NMR. 
[c]
 Isolated yield. 
[d]
 Toluene (1.0 mL) was used as solvent. 
[e]
 Ketone 1 (5.0 equiv). 
[f]
 Ketone 10a (5.0 mmol), ketone 1 (25.0 mmol), DBU (0.5 mmol).  
  
 Next, the best conditions identified for the reaction between 10a and 1 were used for 
aldol reactions of 1 with various aryl trifluoromethyl ketones (Scheme 2.8). A series of 
trifluoromethyl-substituted aldol products 11a–11f were obtained in high yields within 1.0 h 
to 1.5 h regardless the electron-withdrawing or electron-donating substituent on the aryl group 
of the substrate. The thiophene unit in substrate was tolerated under the DBU catalysis, giving 
corresponding aldol product 11g in 87% yield within 1.5 h. For the pyrrole-bearing substrate 
with an acidic proton, protection of the pyrrole NH was not necessary to lead the aldol C-C 
bond formation, and the reaction gave 11h, cyclized forms of the product.  
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Scheme 2.8. Aldol reactions of 1 with various aryl trifluoromethyl ketones. Conditions: 
Ketone 10 (0.5 mmol, 1.0 equiv), ketone 1 (5.0 equiv), and DBU (0.1 equiv) at 25 °C. 
[a]
 Data 
from Table 2.3, entry 4. 
[b]
 DBU (0.2 equiv) was used. Two diastereomers of 11h were 
separately obtained.  
 
 The DBU catalysis was also tested in reactions of various alkyl methyl ketone donors 
with phenyl trifluoromethyl ketone acceptor (Scheme 2.9). The reactions were highly 
diastereoselective.  When using methyl ethyl ketone as the donor, product 11aa was isolated 
in 81% yield within 1 h. The C-C bond formation occurred at the methyl group. Reaction of 
isopropyl methyl ketone with 10a also successfully afforded product 11ab with perfect 
regioselectivities in 85% isolated yield in 3 h (no regioisomer of 11ab was detected). Whereas, 
the reaction of the hindered t-butyl methyl ketone with 10a under DBU catalysis failed to give 
product 11ac at room temperature for 3 h. By heating the reaction to 45
o
C for 12 h, product 
11ac was obtained in 95% yield. The reaction of methyl phenyl ketone with 10a under the 
DBU catalysis afforded 11ad in 89% yield in 2 h.  
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Scheme 2.9. Aldol reactions of 10a with alkyl methyl ketones and with methyl phenyl ketone. 
Conditions: Ketone 10a (0.5 mmol, 1.0 equiv), donor ketone (5.0 equiv), and DBU (0.1 
equiv) at 25 °C except as noted.  
 
 -Keto esters also acted as nucleophiles to give corresponding aldol products 13 under 
the DBU catalysis. For these reactions, the C-C bond formation occurred at the γ-position 
regioselectively (Scheme 2.10). During the reaction to form 13a, formation of 13a was 
observed by 
1
H NMR analyses even at the initial stages of the reaction (such as at 5 min, 50 
min, 130 min, and 220 min); however, no sign of the product with the bond formation at the 
-position of the -keto ester was detected.  
 In reported reactions of -keto esters, the bond-formation often occurs at the -
position.
98,99
 In previously reported methods for bond-forming reactions at the γ-position of -
keto esters, severe conditions, such as the use of two equivalents of strong bases to form a 
dianion, are typically required.
100,101,102,103
 Alternatively, aldol reactions of -keto esters at the 
γ-position have been performed using preformed silyl dienol ethers or alkyl dienol ether 
derivatives.
104 ,105 , 106
 In the DBU-catalyzed reactions described above, -keto esters were 
directly used as the substrates, and only catalytic amounts of DBU were necessary to give the 
aldol products of the bond formation at the γ-position of -keto esters under mild conditions. 
A series of aldol products were obtained with good to high yields within 24-36 h (Scheme 
2.10). The reactions of the substrates 10 containing electron-withdrawing groups were faster 
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than that with electron-donating groups. The ketone containing a thiophene unit also worked 
as acceptor for this aldol reaction (formation of 13ac and 13bc). Further, the reaction was 
easily scaled up. A 15-mmol scale reaction of 10a with ethyl acetoacetate in presence of DBU 
(10 mol%) gave 13a in 74% yield after 4 days. 
 
Scheme 2.10. Aldol reactions of -keto esters with various aryl trifluoromethyl ketones. 
Conditions: Ketone 10 (0.5 mmol, 1.0 equiv), -keto ester (10.0 equiv), and DBU (0.2 equiv) 
at 25 °C except where noted. 
[a]
 Data in parentheses from a 15 mmol-scale reaction: ketone 
10a (15 mmol, 1.0 equiv), -keto ester (5.0 equiv), and DBU (0.1 equiv).  
 
 The DBU catalysis was also useful for the vinylogous aldol reactions of -methyl-
substituted cyclic enones 14 with 10 (Scheme 2.11). When the reaction of 10a and 14b was 
catalyzed by DBU (0.1 equiv) in toluene, the desired vinylogous aldol reaction product 15a 
was obtained in 65% yield in 24 h (Table 2.4, entry 1). Similar to above reactions, when the 
reaction was performed in neat conditions, product 15a was obtained in high yield (81%) only 
in 1 h (Table 2.4, entry 2). Note that other amine bases such as Et3N, DMAP, and DABCO 
did not act as catalyst for this reaction (Table 2.4, entries 4-6).  
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Table 2.4. Reaction of 14b with 10a to give 15a.
[a] 
 
 
Entry Catalyst (equiv) Time (h) Conversion
[b]
 (%) Yield
[c]
 (%) 
1
[d]
 DBU (0.1) 24 ND 65 
2 DBU (0.1) 1 >95 81 
3
[e]
 DBU (0.1) 1 85 ND 
4 Et3N (XIII) (0.2) 3 0 - 
5 DABCO (XV) (0.2) 3 0 - 
6 DMAP (XVI) (0.2) 3 0 - 
[a]
 Conditions: Ketone 10a (0.5 mmol, 1 equiv), 14b (5 equiv), and catalyst (0.2 or 0.1 equiv as indicated) were 
stirred at 25 °C except where noted. DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene; DMAP = 4-
(dimethylamino)pyridine; DABCO = 1,4-diazabicyclo[2.2.2]octane. ND = not determined. 
[b] 
Conversion of 10a 
was determined by 
1
H NMR. 
[c]
 Isolated yield. 
[d]
 Toluene (1.0 mL) was used as solvent. 
[e]
 14b (2.0 equiv). 
 
 With the best reaction conditions (Table 2.4, entry 2), a series of trifluoromethyl-
substituted aldol products 15 were obtained within 30 min to 1 h in good to high yields under 
solvent free mild conditions (Scheme 2.11). The reactions using trifluoromethyl ketone 
derivatives 10 with electron donating substituents such as methyl and methoxyl group on the 
aromatic ring as acceptors were clean and the products were obtained in high yields (80-84%, 
15b, 15c, and 15i). For the reactions of electron withdrawing group-substituted phenyl 
trifluoromethyl ketones, such as chloro-, bromo-, and trifluoromethyl-substituted phenyl 
ketones 10, formation of by-products was detected with the desired aldol products by 
1
H 
NMR analyses of the reaction mixtures. But, products 15 were reasonably obtained (53-70%, 
15d, 15e, 15f and 15j). The reaction of the substrate with a thiophene unit with 14b also 
afforded the desired product 15g in 76% in 1 h.  Both five member ring (14a) and six member 
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ring (14b) cyclic enones acted as donors. The reactions of 14a were faster than the reactions 
of 14b.  
 
Scheme 2.11. Vinylogous aldol reactions of -methyl-sustituted cyclic enones. Conditions: 
Ketone 10 (1.0 equiv), enone (5.0 equiv), and DBU (0.1 equiv) at 25 °C. 
 
 Vinylogous aldol reactions of 14b with -keto esters were previously reported.107 In 
these reactions, a bifunctional primary amine-thiourea catalyst was used and products were 
obtained in moderate to good yields with good enantioselectivity. However, their reaction 
method did not work for the reaction of 14a. Here, the developed DBU catalysis was 
applicable to reactions of both the six- and five- membered substrates 14 with 10.  
 
2.3.2 Resolution of the Enantiomers of Aldol Products Derived from -Keto 
Esters 
 The DBU-catalyzed aldol reactions described above give racemic products. For the 
aldol products generated from -keto esters, the enantiomerically pure forms were obtained 
through resolution via the formation of enamines with a homochiral amine (Scheme 2.12).  
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Scheme 2.12. Resolution of 13 to give the enantiomerically pure forms. Separations of 16a-1 
and 16a-2, and of 16ac-1 and 16ac-2, were performed using single-time, typical silica gel 
flash column chromatography. The dr values were determined by 
1
H NMR. The ee values 
were determined by HPLC. 
[a]
 Data after crystallization. 
 
 When aldol products 13 were mixed with (R)-1-phenylethylamine, stable enamines 16 
were obtained. Purification of each of the diastereomers of the enamines by usual silica gel 
flash column chromotography, followed by hydrolysis of the enamines afforded essentially 
enantiomerically pure forms (such as >99% ee) of the aldol products (Scheme 2.12). A 10 
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mmol-scale chiral resolution of the aldol product (±)-13a was easily performed; with the 
resolution of enamine 16a, 0.43 g of the enantiopure form of (R)-13a (99% ee) was concisely 
obtained.   
 The absolute stereochemistry of enantiomer 13a obtained from enamine 16a-1 (upper 
spot product on TLC) was determined to be R by converting to known ketone 17 and also by 
X-ray crystal structure analysis of enamine 16a-1. 
 Besides 1-phenylethylamine, several other amines 18 were also tested to form 
enamines 19 with racemic 13a as shown in Scheme 2.13. The enamines 19 were formed 
smoothly, but the diastereomers were difficult to be separated by silica gel column (see 
Experimental Section Chapter 6.2.2 for more information). 
 
Scheme 2.13. Reactions of amines 18 with 13a to give enamines 19. 
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Chapter 3 
Deuteration Studies of Enolizable Ketones 
under Aldol Reactions Catalysis Conditions 
 
 The DBU-catalyzed aldol reactions described in Chapter 2 were relatively fast and 
provided the aldol products in good to high yields with perfect regioselectivities under mild 
conditions. In these aldol reactions, the C-C bonds formed at the methyl group of the pyruvic 
aldehyde derivative, at the methyl group of alkyl methyl ketones, and at the γ-position of -
keto esters. To elucidate the mechanism of the regioselective formation of the products in the 
aldol reactions and to understand the relationship between the carbanion formation and the 
bond-formation, deuteration of the ketone donors in the presence of DBU or other amines was 
analyzed. 
 Ketones were treated with amine catalysts in the presence of D2O in CDCl3 or 
deuterated DMSO and deuteration was monitored by 
1
H NMR (Scheme 3.1).  
 
Scheme 3.1. Deuteration of the aldol reaction donors under aldol reaction catalysis conditions. 
 
 First, deuteration of ketone 1 was analyzed in the presence of DBU and D2O in CDCl3. 
The -methyl group (position A) was deuterated (Figure 3.1, Table 3.1); this was consistent 
with the bond-formation regioselectivity. After 6 h, more than 70% of the protons at position 
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A were exchanged by deuteriums. No deuteration for the CH at position B was observed after 
2 days.  
 When L-proline was used instead of DBU (in (CD3)2SO for the use of L-proline versus 
in CDCl3 for the use of DBU), the -methyl group (position A) were also deuterated (Figure 
3.2, Table 3.1). After 7 days, around 40% of the protons at position A were exchanged by 
deuteriums in the deuteration reaction using L-proline. Similar to the deuteration using DBU, 
no deuteration for the CH at position B was observed after 7 days.  
 The initial deuteration rate of -methyl group in pyruvic aldehyde derivative 1 under 
DBU-catalysis conditions was approximately 50 times faster than that under L-proline-
catalysis conditions. Although the deuteration rates are not necessarily directly related to the 
aldol reaction rates, it gives the clues for the fast DBU-catalyzed aldol reactions. Reported 
proline-catalyzed aldol reactions of 1 took 5-10 days;
73
 this slow reaction is well explained by 
the slow deuteration. 
 Deuteration of 1 was further tested in the presence of β-proline in (CD3)2SO (Figure 
3.3, Table 3.1). Deuteration of 1 by β-proline catalysis also occurred only at the methyl group 
at position A of 1, and the initial rate of the deuteration by β-proline catalysis was 
approximately 100-fold faster than that by the proline catalysis and also faster than that by the 
DBU catalysis in CDCl3 described above.   
 Deuteration of 1 was also tested in the presence of pyrrolidine-CH3COOH in 
(CD3)2SO (Figure 3.4, Table 3.1). In this case, the initial rate of the deuteration at the methyl 
group was 6.6    -3 min-1, similar to the rate by the DBU catalysis in CDCl3 (5.7    
-3
 
min
-1
). No deuteration at position B was also detected in the presence of pyrrolidine-
CH3COOH.   
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 When deuteration of 1 was tested in the presence of Et3N in CDCl3, no deuteration of 
1 was observed. This was consistent with that Et3N did not work as the catalyst for aldol 
reactions of 1 with phenyl trifluoromethyl ketone.  
 
 
Figure 3.1. Deuteration of CH3 at position A of pyruvic aldehyde derivative 1 in the presence 
of DBU. (a) Time course, full range of the time analyzed, and (b) the initial range. X = Time 
after addition of DBU, Y = [Integration of the CH3 (including CH2D and CHD2) at position 
A]/{[Integration of (OCH3)2]×1/2}. As the result, the slope of the equation is the rate of per 
original proton. Deuteration experiments were carried out twice.  
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Figure 3.2. Deuteration of CH3 at position A of pyruvic aldehyde derivative 1 in the presence 
of L-proline. (a) Time course, full range of the time analyzed, and (b) the initial range. X = 
Time after addition of L-proline, Y = [Integration of the CH3 (including CH2D and CHD2) at 
position A]/{[Integration of (OCH3)2]×1/2}. As the result, the slope of the equation is the                                                
rate of per original proton. Deuteration experiments were carried out twice.  
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Figure 3.3. Deuteration of CH3 at position A of pyruvic aldehyde derivative 1 in the presence 
of (S)-(+)-pyrrolidine-3-carboxylic acid. (a) Time course, full range of the time analyzed, and 
(b) the initial range. X = Time after addition of (S)-(+)-pyrrolidine-3-carboxylic acid, Y = 
[Integration of the CH3 (including CH2D and CHD2) at position A]/{[Integration of 
(OCH3)2]×1/2}. As the result, the slope of the equation is the rate of per original proton. 
Deuteration experiments were carried out twice.  
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Figure 3.4. Deuteration of CH3 at position A of pyruvic aldehyde derivative 1 in the presence 
of pyrrolidine-CH3COOH. X = Time after addition of pyrrolidine-CH3COOH, Y = 
[Integration of the CH3 (including CH2D and CHD2) at position A]/{[Integration of 
(OCH3)2]×1/2}. As the result, the slope of the equation is the rate of per original proton. 
Deuteration experiments were carried out twice.  
 
 Similarly, deuteration of methyl ethyl ketone, methoxyacetone, hydroxyacetone, and 
ethyl acetoacetate with D2O were also analyzed. 
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 For methyl ethyl ketone, in the presence of DBU, deuteration occurred at both the -
methyl group (position C) and the -methylene group (position D) as shown in Figure 3.5, 
Figure 3.6, and Table 3.1. The initial deuteration rates at Position C and position D were 
similar. In the DBU-catalyzed aldol reaction of methyl ethyl ketone with aryl trifluoromethyl 
ketone, the bond-formation occurred mostly at the -methyl group (position C). The 
regioselectivity of the aldol reaction is likely controlled by steric factors.  
 In L-proline-catalysis, also both the -methyl group (position C) and the -methylene 
group (position D) were deuterated as shown in Figure 3.7, Figure 3.8, and Table 3.1. The 
initial deuteration rate at position C was approximately 7-fold faster than that at position D.  
 In β-proline-catalysis, both position C and position D were deuterated as shown in 
Figure 3.9, Figure 3.10, and Table 3.1. The initial rate of the deuteration at position C by β-
proline catalysis was approximately 40-fold faster than that by proline catalysis and the initial 
rate of the deuteration at position D by β-proline catalysis was approximately 160-fold faster 
than that by proline catalysis.  
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Figure 3.5. Deuteration of CH3 at position C of methyl ethyl ketone in the presence of DBU. 
X = Time after addition of DBU, Y = [Integration of the CH3 (including CH2D and CHD2) at 
position C]/(Integration of CH3 of the ethyl group). As the result, the slope of the equation is 
the rate of per original proton. Deuteration experiments were carried out twice.  
 
 
Figure 3.6. Deuteration of CH2 at position D of methyl ethyl ketone in the presence of DBU. 
X = Time after addition of DBU, Y = [Integration of the CH2 (including CHD) at position 
D]/[(Integration of CH3 of the ethyl group)×(2/3)]. As the result, the slope of the equation is 
the rate of per original proton. Deuteration experiments were carried out twice 
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Figure 3.7. Deuteration of CH3 at position C of methyl ethyl ketone in the presence of L-
proline. (a) Time course, full range of the time analyzed, and (b) the initial range. X = Time 
after addition of L-proline, Y = [Integration of the CH3 (including CH2D and CHD2) at 
position C]/(Integration of CH3 of the ethyl group). As the result, the slope of the equation is 
the rate of per original proton.  Deuteration experiments were carried out twice. 
Chapter 3                                                                                                                                                               42   
 
 
 
Figure 3.8. Deuteration of CH2 at position D of methyl ethyl ketone in the presence of L-
proline. X = Time after addition of L-proline, Y = [Integration of the CH2 (including CHD) at 
position D]/[(Integration of CH3 of the ethyl group)×(2/3)]. As the result, the slope of the 
equation is the rate of per original proton. Deuteration experiments were carried out twice. 
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Figure 3.9. Deuteration of CH3 at position C of methyl ethyl ketone in the presence of (S)-
(+)-pyrrolidine-3-carboxylic acid. (a) Time course, full range of the time analyzed, and (b) the 
initial range. X = Time after addition of (S)-(+)-pyrrolidine-3-carboxylic acid, Y = 
[Integration of the CH3 (including CH2D and CHD2) at position C]/(Integration of CH3 of the 
ethyl group). As the result, the slope of the equation is the rate of per original proton.  
Deuteration experiments were carried out twice. 
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Figure 3.10. Deuteration of CH2 at position D of methyl ethyl ketone in the presence of (S)-
(+)-pyrrolidine-3-carboxylic acid. X = Time after addition of (S)-(+)-pyrrolidine-3-carboxylic 
acid, Y = [Integration of the CH2 (including CHD) at position D]/[(Integration of CH3 of the 
ethyl group)×(2/3)]. As the result, the slope of the equation is the rate of per original proton. 
Deuteration experiments were carried out twice. 
 
 For methoxyacetone, the initial rate of the deuteration per proton at the methyl group 
at position E was 2- to 3-fold faster than that per proton at the methoxy-substituted methylene 
group at position F in each of all the cases of the DBU-, proline-, and β-proline-catalysis 
(Figure 3.11-Figure 3.16, Table 3.1).  
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Figure 3.11. Deuteration of CH3 at position E of methoxyacetone in the presence of DBU. (a) 
Time course, full range of the time analyzed, and (b) the initial range. X = Time after addition 
of DBU, Y = [Integration of the CH3 (CH2D and CHD2) at position E]/(Integration of OCH3). 
As the result, the slope of the equation is the rate of per original proton. Deuteration 
experiments were carried out twice. 
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Figure 3.12. Deuteration of CH2 at position F of methoxyacetone in the presence of DBU. (a) 
Time course, full range of the time analyzed, and (b) the initial range. X = Time after addition 
of DBU, Y = [Integration of the CH2 (including CHD) at position F]/[(Integration of 
OCH3)×(2/3)]. As the result, the slope of the equation is the rate of per original proton. 
Deuteration experiments were carried out twice. 
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Figure 3.13. Deuteration of CH3 at position E of methoxyacetone in the presence of L-proline. 
(a) Time course, full range of the time analyzed, and (b) the initial range. X = Time after 
addition of L-proline, Y = Integration of the CH3 (including CH2D and CHD2) per original 
proton at position E (an internal standard was used). Deuteration experiments were carried out 
twice.  
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Figure 3.14. Deuteration of CH2 at position F of methoxyacetone in the presence of L-proline. 
(a) Time course, full range of the time analyzed, and (b) the initial range. X = Time after 
addition of L-proline, Y = Integration of the CH2 (including CHD) per original proton at 
position F (an internal standard was used). Deuteration experiments were carried out twice. 
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Figure 3.15. Deuteration of CH3 at position E of methoxyacetone in the presence of (S)-(+)-
pyrrolidine-3-carboxylic acid. (a) Time course, full range of the time analyzed, and (b) the 
initial range. X = Time after addition of (S)-(+)-pyrrolidine-3-carboxylic acid, Y = 
[Integration of the CH3 (CH2D and CHD2) at position E]/(Integration of OCH3). Deuteration 
experiments were carried out twice. 
 
Chapter 3                                                                                                                                                               50   
 
 
 
Figure 3.16. Deuteration of CH2 at position F of methoxyacetone in the presence of (S)-(+)-
pyrrolidine-3-carboxylic acid. (a) Time course, full range of the time analyzed, and (b) the 
initial range. X = Time after addition of (S)-(+)-pyrrolidine-3-carboxylic acid, Y = 
[Integration of the CH2 (including CHD) at position F]/[(Integration of OCH3)×(2/3)]. As the 
result, the slope of the equation is the rate of per original proton. Deuteration experiments 
were carried out twice. 
 
 For the deuteration of hydroxyacetone, DBU was not used based on the results that the 
DBU was not a good catalyst for the reaction of hydroxyacetone with aryl trifluoromethyl 
ketones. Proline and β-proline have been used as the catalysts for reactions of hydroxyacetone; 
deuteration of hydroxyacetone in the presence of these catalysts was analyzed (Figure 3.17-
Figure 3.19, Table 3.1).  
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Figure 3.17. Deuteration of CH3 at position G of hydroxyacetone in the presence of L-proline. 
(a) Time course, full range of the time analyzed, and (b) the initial range. X = Time after 
addition of L-proline, Y = Integration of the CH3 (including CH2D and CHD2) per original 
proton at position G (an internal standard was used). Deuteration experiments were carried 
out twice. 
 
 The initial deuteration rate at the methyl group at position G of hydroxyacetone was 
similar to that at the methyl group at position A of ketone 1 under the both proline- and β-
proline-catalysis. In proline-catalysis, the deuteration rate of the hydroxyl group-substituted 
methylene group at position H was significantly slower or at least 10-times slower than that of 
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the methyl group at position G. In the β-proline-catalysis, initial deuteration rate at the methyl 
group at position G was approximately 100-fold faster than that at the same methyl group by 
proline catalysis.  
 
 
Figure 3.18. Deuteration of CH3 at position G of hydroxyacetone 4 in the presence of (S)-(+)-
pyrrolidine-3-carboxylic acid. (a) Time course, full range of the time analyzed, and (b) the 
initial range. X = Time after addition of (S)-(+)-pyrrolidine-3-carboxylic acid, Y = Integration 
of the CH3 (including CH2D and CHD2) per original proton at position G (an internal standard 
was used). Deuteration experiments were carried out twice. 
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Figure 3.19. Deuteration of CH2 at position H of hydroxyacetone 4 in the presence of (S)-(+)-
pyrrolidine-3-carboxylic acid. (a) Time course, full range of the time analyzed, and (b) the 
initial range. X = Time after addition of (S)-(+)-pyrrolidine-3-carboxylic acid, Y = Integration 
of the CH2 (including CHD) per original proton at position H (an internal standard was used). 
Deuteration experiments were carried out twice. 
 
 For ethyl acetoacetate, the deuteration of the methyl group at position I was observed 
under DBU-catalysis. The methylene group at position J was immediately deuterated in more 
than 70% in all the cases of the DBU-, proline-, and β-proline-catalysis (Figure 3.20, Table 
3.1). For the reaction of ethyl acetoacetate with aryl trifluoromethyl ketones in the presence of 
DBU, only afforded the product with C-C bond formation at position I.  
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Figure 3.20. Deuteration of CH3 at position I of ethyl acetoacetate 5 in the presence of DBU. 
X = Time after addition of DBU, Y = [Integration of the CH3 (CH2D and CHD2) at position 
I]/[Integration of OCH2CH3)×(3/2)]. As the result, the slope of the equation is the rate of per 
original proton. Deuteration experiments were carried out twice. 
 
 Initial deuteration rates of ketone donors were summarized in Table 3.1. To conclude 
from these deuteration experiments: Carbanion formation is necessary for aldol reactions and 
DBU can deprotonate ketones to form carbanions. However, the C-C bond formation site is 
not necessarily to be related to the deprotonation site. The reaction site may be controlled by 
steric reasons and other factors. For the C-C bond formation in aldol reactions, formation of 
the products may rely on the transition states to form the bond. Easiness of the formation of 
carbanions (ie, deuteration) was not directly related to the formation of the aldol products. 
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Table 3.1. Observed deuteration rates per original proton.
[a] 
 
 
ketone position 
 
deuteration rate per proton (min
-1
) 
 
DBU catalysis 
 
L-proline 
 
β-proline 
 
CH3 at A 5.7 × 10
-3
 1.2 × 10
-4
 1.0 × 10
-2
 
CH at B Not observed Not observed Not observed 
 
CH3 at C 1.7 × 10
-4
  1.4 × 10
-4
  5.5 × 10
-3
  
CH2 at D 1.9 × 10
-4
  2.1 × 10
-5
  3.4 × 10
-3
  
 
CH3 at E 2.5 × 10
-3
  3.6 × 10
-4
  1.4 × 10
-2
  
CH2 at F 8.6 × 10
-4
  1.1 × 10
-4
  6.5 × 10
-3
  
 
CH3 at G Not performed 1.1 × 10
-4
  1.3 × 10
-2
  
CH2 at H Not Performed <1.3 × 10
-5
 2.8 × 10
-3
  
 
CH3 at I 3.2 × 10
-3
  --
[b]
 --
[b]
 
CH2 at J --
[c]
 --
[c]
 --
[c]
 
[a]
 Conditions: Ketone (1.8 mmol). D2O (8.0 mmol), and catalyst (0.18 mmol) in CDCl3 (9.0 mL) or (CD3)2SO 
(9.0 mL) as indicated. Average data are listed. 
[b]
 It was likely that catalyst formed stable enamine with ketone. 
[c]
 
More than 70% was deuterated within 5 minutes.  
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Chapter 4  
Development of Enantioselective Oxa-Hetero-
Diels-Alder Reactions  
 
4.1 Introduction for Chapter 4 
 Tetrahydropyranones are core structures of great importance, and can be easily 
transformed to substituted tetrahydropyrans and related 
derivatives.
53,54,55, 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117  
Compounds featuring a trifluoromethyl 
carbinol motif are often found in pharmaceuticals, biological probes, enantiomer-
discriminating reagents, and synthons and building blocks of these molecules.
69,85,86,87,88
 So 
Trifluoromethyl-substituted tetrahydropyranones will likely be useful to aid the search for 
biofunctional molecules. Hence, there is a high demand for the development of concise 
asymmetric methods that providing highly enantiomerically enriched tetrahydropyranones 
bearing a trifluoromethyl group. 
 
Scheme 4.1. Synthesis of tetrahydropyranones via reactions of preformed dienes with ketones 
or aldehydes, which has been often used.   
 
 The synthesis of tetrahydropyranones are often based on formal hDA reactions using 
silyl enol ether derived dienes or siloxybutadiene derivatives as dienes.
108,109,110,111,112,113
 In 
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these reactions, after the reactions, the deprotection step is necessary to give 
tetrahydropyranones (Scheme 4.1). 
 Both metal catalysis
108,109,110 
and organocatalysis using hydrogen bonding donors as 
catalysts
111,112,113
 have been reported by using the preformed dienes. In this chapter, the 
development of enantioselective direct oxa-hetero-Diels-Alder reactions of enones with aryl 
trifluoromethyl ketones that afford trifluoromethyl-substituted tetrahydropyranones is 
described, in which dienes are generated in situ from enones.  
 
4.2 Development of Enantioselective Oxa-Hetero-Diels-Alder 
Reactions of Enones with Aryl Trifluoromethyl Ketones  
 Recently, enantioselective oxa-hetero-Diels-Alder reactions of enones with isatins that 
are catalyzed by amine-based catalyst systems have been developed to synthesize 
functionalized tetrahydropyranones.
53,54,55
 In the reactions, enamines of enones are formed in 
situ, and the enamines act as dienes of the [4+2] cycloaddition resulting in the formation of 
the tetrahydropyranones under mild conditions.
53,54,55
 Based on these studies, the development 
of amine-catalyzed enantioselective oxa-hetero-Diels-Alder reactions of enones with 
trifluomethyl ketones was investigated (Scheme 4.2) to provide concise, atom-economical 
access to trifluoromethyl-substituted tetrahydropyranone derivatives. Inspite of the presence 
of previous oxa-hetero-Diels-Alder reactions of enones, direct use of enones as diene 
precursors to form tetrahydropyranones is still a challenge; reported reactions of enones with 
ketones or aldehydes often give aldol products as the main product or as a significant by-
product.
63,118,119,120,121,122,123
 That is, formation of oxa-hetero-Diels-Alder reaction product is 
not promised in the reactions of enones with ketones or aldehydes as dienophiles either in 
racemic or highly enantioselective versions.
53,54,55,124,125,126  
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Scheme 4.2. The oxa-hetero-Diels-Alder reactions of enones with aryl trifluoromethyl 
ketones catalyzed by amine-based catalyst systems to afford trifluoromethyl-substituted 
tetrahydropyranones. 
 
 To synthesize highly enantiomerically enriched trifluoromethyl-substituted 
tetrahydropyranones, first, catalyst systems for the reaction of enone 20a with ketone 10b to 
form trifluoromethyl-substituted tetrahydropyranone product 21a (21a-1 and/or 21a-2) were 
screened. Selected results are shown in Table 4.1. Previously reported catalyst systems (such 
as combination of IX with X, IX with X and XI, and IX with XIV) for the reactions of 
enones with isatins to afford tetrahydropyranones in high enantioselectivity did not work 
efficiently for the reaction with ketone 10b; the use of these catalysts significantly generated 
aldol product 22a with oxa-hetero-Diels-Alder product 21a (Table 4.1, entries 1-4). Use of  
catalyst systems combining amines XVIII and XIX with acetic acid (XIV) gave desired 
product 21a (Table 4.1, entries 5 and 6). Although the formation of aldol product 22a was 
suppressed in these reactions, the er of the major diastereomer 21a-1 was moderate. When L-
proline (I) in toluene, the reaction was very slow (Table 4.1, entries 7). Switching the solvent 
of this L-proline (I)-catalyzed reaction to DMF, hetero-Diels-Alder product 21a was obtained 
and the aldol product 22a was not detected (Table 4.1, entries 8). When the combination of L-
proline (I) and Et3N (XIII) was used as the catalyst system in toluene, the reaction also 
afforded only 21a (Table 4.1, entries 9). 
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Table 4.1. Screening of catalyst systems in the hetero-Diels-Alder reaction of 20a and 10b.
[a]
 
 
entry catalyst system 
time 
(h) 
21a:22a
[b]
 
dr
[b]
 
21a-1:21a-2 
er
[c] 
21a-1/21a-2 
1 IX (0.2 equiv)-X (0.4 equiv) 24 62:38 5.0:1 85:15/20:80 
2 
IX (0.2 equiv)-X (0.4 equiv)-XI 
(0.4 equiv) 
36 71:29 2.5:1 ND/ND 
3 XVII (0.2 equiv)-X (0.4 equiv) 12 67:33 3.1:1 ND/ND 
4 IX (0.2 equiv)-XIV (0.4 equiv) 24 70:30 8:1 ND/ND 
5 XVIII (0.2 equiv)-XIV (0.4 equiv) 24 95:5 2.0:1 18:82/1:1 
6 XIX (0.2 equiv)-XIV (0.4 equiv) 24 >95:5 1.7:1 68:32/ND 
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7
[d]
 I (0.2 equiv) 48
[d]
 - - - 
8
[e]
 I (0.2 equiv) 24 >95:5 1.6:1 ND/85:15 
9 I (0.2 equiv)-XIII (0.2 equiv) 36 >95:5 1.3:1 ND/91:9 
10 I (0.2 equiv)-XX (0.2 equiv) 30 >95:5 1:2.3 ND/91:9 
11 I (0.2 equiv)-XV (0.2 equiv) 36 >95:5 1:1.2 ND/95:5 
12 XXI (0.2 equiv)-XV (0.2 equiv) 24 >95:5 1:1.9 1:1/97:3 
13 XXI (0.1 equiv)-XV (0.2 equiv) 24 >95:5 1:1.9 1:1/97:3 
14 I (0.2 equiv)-XXII (0.2 equiv) 24 >95:5 1:1 ND/94:6 
15 I (0.2 equiv)-XXIII (0.2 equiv) 24 >95:5 1:1.3 82:18/88:12 
16 I (0.2 equiv)-XXIV (0.2 equiv) 27 95:5 1:2.2 81:19/90:10 
17 I (0.2 equiv)-XXV (0.2 equiv) 36 95:5 1:1.5 85:15/91:9 
18 I (0.2 equiv)-XXVI (0.2 equiv) 48 >95:5 1:1.3 ND/94:6 
19 I (0.2 equiv)-XXVII (0.2 equiv) 36 >95:5 1.3:1 ND/80:20 
[a] 
Reaction was performed by using enone 20a (0.5 mmol) and aryl trifluoromethyl ketone 10b (0.1 mmol) in the 
presence of the indicated catalyst system in toluene (0.2 mL) at 25 °C until 10b was consumed except where 
indicated. The relative stereochemistry of 21a-1 and 21a-2 was determined to be as shown; the absolute 
stereochemistry of 21a-1 and 21a-2 is tentative; see Experimental Section Chapter 6.4.1. 
[b]
 Determined by 
1
H 
NMR analysis of the crude mixture. 
[c]
 Determined by HPLC analysis. ND = Not determined. 
[d] 
Conversion 
<20%. 
[e]
 Reaction in DMF; DMF: N,N-dimethylformamide. 
 
 Because the use of L-proline (I) with a base as the catalyst system in toluene gave the 
desired hetero-Diels-Alder product without the formation of the aldol product, L-proline (I) 
and proline derivative XXI were further screened with a series of organobases as catalyst 
systems to afford 21a (Table 4.1, entries 9-19). The er of 21a-2 was 91:9 when Et3N (XIII) 
or iPr2Et (XX) was used (Table 4.1, entries 9 and 10). When DABCO (XV) was used with L-
proline (I), hetero-Diels-Alder product 21a was obtained with dr 1:1.2 and with er 95:5 for 
the major diastereomer 21a-2 (Table 4.1, entry 11). The use of catalyst 4-substituted proline 
XXI with DABCO (XV) in the reaction afforded 21a with dr 1:1.9 and with er 97:3 for 21a-2 
(Table 4.1, entry 12). The reaction using less loading of XXI (0.1 equiv) with XV (0.2 equiv) 
gave essentially the same results as the reaction using XXI (0.2 equiv) and XV (0.2 equiv) 
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(Table 4.1, entry 13 versus entry 12). The major diastereomer (i.e., 21a-2) obtained under the 
catalysis by XXI-XV differed from that obtained under the catalysis by IX-X (Table 4.1, 
entries 12 and 13 versus entry 1).   
Table 4.2. Scope of the hetero-Diels-Alder reaction.
[a]
  
 
[a]
 Reaction conditions: Enone 20 (1.0 mmol) and aryl trifluoromethyl ketone 10 (0.2 mmol) in the presence of 
proline derivative XXI (0.02 mmol) and DABCO (XV, 0.04 mmol) in toluene (0.4 mL) at 25 °C. The isolated 
yields of 21 (combined for both the diastereomers) are shown except where noted. The dr was determined by 
1
H 
NMR analysis before purification. The er of the major diastereomer was determined by HPLC analysis. The ratio 
21:22 (4 = aldol product) was determined by 
1
H NMR analysis before purification: >95:5 for the formation of 
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21a-21h and 21j-21l; 95:5 for the formation of 21i. 
[b]
 Ketone 10 was not consumed.
 [c] 
Data of 1 mmol-scale 
reaction; isolated yield of the major isomer, the dr of the major diastereomer after purification.  
 
 Next, using the best catalyst system identified [i.e., XXI (0.1 equiv)-XV (0.2 equiv), 
Table 4.1, entries 13], reactions of various enones and aryl trifluoromethyl ketones were 
performed (Table 4.2). In all cases, trifluoromethyl-substituted tetrahydropyranones were 
obtained with high enantioselectivities for the major diastereomer products, and 
tetrasubstituted carbon centers were concisely constructed (Table 4.2). The reactions of 
phenyl trifluoromethyl ketones bearing electron-withdrawing substituents on the phenyl group 
(such as the formation of 21d) were faster than the reactions of those bearing electron-
donating groups (such as the formation of 21f). In all cases shown in Table 4.2, the formation 
of the aldol product was negligible (3:4 were >95:5 or 95:5). 
 The catalyst system was useful for the reactions of -alkyl substituted enones and also 
-aryl substituted enones to afford the hetero-Diels-Alder reaction products with high 
enantioselectivities for the major product diastereomers. This is significant because 
previously reported conditions for the hetero-Diels-Alder reactions of -alkyl substituted 
enones often do not work for the -aryl substituted enones.53,54,55,124  
Further, the reaction using the XXI-XV catalyst system was easily scaled up: a 1.0 mmol-
reaction to form 21j gave the major isomer, 21j-2, as a single diastereomer (purity >95% after 
flash column chromatography) in 61% yield with er 92:8.  
 When a mixture of 21a and 22a (racemic, 21a/22a = 2.5:1, 21a-1:21a-2 = 3:1) was 
treated under the hetero-Diels-Alder reaction conditions with the XXI-XV catalyst system, no 
decomposition of the compounds and no changes in the ratios were detected. This indicates 
that product 21a is stable under the XXI-XV catalyst system and that aldol 22a is not 
converted to 21a in the presence of this catalyst system. Thus, the formation of 21a under the 
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XXI-XV catalyst system is likely a kinetically controlled [4+2] cycloaddition reaction of in 
situ-generated enamine of enone 20a with ketone 10b.  
 To demonstrate the use of the hetero-Diels-Alder reactions, the product 
tetrahydropyranones were transformed into tetrahydropyran derivatives (Scheme 4.3). Oxime 
formation, allylation, and reductive amination gave the corresponding products 23-26. 
Although for most cases, the hetero-Diels-Alder reactions afforded tetrahydropyranones 21 as 
diastereomer mixtures which are difficult to be separated by silica gel column, 
tetrahydropyran derivatives were obtained as a single diastereomer with high 
enantioselectivity (25-1 and 26) via reductive amination of the corresponding 
tetrahydropyranones.  
 
Scheme 4.3. Transformation of the hetero-Diels-Alder products. 
 
Chapter 5                                                                                                                                                               64   
 
 
Chapter 5 
Summary and Conclusions 
 
 In Chapter 2.2.1, the development of an efficient method for concise aldol reactions 
of a pyruvic aldehyde derivative with various isatins catalyzed by DBU is described. The 
reactions were fast to provide the desired aldol products with tetrasubstituted carbon centers 
under mild conditions; reactions for only 15 to 30 min gave the aldol products in good to high 
yields. 
 In Chapter 2.2.2, the development of a concise method to synthesize furanose 
spirooxindoles via the DBU-catalyzed aldol reaction of a pyruvic aldehyde derivative with 
isatins is described. The furanose spirooxindoles were obtained in good to high yields from 
the aldol products through the reaction sequence with reduction followed by the acidic 
treatment. The furanose spirooxindoles synthesized by this method will likely be useful to aid 
the search for biofunctional molecules. 
 In Chapter 2.3.1, the developement of DBU-catalyzed aldol and vinylogous aldol 
reactions of ketone donors with aryl trifluoromethyl ketones is described. The reactions were 
concise, fast, and practical, to give aldol products bearing tetrasubstituted carbon centers with 
trifluoromethyl-substituted alcohols under neat, mild conditions. In the reactions, the C-C 
bond formation occurred regioselectively at the methyl group of alkyl methyl ketones, at the 
γ-position of -keto esters, and at the methyl group of -methyl-substituted cyclic enones to 
give the products, respectively. The DBU catalysis methods described here efficiently 
provided products including those that were previously difficult to synthesize, that were 
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synthesized only in slow reactions, and/or that required preactivation/protection and 
deprotection steps. The DBU catalysis methods are complementary to other methods 
including organocatalytic methods, such as amine-based organocatalysis methods involving 
formation of enamines in situ, and Mukaiyama aldol methods. 
 In Chapter 2.3.2, resolution of the aldol products derived from -keto esters is 
described. Resolution of the aldol products was concisely achieved via the formation of stable 
enamines of the -keto ester groups with a homochiral amine. The enantiomerically pure 
forms of the aldol products, 5-aryl-5-trifluoromethyl-5-hydroxyl-3-oxo-pentanoate derivatives 
were concisely obtained. These enantiomerically pure forms of the compounds may be used 
for chiral resolution of amines that form stable enamines. These homochiral trifluoromethyl-
substituted tertiary alcohols may also be useful for the synthesis of functional molecules and 
as chiral building blocks.  
 In Chapter 3, deuteration studies of enolizable ketone under aldol reaction catalysis 
conditions are described. The initial deuteration rates of various ketone donors under DBU-, 
proline-, and β-proline-catalysis were compared. The deuteration results indicate that 
formation of the carbanion is necessary to be the reaction sites. The results also indicate that 
the aldol reaction sites and the aldol reaction rates largely depend on the transion states to lead 
the products, not just on the easiness of the formation of the carbanion.  
 In Chapter 4, the development of an organocatalytic enantioselective oxa-hetero-
Diels-Alder reaction of enones with aryl trifluoromethyl ketones that afforded 
trifluoromethyl-substituted tetrahydropyranones is described. With the novel amine-based 
catalyst systems, tetrasubstituted carbon centers bearing a trifluoromethyl group were 
concisely constructed with the formation of the tetrahydropyranone ring. The hetero-Diels-
Alder products were further transformed to various trifluoromethyl-substituted 
tetrahydropyran derivatives. The trifluoromethyl-substituted tetrahydropyranones and 
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tetrahydropyran derivatives that can be synthesized by the methods described here may be 
useful in the search for biofunctional molecules. 
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Chapter 6 
Experimental Section  
 
6.1 General Methods 
 For thin layer chromatography (TLC), Merck silica gel 60 F254 aluminum sheets were 
used. Flash column chromatography was performed using Merck silica gel 60 (230-400 mesh) 
or Yamazen flash column (60 Å, 40 µm). 
1
H NMR and 
13
C NMR were recorded on a Bruker 
Advance 400. Proton chemical shifts are reported in ppm downfield from tetramethylsilane or 
from the residual solvent as internal standard in CDCl3 (δ 7.26 ppm), in CD3OD (δ 3.31 ppm) 
and in (CD3)2SO (2.50 ppm). Carbon chemical shifts were internally referenced to the 
deuterated solvent signals in CDCl3 (δ 77.0 ppm), in CD3OD (δ 49.0 ppm) and in (CD3)2SO 
(39.5 ppm). High-resolution mass spectra were recorded on a Thermo Scientific LTQ 
Orbitrap ESI ion trap mass spectrometer. Enantiomeric excesses were determined by chiral-
phase HPLC using a Hitachi instrument. Optical rotations were measured on a Jasco P2200 
polarimeter.  
 
 
6.2 Experimental Section for Chapter 2 
6.2.1Experimental Section for Chapter 2.2 
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DBU Catalyzed Aldol Reactions of 1 with 6   
 
 General Procedure for the DBU-Catalyzed Aldol Reactions (Table 2.1 entries 7 
and 8, Table 2.2). To a mixture of 1 (5.0 mmol) and 6 (0.5 mmol) in toluene (1.0 mL) was 
added DBU (0.05 mmol or 0.1 mmol as indicated) and the mixture was stirred at at rt (25 °C) 
until 6 was consumed (monitored by TLC). EtOAc and saturated NH4Cl solution were added 
to the mixture, and the mixture was extracted with EtOAc. Organic layers were combined, 
washed with brine, dried over MgSO4, concentrated in vacuo, and purified by silica gel flash 
column chromatography (hexane/EtOAc = 1:1 or 1:2) to give 7. 
3-(3,3-Dimethoxy-2-oxopropyl)-3-hydroxyindolin-2-one (7a)
75 
 
1
H NMR (400 MHz, CDCl3): δ = 3.12 (d, J = 17.6 Hz, 1H, CHHC=O), 3.31 (s, 3H, OCH3), 
3.35 (s, 3H, OCH3), 3.45 (d, J = 17.6 Hz, 1H, CHHC=O), 4.39 (s, 1H, CH(OMe)2), 6.87 (d, J 
= 7.6 Hz, 1H, ArH), 7.01 (dt, J = 0.8 Hz, 7.6 Hz, 1H, ArH), 7.22 (dt, J = 0.8 Hz, 7.6 Hz, 1H, 
ArH), 7.33 (d, J = 7.6 Hz, 1H, ArH), 8.58 (brs, 1 H, NH) ppm. 
4-Chloro-3-(3,3-dimethoxy-2-oxopropyl)-3-hydroxyindolin-2-one (7b) 
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1
H NMR (400 MHz, CD3OD): δ = 3.28 (s, 3H, OCH3), 3.32 (s, 3H, OCH3), 3.36 (d, J = 18.8 
Hz, 1H, CHHC=O), 4.07 (d, J = 18.8 Hz, 1H, CHHC=O), 4.41 (s, 1H, CH(OMe)2), 6.82 (dd, 
J = 0.8 Hz, 7.6 Hz, 1H, ArH), 6.91 (dd, J = 0.8 Hz, 8.0 Hz 1H, ArH), 7.20 (dd, J = 7.6 Hz, 8.0 
Hz, 1H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 42.9, 53.6, 53.6, 73.8, 103.3, 108.6, 
110.2, 122.8, 126.8, 130.7, 144.6, 178.7, 202.4 ppm; HRMS (ESI): calcd. for C13H15NO5Cl 
([M + H]
+
)
 
300.0633, found 300.0632.  
4-Bromo-3-(3,3-dimethoxy-2-oxopropyl)-3-hydroxyindolin-2-one (7c) 
 
1
H NMR (400 MHz, CD3OD): δ = 3.29 (s, 3H, OCH3), 3.32 (d, J = 18.4 Hz, 1H, CHHC=O), 
3.33 (s, 3H, OCH3), 4.17 (d, J = 18.4 Hz, 1H, CHHC=O), 4.42 (s, 1H, CH(OMe)2), 6.87 (dd, 
J = 1.2 Hz, 7.6 Hz, 1H, ArH), 7.07-7.15 (m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ 
= 42.8, 53.58, 53.64, 74.5, 103.3, 109.1, 118.7, 126.0, 128.5, 130.9, 144.9, 178.8, 202.4 ppm; 
HRMS (ESI): calcd. for C13H15NO5Br ([M + H]
+
) 344.0128, found 344.0138. 
6-Chloro-3-(3,3-dimethoxy-2-oxopropyl)-3-hydroxyindolin-2-one (7d) 
 
1
H NMR (400 MHz, CD3OD): δ = 3.25 (d, J = 18.0 Hz, 1H, CHHC=O), 3.27 (s, 3H, OCH3), 
3.32 (s, 3H, OCH3), 3.54 (d, J = 18.0 Hz, 1H, CHHC=O), 4.40 (s, 1H, CH(OMe)2), 6.90 (d, J 
= 2.0 Hz, 1H, ArH), 6.98 (dd, J = 2.0 Hz, 8.0 Hz, 1H, ArH), 7.24 (d, J = 8.0 Hz, 1H, ArH) 
ppm; 
13
C NMR (100 MHz, CD3OD): δ = 44.3, 53.7, 53.8, 72.6, 103.5, 110.2, 121.7, 124.7, 
129.4, 134.8, 143.9, 179.4, 202.1 ppm; HRMS (ESI): calcd. for C13H15NO5Cl ([M + H]
+
) 
300.0633, found 300.0631. 
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5-Bromo-3-(3,3-dimethoxy-2-oxopropyl)-3-hydroxyindolin-2-one (7e)
75
 
 
1
H NMR (400 MHz, CD3OD): δ = 3.24 (d, J = 18.0 Hz, 1H, CHHC=O), 3.28 (s, 3H, OCH3), 
3.33 (s, 3H, OCH3), 3.54 (d, J = 18.0 Hz, 1H, CHHC=O), 4.40 (s, 1H, CH(OMe)2), 6.81 (d, J 
= 8.4 Hz, 1H, ArH), 7.38 (dd, J = 2.0 Hz, 8.4 Hz, 1H, ArH), 7.43 (d, J = 2.0 Hz, 1H, ArH) 
ppm; 
13
C NMR (100 MHz, CD3OD): δ = 44.3, 53.7, 53.8, 73.1, 103.5, 111.5, 114.2, 126.8, 
132.1, 133.1, 141.7, 179.0, 202.0 ppm; HRMS (ESI): calcd. for C13H15NO5Br ([M + H]
+
) 
344.0128, found 344.0125.  
3-(3,3-Dimethoxy-2-oxopropyl)-3-hydroxy-5-methylindolin-2-one (7f) 
 
1
H NMR (400 MHz, CD3OD): δ = 2.27 (s, 3H, ArCH3), 3.20 (d, J = 17.6 Hz, 1H, CHHC=O), 
3.25 (s, 3H, OCH3), 3.31 (s, 3H, OCH3), 3.53 (d, J = 17.6 Hz, 1H, CHHC=O), 4.38 (s, 1H, 
CH(OMe)2), 6.76 (d, J = 8.0 Hz, 1H, ArH), 7.02-7.05 (m, 1H, ArH), 7.12 (d, J = 0.8 Hz, 1H, 
ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 21.1, 45.8, 55.0, 55.1, 74.6, 104.8, 111.0, 
125.6, 131.0, 132.1, 133.0, 141.2, 181.0, 203.4 ppm; HRMS (ESI): calcd. for C14H18NO5 ([M 
+ H]
+
) 280.1179, found 280.1191. 
3-(3,3-Dimethoxy-2-oxopropyl)-3-hydroxy-5-methoxyindolin-2-one (7g) 
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1
H NMR (400 MHz, CD3OD): δ = 3.21 (d, J = 17.8 Hz, 1H, CHHC=O), 3.28 (s, 3H, 
CHOCH3), 3.32 (s, 3H, CHOCH3), 3.54 (d, J = 17.8 Hz, 1H, CHHC=O), 3.74 (s, 3H, 
ArOCH3), 4.40 (s, 1H, CH(OMe)2), 6.79-6.80 (m, 2H, ArH), 6.94 (t, J = 1.6 Hz, H, ArH) ppm. 
13
C NMR (100 MHz, CD3OD): δ = 44.4, 53.6, 53.7, 54.9, 73.6, 103.5, 110.3, 110.6, 114.0, 
131.9, 135.5, 156.0, 179.6, 202.0 ppm; HRMS (ESI): calcd. for C14H18NO6 ([M + H]
+
) 
296.1129, found 296.1142. 
3-(3,3-Dimethoxy-2-oxopropyl)-3-hydroxy-5-nitroindolin-2-one (7h)
75
 
 
1
H NMR (400 MHz, CD3OD): δ = 3.28 (s, 3H, OCH3), 3.34 (s, 3H, OCH3), 3.34 (d, J = 18.4 
Hz, 1H, CHHC=O), 3.65 (d, J = 18.4 Hz, 1H, CHHC=O), 4.41 (s, 1H, CH(OMe)2), 7.04 (d, J 
= 8.8 Hz, 1H, ArH), 8.19-8.24 (m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 45.8, 
55.1, 55.3, 73.9, 104.3, 111.0, 120.8, 127.7, 133.3, 144.5, 150.3, 180.9, 203.6 ppm; HRMS 
(ESI): calcd. for C13H15N2O7 ([M + H]
+
) 311.0874, found 311.0880. 
 
Reduction of Aldol Product 7a 
 
 Reduction of 7a Using NaBH4. To a solution of aldol product 7a (42.8 mg, 0.16 
mmol) in MeOH (1.0 mL) was added NaBH4 (12.2 mg, 0.32 mmol) at 0 °C. The mixture was 
stirred at the same temperature for 1 h (consumption of 7a was analyzed by TLC). Acetic acid 
(40 μL, 0.70 mmol) was added to the mixture and the solvent was removed in vacuo. The 
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residue was purified by flash column chromatography (hexane/EtOAc = 1:2 to EtOAc) to 
give 8a (28.6 mg, 66%, dr 1.6:1). 
 Reduction of 7a Using NaBH(OAc)3. To a solution of aldol product 7a (52.3 mg, 
0.20 mmol) in CH2Cl2 (1.0 mL) was added NaBH(OAc)3 (83.5 mg, 0.39 mmol) at -10 °C. 
The mixture was stirred at the same temperature for 18 h (consumption of 7a was analyzed by 
TLC). Acetic acid (40 μL, 0.70 mmol) was added to the mixture and the solvent was removed 
in vacuo. The residue was purified by flash column chromatography (hexane/EtOAc = 1:2 to 
EtOAc) to give 8a (72.7 mg, 72 %, dr 20:1).  
 The major diastereomer of 8a obtained by the reduction using NaBH(OAc)3 was the 
same as the major diastereomer of 8a obtained by the reduction using NaBH4. The relative 
stereochemistry of the major diastereomer of 8 was deduced from 9a. The relative 
stereochemistry of 9a was determined by the coupling constants in 
1
H NMR and by NOESY 
experiments (see Table 6.1 and Figure 6.1).  
3-Hydroxy-3-(2-hydroxy-3,3-dimethoxypropyl)indolin-2-one (8a) 
 
Compound 8a (dr 1.6:1). 
1
H NMR (400 MHz, CD3OD): δ =1.88 (dd, J = 9.3 Hz, 14.5 Hz, 
1H x 1.6/2.6, CHHCH(OH)), 1.98 (dd, J = 2.9 Hz, 14.5 Hz, 1H x 1.6/2.6, CHHCH(OH)), 
2.01-2.11 (m, 2H x 1.0/2.6, CH2CH(OH)), 3.24 (s, 3H x 1.0/2.6, OCH3), 3.25 (s, 3H x 1.0/2.6, 
OCH3), 3.26 (s, 3H x 1.6/2.6, OCH3), 3.30 (s, 3H x 1.6/2.6, OCH3), 3.39 (m, 1H x 1.0/2.6, 
CH(OH)), 3.87 (m, 1H x 1.6/2.6, CH(OH)), 3.94 (s, J = 5.4 Hz, 1H x 1.0/2.6, CH(OMe)2), 
4.02 (s, J = 5.4 Hz, 1H x 1.6/2.6, CH(OMe)2), 6.77-6.80 (m, 1H, ArH), 6.92-6.97 (m, 1H, 
ArH), 7.12-7.17 (m, 1H, ArH), 7.21 (d, J = 7.4 Hz, 1H x 1.0/2.6, ArH), 7.28 (dd, J = 0.6 Hz, 
7.4 Hz, 1H x 1.6/2.6, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 38.3, 38.6, 54.0, 54.2, 
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54.3, 54.4, 67.7, 67.8, 75.3, 75.7, 106.9, 107.2, 109.8, 109.9, 122.0, 122.3, 123.9, 124.1, 129.1, 
129.2, 131.0, 132.0, 141.0, 141.8, 180.7, 180.9 ppm. 
Compound 8a (major diastereomer). 
1
H NMR (400 MHz, CD3OD): δ =1.88 (dd, J = 9.3 Hz, 
14.5 Hz, 1H, CHHCH(OH)), 1.98 (dd, J = 2.9 Hz, 14.5 Hz, 1H, CHHCH(OH)), 3.26 (s, 3H, 
OCH3), 3.30 (s, 3H, OCH3), 3.87 (m, 1H, CH(OH)), 4.02 (d, J = 5.4 Hz, 1H, CH(OMe)2), 
6.78 (d, J = 7.6 Hz, 1H, ArH), 6.95 (m, 1H, ArH), 7.15 (m, 1H, ArH), 7.28 (dd, J = 0.6 Hz, 
7.6 Hz, 1H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 38.3, 54.0, 54.4, 67.8, 75.7, 106.9, 
109.9, 122.3, 124.1, 129.1, 132.0, 140.9, 180.7 ppm; HRMS (ESI): calcd. for C13H17NO5 ([M 
+ Na]
+
) 290.0999, found 290.0998.  
 
Synthesis of Furanose Spirooxindoles 9 from Aldol Product 7 
 
 General Procedure for the Synthesis of 9 from 7 (Scheme 2.6). To a solution of 
aldol product 7 (0.20 mmol) in CH2Cl2 (1.0 mL) was added NaBH(OAc)3 (0.40 mmol) at -
10 °C. The mixture was stirred at the same temperature for 18 h (consumption of 7 was 
analyzed by TLC). The mixture was added to 3 M HCl in MeOH (1.5 mL) dropwise at 0 °C, 
stirred at rt (25 °C) for 30 min, and purified by flash column chromatography (hexane/EtOAc 
= 1:1 or 1:2) to give 9. The diastereomers of 9 generated at the acetal carbon were purified 
separately or purified as a mixture. For 9a, 9c, 9d, and 9f, the diastereomer with a larger Rf 
value on TLC is named 9a-1, 9c-1, 9d-1, and 9f-1, and the diastereomer with a smaller Rf 
value on the same TLC is named 9a-2, 9c-2, 9d-2, and 9f-2, respectively.  
 Isomers 9a-1, 9d-1, and 9f-1 were assigned to be OMe/OH trans and isomers 9a-2, 
9d-2, and 9f-2 were assigned to be OMe/OH cis based on the coupling constants (J values) in 
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the 
1
H NMR (see Table 6.1 on page 81). The relative stereochemistry of 9a was determined 
by the coupling constants in 
1
H NMR and by NOESY experiments (see Table 6.1 and Figure 
6.1).  
 Synthesis of 9a from 8a (Scheme 2.4). To a solution of 8a (50.4 mg, 0.19 mmol) in 
MeOH (1.0 mL), 3 M HCl solution in MeOH (1.5 mL) was added at 0 °C. The mixture was 
stirred at rt (25 °C) for 30 min and purified by flash column chromatography (hexane/EtOAc 
= 1:1 to 1:2) to give 9a (44.2 mg, 87%, dr 1:1). 
4-Hydroxy-5-methoxy-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9a) 
 
Compound 9a-1. Rf = 0.48 (TLC hexane/EtOAc = 1:2); 
1
H NMR (400 MHz, CDCl3): δ = 
2.14 (dd, J = 0.4 Hz, 13.6 Hz, 1H, CHHCH(OH)), 2.74 (dd, J = 4.8 Hz, 13.6 Hz, 1H, 
CHHCH(OH)), 3.43 (s, 3 H, OCH3), 4.59 (dd, J = 0.4 Hz, 4.8 Hz, 1H, CH(OH)), 5.19 (s, 1H, 
CH(OMe)), 6.82 (d, J = 7.6 Hz, 1H, ArH), 7.02 (dt, J = 1.2 Hz, 7.6 Hz, 1H, ArH), 7.20 (dt, J 
= 1.2 Hz, 7.6 Hz, 1H, ArH), 7.64 (dd, J = 1.2 Hz, 7.6 Hz, 1H, ArH), 8.53 (brs, 1H, NH) ppm; 
1
H NMR (400 MHz, CDCl3/CD3OD = 1:1): δ = 1.77 (dd, J = 0.4 Hz, 13.6 Hz, 1H, 
CHHCH(OH)), 2.33 (dd, J = 4.8 Hz, 13.6 Hz, 1H, CHHCH(OH)), 3.09 (s, 3H, OCH3), 4.13 
(dd, J = 0.4 Hz, 4.8 Hz, 1H, CH(OH)), 4.81 (s, 1H, CH(OMe)), 6.51 (d, J = 7.8 Hz, 1H, ArH), 
6.69 (dt, J = 0.8 Hz, 7.6 Hz, 1H, ArH), 6.89 (dt, J = 1.2 Hz, 7.6 Hz, 1H, ArH), 7.34 (dd, J = 
0.8 Hz, 7.6 Hz, 1H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 40.1, 53.7, 75.4, 84.0, 109.0, 
110.2, 122.3, 125.2, 128.7, 129.7, 139.5, 177.7 ppm; HRMS (ESI): calcd. for C12H14NO4 ([M 
+ H]
+
) 236.0917, found 236.0908.  
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Compound 9a-2. Rf = 0.46 (TLC hexane/EtOAc = 1:2); 
1
H NMR (400 MHz, CDCl3): δ = 
2.18 (dd, J = 10.0 Hz, 12.8 Hz, 1H, CHHCH(OH)), 2.55 (d, J = 10.0 Hz, 1H, OH), 2.61 (dd, J 
= 7.6 Hz, 12.8 Hz, 1H, CHHCH(OH)), 3.56 (s, 3H, OCH3), 4.79 (m, 1H, CH(OH)), 5.12 (d, J 
= 4.4 Hz, 1H, CH(OMe)), 6.85 (d, J = 7.7 Hz, 1H, ArH), 7.08 (m, 1H, ArH), 7.25 (m, 1H, 
ArH), 7.33 (d, J = 7.4 Hz, 1H, ArH), 8.36 (brs, 1H, NH) ppm; 
1
H NMR (400 MHz, 
CDCl3/CD3OD = 1:1): δ = 2.08 (dd, J = 10.4 Hz, 12.5 Hz, 1H, CHHCH(OH)), 2.34 (dd, J = 
7.8 Hz, 12.5 Hz, 1H, CHHCH(OH)), 3.38 (s, 3H, OCH3), 4.55 (ddd, 1H, J = 4.4 Hz, 7.8 Hz, 
10.4 Hz, CH(OH)), 4.89 (d, J = 4.4 Hz, 1H, CH(OMe)), 6.68 (d, J = 7.8 Hz, 1H, ArH), 6.90 
(m, 1H, ArH), 7.08 (dt, J = 1.2 Hz, 7.8 Hz, 1H, ArH), 7.17 (d, J = 7.8 Hz, 1H, ArH) ppm; 
13
C 
NMR (100 MHz, CDCl3): δ = 39.7, 54.6, 71.0, 81.3, 102.1, 109.2, 122.5, 123.9, 129.0, 129.2, 
139.7, 177.7 ppm; HRMS (ESI): calcd. for C12H14NO4 ([M + H]
+
) 236.0917, found 236.0909.  
4'-Chloro-4-hydroxy-5-methoxy-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9b) 
 
Compound 9b (major diastereomer). Rf = 0.50 (TLC hexane/EtOAc = 1:2); 
1
H NMR (400 
MHz, CDCl3): δ = 2.38 (dd, J = 7.4 Hz, 12.4 Hz, 1H, CHHCH(OH)), 2.70 (d, J = 10.4 Hz, 1H, 
OH), 2.76 (dd, J = 10.4 Hz, 12.4 Hz, 1H, CHHCH(OH)), 3.55 (s, 3H, OCH3), 5.06 (m, 1H, 
CH(OH)), 5.17 (d, J = 5.2 Hz, 1H, CH(OMe)), 6.76 (dd, J = 0.8 Hz, 7.8 Hz, 1H, ArH), 7.00 
(dd, J = 0.8 Hz, 8.2 Hz, 1H, ArH), 7.20 (t, J = 8.0 Hz, 1H, ArH), 8.45 (brs, 1H, NH) ppm; 
1
H 
NMR (400 MHz, CDCl3/CD3OD = 1:1): δ = 2.15 (dd, J = 7.2 Hz, 12.0 Hz, 1H, 
CHHCH(OH)), 2.77 (dd, J = 11.2 Hz, 12.0 Hz, 1H, CHHCH(OH)), 3.41 (s, 3H, CH3), 4.91 
(ddd, J = 5.2 Hz, 7.2 Hz, 11.2 Hz, 1H, CH(OH)), 4.99 (d, J = 5.2 Hz, 1H, CH(OMe)), 6.69 
(dd, J = 0.8 Hz, 7.8 Hz, 1H, ArH), 6.89 (dd, J = 0.8 Hz, 8.2 Hz, 1H, ArH), 7.13 (t, J = 8.0 Hz, 
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1H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 35.8, 54.4, 70.0, 81.6, 101.7, 107.7, 123.2, 
123.7, 130.4, 131.3, 141.7, 177.2 ppm; HRMS (ESI): calcd. for C12H13NO4Cl ([M + H]
+
) 
270.0528, found 270.0534.  
4'-Bromo-4-hydroxy-5-methoxy-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9c) 
 
Compound 9c-1 (major diastereomer). Rf = 0.50 (TLC hexane/EtOAc = 1:2); 
1
H NMR 
(400 MHz, CDCl3): δ = 2.37 (dd, J = 7.2 Hz, 12.5 Hz, 1H, CHHCH(OH)), 2.71 (d, J = 10.4 
Hz, 1H, OH), 2.81 (dd, J = 10.6 Hz, 12.5 Hz, 1H, CHHCH(OH)), 3.59 (s, 3H, OCH3), 5.10 
(m, 1H, CH(OH)), 5.20 (d, J = 5.2 Hz, 1H, CH(OMe)), 6.79 (dd, J = 0.8 Hz, 7.6 Hz, 1H, 
ArH), 7.13 (t, J = 8.0 Hz, 1H, ArH), 7.20 (dd, J = 0.8 Hz, 8.0 Hz, 1H, ArH), 8.15 (brs, 1H, 
NH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 35.8, 54.7, 69.8, 82.4, 101.8, 108.3, 119.3, 124.4, 
126.9, 130.5, 141.9, 177.3 ppm; HRMS (ESI): calcd. for C12H13NO4Br ([M + H]
+
) 314.0022; 
found 314.0030. 
Compound 9c-2 (minor diastereomer). Rf = 0.48 (TLC hexane/EtOAc = 1:2); 
1
H NMR 
(400 MHz, CDCl3): δ = 2.33 (m, 1H, OH), 2.44 (dd, J = 7.6 Hz, 13.2 Hz, 1H, CHHCH(OH)), 
2.76 (dd, J = 8.8 Hz, 13.2 Hz, 1H, CHHCH(OH)), 3.46 (s, 3H, OCH3), 4.78 (m, 1H, CH(OH)), 
5.27 (d, J = 4.4 Hz, 1H, CH(OMe)), 6.72 (m, 1H, ArH), 7.07 (t, J = 7.8 Hz, 1H, ArH), 7.14 
(m, 1H, ArH), 7.55 (brs, 1H, NH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 37.3, 55.9, 74.37, 
82.86, 108.27, 110.99, 118.87, 125.51, 126.41, 130.54, 141.57, 176.38 ppm; HRMS (ESI): 
calcd. for C12H13NO4Br ([M + H]
+
) 314.0022; found 314.0028. 
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6'-Chloro-4-hydroxy-5-methoxy-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9d) 
 
Compound 9d-1. Rf = 0.52 (TLC hexane/ethyl acetate = 1:2); 
1
H NMR (400 MHz, CD3OD): 
δ = 1.91 (d, J = 13.2 Hz, 1H, CHHCH(OH)2), 2.48 (dd, J = 4.8 Hz, 13.2 Hz, 1H, 
CHHCH(OH)), 3.26 (s, 3H, OCH3), 4.27 (d, J = 4.8 Hz, 1H, CH(OH)), 4.97 (s, 1H, 
CH(OMe)), 6.75 (d, J = 1.9 Hz, 1H, ArH), 6.89 (dd, J = 1.9 Hz, 8.0 Hz, 1H, ArH), 7.52 (d, J 
= 8.0 Hz, 1H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 42.1, 54.9, 76.9, 86.0, 111.2, 
112.6, 123.5, 128.9, 131.2, 136.1, 144.1, 180.4 ppm; HRMS (ESI): calcd. for C12H13NO4Cl 
([M + H]
+
) 270.0528, found 270.0519. 
Compound 9d-2. Rf = 0.50 (TLC hexane/ethyl acetate = 1:2); 
1
H NMR (400 MHz, CDCl3): δ 
= 2.14 (dd, J = 9.6 Hz, 12.8 Hz, 1H, CHHCH(OH)), 2.60 (dd, J = 7.7 Hz, 12.8 Hz, 1H, 
CHHCH(OH)), 3.55 (s, 3H, OCH3), 4.76 (m, 1H, CH(OH)), 5.11 (d, J = 4.4 Hz, 1H, 
CH(OMe)), 6.87 (d, J = 1.6 Hz, 1H, ArH), 7.06 (dd, J = 1.6 Hz, 8.0 Hz, 1H, ArH), 7.25 (d, J 
= 8.0 Hz, 1H, ArH), 8.12 (brs, 1H, NH) ppm; 
1
H NMR (400 MHz, CDCl3/CD3OD = 1:1): δ = 
2.14 (dd, J = 10.4 Hz, 12.6 Hz, 1H, CHHCH(OH)), 2.39 (dd, J = 7.8 Hz, 12.6 Hz, 1H, 
CHHCH(OH)), 3.44 (s, 3H, OCH3), 4.60 (m, 1H, CH(OH)), 4.94 (d, J = 4.4 Hz, 1H, 
CH(OMe)), 6.77 (d, J = 1.6 Hz, 1H, ArH), 6.95 (dd, J = 1.6 Hz, 8.0 Hz, 1H, ArH), 7.18 (d, J 
= 8.0 Hz, 1H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 39.6, 54.8, 71.0, 80.8, 102.3, 
109.9, 122.5, 125.0, 127.6, 134.6, 140.8, 177.5 ppm; HRMS (ESI): calcd. for C12H13NO4Cl 
([M + H]
+
) 270.0528; found 270.0518. 
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5'-Bromo-4-hydroxy-5-methoxy-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9e) 
 
Compound 9e (dr 1.2:1). Rf = 0.54 (TLC hexane/EtOAc = 1:2); 
1
H NMR (400 MHz, 
CDCl3): δ = 2.10-2.18 (m, 1H, CHHCH(OH)), 2.58 (dd, J = 7.6 Hz, 12.8 Hz, 1H x 1.0/2.2, 
CHHCH(OH)), 2.69 (dd, J = 4.8 Hz, 13.6 Hz, 1H x 1.2/2.2, CHHCH(OH)), 3.40 (s, 3H x 
1.2/2.2, OCH3), 3.55 (s, 3H x 1.0/2.2, OCH3), 4.54 (d, J = 4.4 Hz, 1H x 1.2/2.2, CH(OH)), 
4.73 (m, 1H x 1.0/2.2, CH(OH)), 5.10 (d, J = 4.4 Hz, 1H x 1.0/2.2, CH(OMe)), 5.16 (s, 1H x 
1.2/2.2, CH(OMe)), 6.72-6.76 (m, 1H, ArH), 7.29-7.35 (m, 1H, ArH), 7.41 (d, J = 2.0 Hz, 1H 
x 1.0/2.2, ArH), 7.78 (d, J = 2.0 Hz, 1H x 1.2/2.2, ArH), 9.08-9.10 (1H, NH) ppm; 
1
H NMR 
(400 MHz, CD3OD): δ = 2.02 (d, J = 13.6 Hz, 1H x 1.2/2.2, CHHCH(OH)), 2.20 (dd, J = 10.4 
Hz, 12.8 Hz, 1H x 1.0/2.2, CHHCH(OH)), 2.45 (dd, J = 8.0 Hz, 12.8 Hz, 1H x 1.0/2.2, 
CHHCH(OH)), 2.58 (dd, J = 4.4 Hz, 13.6 Hz, 1H x 1.2/2.2, CHHCH(OH)), 3.36 (s, 3H x 
1.2/2.2, OCH3), 3.51 (s, 3H x 1.0/2.2, OCH3), 4.38 (d, J = 4.4 Hz, 1H x 1.2/2.2, CH(OH)), 
4.62 (m, 1H x 1.0/2.2, CH(OH)), 5.00 (d, J = 4.4 Hz, 1H x 1.0/2.2, CH(OMe)), 5.09 (s, 1H x 
1.2/2.2, CH(OMe)), 6.75-6.79 (m, 1H, ArH), 7.33-7.40 (m, 1H, ArH), 7.44 (d, J = 2.0 Hz, 1H 
x 1.0/2.2, ArH), 7.80 (d, J = 2.0 Hz, 1H x 1.2/2.2, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): 
δ = 40.6, 42.1, 54.9, 55.9, 72.7, 76.9, 83.3, 86.3, 104.8, 105.1, 112.6, 113.0, 116.1, 116.3, 
129.1, 130.8, 133.4, 133.8, 134.3, 134.8, 141.8, 142.2, 179.9, 180.1 ppm. HRMS (ESI): calcd. 
for C12H13NO4Br ([M + H]
+
) 314.0022; found 314.0017. 
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4-Hydroxy-5-methoxy-5'-methyl-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9f) 
 
Compound 9f-1. Rf = 0.48 (TLC hexane/EtOAc = 1:2); 
1
H NMR (400 MHz, CDCl3): δ = 
2.13 (d, J = 13.6 Hz, 1H, CHHCH(OH)), 2.29 (s, 3H, ArCH3), 2.75 (dd, J = 5.2 Hz, 13.6 Hz, 
1H, CHHCH(OH)), 3.43 (s, 3H, OCH3), 4.59 (m, 1H, CH(OH)), 5.18 (s, 1H, CH(OMe)), 6.71 
(d, J = 7.8 Hz, 1H, ArH), 7.02 (m, 1H, ArH), 7.45 (m, 1H, ArH), 8.11 (brs, 1H, NH) ppm; 
13
C 
NMR (100 MHz, CDCl3): δ = 20.1 40.1, 53.7, 75.5, 84.0, 108.6, 110.1, 125.8, 129.0, 129.6, 
131.9, 1367.0, 177.6 ppm; HRMS (ESI): calcd. for C13H16NO4 ([M + H]
+
) 250.1074; found 
250.1078. 
Compound 9f-2. Rf = 0.46 (TLC hexane/EtOAc = 1:2); 
1
H NMR (400 MHz, CDCl3): δ = 
2.16 (dd, J = 9.9 Hz, 12.7 Hz, 1H, CHHCH(OH)), 2.33 (s, 3H, ArCH3), 2.59 (m, 1H, 
CHHCH(OH)), 3.57 (s, 3H, OCH3), 4.79 (m, 1H, CH(OH)), 5.12 (d, J = 4.5 Hz, 1H, 
CH(OMe)), 6.74 (d, J = 8.0 Hz, 1H, ArH), 7.05 (m, 1H, ArH), 7.13 (m, 1H, ArH), 8.26 (brs, 
1H, NH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 20.1, 39.7, 54.7, 71.0, 81.5, 102.1, 109.0, 
124.6, 129.1, 129.2, 132.0, 137.3, 178.0 ppm; HRMS (ESI): calcd. for C13H16NO4 ([M + H]
+
) 
250.1074; found 250.1079. 
4-Hydroxy-5,5'-dimethoxy-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9g) 
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Compound 9g (dr 1:1). Rf = 0.39 (TLC hexane/EtOAc = 1:2); 
1
H NMR (400 MHz, CDCl3): 
δ = 2.09-218 (m, 1H, CHHCH(OH)), 2.61 (dd, J = 7.6 Hz, 12.8 Hz, 1H x 1/2, CHHCH(OH)), 
2.75 (dd, J = 4.8 Hz, 13.6 Hz, 1H x 1/2, CHHCH(OH)), 3. 44 (s, 3H x 1/2, CHOCH3), 3.57 (s, 
3H x 1/2, CHOCH3), 3.76 (s, 3H x 1/2, ArOCH3), 3.80 (s, 3H x 1/2, ArOCH3), 4.58 (d, J = 
4.4 Hz, 1H x 1/2, CH(OH)), 4.78 (m, 1H x 1/2, CH(OH)), 5.11 (d, J = 4.4 Hz, 1H x 1/2, 
CH(OMe)), 5.18 (s, 1H x 1/2, CH(OMe)), 6.72-6.78 (m, 2H, ArH), 6.94 (d, J = 2.0 Hz, 1H x 
1/2, ArH), 7.31 (d, J = 2.0 Hz, 1H x 1/2, ArH), 8.15 (brs, 1H x 1/2, NH), 8.17 (brs, 1H x 1/2, 
NH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 40.8, 41.2, 54.7, 55.7, 55.8, 72.1, 76.5, 77.2, 
82.7, 85.3, 103.2, 110.4, 110.7, 111.2, 111.9, 113.0, 114.6, 114.8, 131.5, 131.9, 133.7, 133.9, 
156.4, 156.6, 178.5, 178.7 ppm; HRMS (ESI): C13H16NO5 ([M + H]
+
) calcd. for 266.1023, 
found 266.1028. 
When a solution of 9g (dr 1:1) in CDCl3 was kept at 25 °C for 5 days, the dr was changed to 
5:1; the minor diastereomer Rf = 0.4 and the major diastereomer Rf = 0.38 (TLC 
hexane/EtOAc = 1:2). The major diastereomer: 
1
H NMR (400 MHz, CDCl3): δ = 2.15 (dd, J = 
9.8 Hz, 12.6 Hz, 1H, CHHCH(OH)), 2.61 (dd, J = 7.8 Hz, 12.6 Hz, 1H CHHCH(OH)), 2.75 
(dd, J = 4.8 Hz, 13.6 Hz, 1H x 1/2, CHHCH(OH)), 3.57 (s, 3H, CHOCH3), 3.79 (s, 3H, 
ArOCH3), 4.78 (ddd, J = 4.4 Hz, 7.8 Hz, 9.8 Hz, 1H, CH(OH)), 5.11 (d, J = 4.4 Hz, 1H, 
CH(OMe)), 6.72-6.78 (m, 2H, ArH), 6.94 (d, J = 2.0 Hz, 1H, ArH), 8.18 (brs, 1H, NH) ppm. 
4-Hydroxy-5-methoxy-5'-nitro-4,5-dihydro-3H-spiro[furan-2,3'-indolin]-2'-one (9h)  
 
Compound 9h (dr 1:1). Rf = 0.52 (TLC hexane/EtOAc = 2:1); 
1
H NMR (400 MHz, CDCl3): 
δ = 2.16-2.26 (m, 1H, CHHCH(OH)), 2.65 (dd, J = 7.6 Hz, 12.8 Hz, 1H x 1/2, CHHCH(OH)), 
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2.76 (dd, J = 4.6 Hz, 13.6 Hz, 1H x 1/2, CHHCH(OH)), 3.43 (s, 3H x 1/2, OCH3), 3.60 (s, 3H 
x 1/2, OCH3), 4.60 (d, J = 4.6 Hz, 1H x 1/2, CH(OH)), 4.76 (m, 1H x 1/2, CH(OH)), 5.15 (d, 
J = 4.4 Hz, 1H x 1/2, CH(OMe)), 5.21 (s, 1H x 1/2, CH(OMe)), 6.97-7.02 (m, 2H, ArH), 
8.18-8.25 (m, 1H + 1H x 1/2, ArH), 8.59 (d, J = 2.3 Hz, 1H x 1/2, ArH), 8.89 (s, 1H x 1/2, 
NH), 8.92 (s, 1H x 1/2, NH) ppm. 
Compound 9h (dr 1.4:1). Rf = 0.52 (TLC hexane/EtOAc = 2:1); 
1
H NMR (400 MHz, 
CD3OD): δ = 2.08 (d, J = 13.6 Hz, 1H x 1.4/2.4, CHHCH(OH)), 2.26 (dd, J = 10.0 Hz, 12.8 
Hz, 1H x 1.0/2.4, CHHCH(OH)), 2.51 (dd, J = 7.6 Hz, 12.8 Hz, 1H x 1.0/2.4, CHHCH(OH)), 
2.61 (dd, J = 4.4 Hz, 13.6 Hz, 1H x 1.4/2.4, CHHCH(OH)), 3.37 (s, 3H x 1.4/2.4, OCH3), 
3.54 (s, 3H x 1.0/2.4, OCH3), 4.40 (d, J = 4.4 Hz, 1H x 1.4/2.4, CH(OH)), 4.63 (m, 1H x 
1.0/2.4, CH(OH)), 5.04 (d, J = 4.4 Hz, 1H x 1.0/2.4, CH(OMe)), 5.13 (s, 1H x 1.4/2.4, 
CH(OMe)), 6.96-7.01 (m, 1H, ArH), 8.15-8.22 (m, 2H x 1.0/2.4 + 1H x 1.4/2.4, ArH), 8.55 (d, 
J = 2.3 Hz, 1H x 1.4/2.4, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 40.5, 42.1, 54.9, 56.0, 
72.8, 76.8, 82.8, 85.7, 105.3, 110.9, 111.3, 112.7, 121.8, 123.7, 127.4, 127.8, 133.2, 133.5, 
144.8, 145.0, 148.9, 149.2, 180.4 ppm; HRMS (ESI): calcd. for C12H13N2O6 ([M + H]
+
) 
281.0768, found 281.0761. 
Table 6.1. Chemical shifts (ppm) and J values (Hz) of 9.  
Compound 
(solvent) 
CH(OMe) CH(OH) CH2  
Compound 
(solvent) 
CH 
(OMe) 
CH 
(OH) 
CH2  
9a-1 
(CDCl3) 
5.19 (s) 
4.59 
(dd, 
0.4, 
4.8) 
2.74 
(dd, 
4.8, 
13.6) 
2.14 
(dd, 
0.4, 
13.6) 
9a-2 
(CDCl3) 
5.12 (d, 
4.4) 
4.79 
(m) 
2.61 
(dd, 
7.6, 
12.8) 
2.18 
(dd, 
10.0, 
12.8) 
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9a-1 
(CDCl3-
CD3OD 
1:1) 
4.81 (s) 
4.13 
(dd, 
0.4, 
4.8) 
2.33 
(dd, 
4.8, 
13.6) 
1.77 
(dd, 
0.4, 
13.6) 
9a-2 
(CDCl3-
CD3OD 1:1) 
4.89 (d, 
4.4) 
4.55 
(ddd, 
4.4, 
7.8, 
10.4) 
2.34 
(dd, 
7.8, 
12.5) 
2.08 
(dd, 
10.4, 
12.5) 
9d-1 
(CD3OD) 
4.97 (s) 
4.27 (d, 
4.8) 
2.48 
(dd, 
4.8, 
13.2) 
1.91 
(d, 
13.2) 
9d-2 
(CDCl3-
CD3OD 1:1) 
4.94 (d, 
4.4) 
4.60 
(m) 
2.39 
(d, 
7.8, 
12.6) 
2.14 
(dd, 
10.4, 
12.6) 
9f-1 
(CDCl3) 
5.18 (s) 
4.59 
(m) 
2.75 
(dd, 
5.2, 
13.6) 
2.13 
(13.6) 
9f-2 (CDCl3) 
5.12 (d, 
4.5) 
4.79 
(m) 
2.59 
(m) 
2.16 
(dd, 
9.9, 
12.7) 
9c-1 
(CDCl3) 
5.20 (d, 
5.2) 
5.10 
(m) 
2.81 
(dd, 
10.6, 
12.5) 
2.37 
(dd, 
7.2, 
12.5) 
9c-2 
(CDCl3) 
5.27 (d, 
4.4) 
4.78 
(m) 
2.76 
(dd, 
8.8, 
13.2) 
2.44 
(dd, 
7.6, 
13.2) 
9b (CDCl3) 
5.17 (d, 
5.2) 
5.06 
(m) 
2.76 
(dd, 
10.4, 
12.4) 
2.38 
(dd, 
7.4, 
12.4) 
9b (CDCl3-
CD3OD 1:1) 
4.99 (d, 
5.2) 
4.91 
(ddd, 
5.2, 
7.2, 
11.2) 
2.77 
(dd, 
11.2, 
12.0) 
2.15 
(dd, 
7.2, 
12.0) 
 
 Isomers 9a-1, 9d-1, and 9f-1 were assigned to be OMe/OH trans and isomers 9a-2, 
9d-2, and 9f-2 were assigned to be OMe/OH cis based on the coupling constants (J values) in 
the 
1
H NMR. 
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Figure 6.1. NOE in NOESY experimetns and J values observed in 9a-1. 
 
 The ratio of the intensities of a pair of NOE signals within that spectrum can be 
assumed inversely proportional to their ratio of inter-proton distances to the 6
th
 power,127 i.e.  
rij = rref (aref/aij)
1/6 
where aij is the relative NOE intensity (integration of the area of the signal in NOESY 
specturm) and rij is the inter-proton distance of the two protons i and j. Given a known 
distance between two protons (rref) and its NOE volume (aref), rij can be calculated from its 
relative NOE intensity aij.  
 Based on this method, the proton distance between H4 and H10a was estimated as 
shown below. The proton distance of the geminal protons H10a-H10b was used as the 
reference to be 1.75 Å.127 Only F2-slices were usded to determine the NOE intensity.
127
 
 Relative NOE Intensity Proton distance 
H10a-H10b 55.89 (aref) 1.75 Å (rref) 
H4-H10a 1.72 (a4-10a) 3.13 Å (r4-10a) 
 
 
6.2.2 Experimental Section for Chapter 2.3 
DBU Catalyzed Aldol Reactions of Ketone Donors with 10 
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 General procedure for the DBU-catalyzed aldol reactions of ketone donors with 
10 to give 11 (Schemes 2.8 and Scheme 2.9). To a mixture of donor ketone (2.5 mmol) and 
10 (0.5 mmol) was added DBU (0.05 mmol), and the mixture was stirred at rt (25 °C) until 10 
was consumed (monitored by TLC). The reaction mixture was diluted with hexane-EtOAc 
and purified by silica gel flash column chromatography (hexane/EtOAc = 8:1 to 4:1) to give 
11. 
 A gram-scale reaction to give 11a. To a mixture of 1 (2.95 mL, 25.0 mmol) and 10a 
(702 L, 5.0 mmol) was added DBU (74.5 L, 0.5 mmol), and the mixture was stirred at rt 
(25 °C) for 1.5 h. The reaction mixture was diluted with hexane-EtOAc and purified by silica 
gel flash column chromatography (hexane/EtOAc = 8:1 to 4:1) to give 11a (1.38 g, 94%).  
5,5,5-Trifluoro-4-hydroxy-1,1-dimethoxy-4-phenylpentan-2-one (11a)
74
 
 
Synthesized by the general procedure, 1.5 h, 122.5 mg (84%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.29 (d, J = 17.8 Hz, 1H, CHHC=O), 3.30 (s, 
3H, CH3), 3.40 (s, 3H, OCH3), 3.67 (d, J = 17.8 Hz, 1H, CHHC=O), 4.29 (s, 1H, CH(OCH3)2), 
5.01 (s, 1H, OH), 7.33-7.40 (m, 3H, ArH), 7.59 (dd, J = 0.4 Hz, 7.5 Hz, 2H, ArH) ppm; 
13
C 
NMR (100 MHz, CDCl3): δ = 39.9, 55.21, 55.22, 76.0 (q, JC,F = 29 Hz), 104.4, 124.4 (q, JC,F 
= 283 Hz), 126.4, 128.3, 128.8, 137.1, 204.7 ppm; HRMS (ESI) calcd for C13H14O4F3 ([M – 
H]
–
) 291.0839, found 291.0843. 
4-(4-Chlorophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one (11b) 
 
Synthesized by the general procedure, 1.0 h, 155.0 mg (95%). 
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Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.28 (d, J = 17.8 Hz, 1H, CHHC=O), 3.33 (s, 
3H, OCH3), 3.42 (s, 3H, OCH3), 3.60 (d, J = 17.8 Hz, 1H, CHHC=O), 4.27 (s, 1H, 
CH(OCH3)2), 5.02 (s, 1H, OH), 7.33-7.37 (m, 2H, ArH), 7.52 (d, J = 8.5 Hz, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 39.6, 55.4, 55.5, 75.8 (q, JC,F = 30 Hz), 104.5, 124.2 (q, JC,F  
= 283 Hz), 128.0, 128.5, 135.0, 135.7, 204.5 ppm; HRMS (ESI) calcd for C13H13O4F3Cl ([M 
– H]–) 325.0449, found 329.0458.  
4-(4-Bromophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one (11c) 
 
Synthesized by the general procedure, 1.0 h, 159.4 mg (86%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.27 (d, J = 17.8 Hz, 1H, CHHC=O), 3.32 (s, 
3H, OCH3), 3.41 (s, 3H, OCH3), 3.60 (d, J = 17.8 Hz, 1H, CHHC=O), 4.27 (s, 1H, 
CH(OCH3)2), 5.03 (s, 1H, OH), 7.46 (d, J = 8.5 Hz, 2H, ArH), 7.49-7.52 (m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 39.5, 55.37, 55.42, 75.8 (q, JC,F = 29 Hz), 104.4, 123.2, 
124.1 (q, JC,F = 283 Hz), 128.3, 131.4, 136.3, 204.4 ppm; HRMS (ESI) calcd for 
C13H13O4F3Br ([M – H]
–
) 368.9944, found 368.9975.   
5,5,5-Trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-(trifluoromethyl)phenyl)pentan-2-one 
(11d) 
 
Synthesized by the general procedure, 1.0 h, 156.4 mg (87%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.32 (s, 3H, OCH3), 3.34 (d, J = 17.8 Hz, 1H, 
CHHC=O), 3.42 (s, 3H, OCH3), 3.64 (d, J = 17.8 Hz, 1H, CHHC=O), 4.28 (s, 1H, 
CH(OCH3)2), 5.12 (s, 1H, OH), 7.64 (d, J = 8.4 Hz, 2H, ArH), 7.73 (d, J = 8.4 Hz, 2H, ArH) 
Chapter 6                                                                                                                                                               86   
 
 
ppm; 
13
C NMR (100 MHz, CDCl3): δ = 39.6, 55.4, 55.5, 75.9 (q, JC,F = 29 Hz), 104.5, 123.9 
(q, JC,F = 271 Hz), 124.1 (q, JC,F = 283 Hz), 125.2 (q, JC,F = 4.0 Hz), 127.1, 131.0 (q, JC,F = 32 
Hz), 141.2, 204.4 ppm; HRMS (ESI) calcd for C14H13O4F6 ([M – H]
–
) 359.0713, found 
359.0716.  
5,5,5-Trifluoro-4-hydroxy-1,1-dimethoxy-4-(p-tolyl)pentan-2-one (11e) 
 
Synthesized by the general procedure, 1.5 h, 139.3 mg (91%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 2.34 (s, 3H, ArCH3) 3.27 (d, J = 17.8 Hz, 1H, 
CHHC=O), 3.32 (s, 3H, OCH3), 3.40 (s, 3H, OCH3) 3.66 (d, J = 17.8 Hz, 1H, CHHC=O), 
4.29 (s, 1H, CH(OCH3)2), 4.95 (s, 1H, OH), 7.19 (d, J = 8.0 Hz, 2H, ArH), 7.47 (d, J = 8.0 Hz, 
2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 20.9, 39.8, 55.15, 55.20, 75.9 (q, JC,F = 29 
Hz), 104.3, 124.4 (q, JC,F = 283 Hz), 126.3, 129.0, 134.1, 138.6, 204.8 ppm; HRMS (ESI) 
calcd for C14H16O4F3 ([M – H]
–
) 305.0995, found 305.0994.   
5,5,5-Trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-methoxyphenyl)pentan-2-one (11f) 
 
Synthesized by the general procedure, 1.5 h, 143.3 mg (89%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.24 (d, J = 17.8 Hz, 1H, CHHC=O), 3.32 (s, 
3H, OCH3), 3.40 (s, 3H, OCH3), 3.64 (d, J = 17.8 Hz, 1H, CHHC=O), 3.80 (s, 3H, OCH3), 
4.28 (s, 1H, CH(OCH3)2), 4.95 (s, 1H, OH), 6.87-6.91 (m, 2H, ArH), 7.50 (d, J = 8.8 Hz, 2H, 
ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 39.8, 55.13, 55.18, 55.23, 75.8 (q, JC,F = 29 Hz), 
104.4, 113.6, 124.4 (q, JC,F = 283 Hz), 127.7, 129.0, 159.9, 204.7 ppm; HRMS (ESI) calcd for 
C14H16O5F3 ([M – H]
–
) 321.0944, found 321.0946. 
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5,5,5-Trifluoro-4-hydroxy-1,1-dimethoxy-4-(thiophen-2-yl)pentan-2-one (11g) 
 
Synthesized by the general procedure, 1.5 h, 129.7 mg (87%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.26 (d, J = 17.7 Hz, 1H, CHHC=O), 3.34 (s, 
3H, OCH3), 3.41 (s, 3H, OCH3), 3.58 (d, J = 17.7 Hz, 1H, CHHC=O), 4.32 (s, 1H, 
CH(OCH3)2), 5.45 (s, 1H, OH), 6.99 (dd, J = 3.6 Hz, 5.1 Hz, 1H, ArH), 7.10 (d, J = 3.6 Hz, 
1H, ArH), 7.32 (dd, J = 1.2 Hz, 5.1 Hz, 1H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 
40.6, 55.2, 55.3, 75.4 (q, JC,F = 31 Hz), 104.3, 123.7 (q, JC,F = 283 Hz), 126.0, 126.6, 127.0, 
141.4, 204.5 ppm; HRMS (ESI) calcd for C11H12O4F3S ([M – H]
–
) 297.0403, found 297.0417. 
3-(Dimethoxymethyl)-1-(trifluoromethyl)-2,3-dihydro-1H-pyrrolizine-1,3-diol (11h) 
 
Synthesized by the general procedure using DBU (0.1 mmol, 0.2 equiv), 48 h. 
Upper spot on TLC, Rf = 0.34 (hexane/EtOAc = 2:1): 11h-1 (50.5 mg, 36%) 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 2.87 (d, J = 14.8 Hz, 1H, CHHC=O), 2.94 (d, 
J = 14.8 Hz, 1H, CHHC=O), 3.32 (s, 3H, OCH3), 3.52 (s, 3H, OCH3), 3.50-3.70 (br, 2H, OH), 
4.41 (s, 1H, CH(OCH3)2), 6.16 (d, J = 3.2 Hz, 1H, ArH), 6.33 (t, J = 3.2 Hz, 1H, ArH), 6.80 
(m, 1H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 48.4, 57.2, 58.3, 74.6 (q, JC,F = 32 Hz), 
89.7, 102.4, 106.9, 113.7, 114.9, 124.5 (q, JC,F = 289 Hz), 132.9 ppm; HRMS (ESI) calcd for 
C11H15NO4F3 ([M + H]
+
) 282.0948, found 282.0949. 
Lower spot on TLC, Rf = 0.23 (hexane/EtOAc = 2:1): 11h-2 (63.1 mg, 45%) 
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Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 2.48 (d, J = 14.8 Hz, 1H, CHHC=O), 3.20 (d, 
J = 14.8 Hz, 1H, CHHC=O), 3.49 (s, 3H, OCH3), 3.52 (s, 3H, OCH3), 4.09 (br, 1H, OH), 4.44 
(s, 1H, CH(OCH3)2), 6.12 (d, J = 3.2 Hz, 1H, ArH),6.29 (t, J = 3.2 Hz, 1H, ArH), 6.81-6.82 
(m, 1H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 47.5, 56.85, 56.99, 74.8 (q, JC,F = 32 
Hz), 89.4, 102.3, 105.3, 114.70, 114.72, 124.5 (q, JC,F = 280 Hz), 133.1 ppm; HRMS (ESI) 
calcd for C11H15NO4F3 ([M + H]
+
) 282.0948, found 282.0947. 
6,6,6-Trifluoro-5-hydroxy-5-phenylhexan-3-one (11aa)
91
 
 
Synthesized by the general procedure, 1.0 h, 99.7 mg (81%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 0.99 (t, J = 7.2 Hz, 3H, CH3), 2.35-2.45 (m, 
1H, CHHCH3), 2.50-2.60 (m, 1H, CHHCH3), 3.18 (d, J = 17.2 Hz, 1H, C(OH)CHHC=O), 
3.31 (d, J = 17.2 Hz,1H, C(OH)CHHC=O), 5.65 (s, 1 H, OH), 7.34-7.44 (m, 3 H, ArH), 7.57-
7.59 (m, 2 H, ArH) ppm. 
6,6,6-Trifluoro-5-hydroxy-2-methyl-5-phenylhexan-3-one (11ab)
94
 
 
Synthesized by the general procedure, 3.0 h, 110.3 mg (85%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.02 (d, J = 7.0 Hz, 3H, CH3), 1.11 (d, J = 7.0 
Hz, 3H, CH3), 2.59 (septet, J = 7.0 Hz, 1H, CH(CH3)2), 3.23 (d, J = 17.2 Hz, 1H, CHHC=O), 
3.35 (d, J = 17.2 Hz, 1H, CHHC=O), 5.79 (s, 1H, OH), 7.33-7.41 (m, 3H, ArH), 7.57-7.59 (m, 
2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 17.3, 17.5, 42.3, 42.5, 76.1 (q, JC,F = 30 Hz), 
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124.6 (q, JC,F = 283 Hz), 126.1, 128.3, 128.7, 137.6, 215.1 ppm; HRMS (ESI) calcd for 
C13H16O2F3 ([M + H]
+
) 261.1097, found 261.1078.   
6,6,6-Trifluoro-5-hydroxy-2,2-dimethyl-5-phenylhexan-3-one (11ac)
94
 
 
Synthesized by the general procedure at 45 °C, 12 h, 130.0 mg (95%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.11 (s, 9H, (CH3)3), 3.24 (d, J = 17.6 Hz, 1H, 
CHHC=O), 3.41 (d, J = 17.6 Hz, 1H, CHHC=O), 5.97 (s, 1H, OH), 7.33-7.41 (m, 3H, ArH), 
7.58 (d, J = 7.2 Hz, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 25.7, 38.9, 45.1, 76.2 (q, 
JC,F = 29 Hz), 124.7 (q, JC,F = 283 Hz), 126.1, 128.3, 128.6, 137.8, 216.6 ppm; HRMS (ESI) 
calcd for C14H18O2F3 ([M + H]
+
) 275.1253, found 275.1239. 
4,4,4-Trifluoro-3-hydroxy-1,3-diphenylbutan-1-one (11ad)
94
 
 
Synthesized by the general procedure, 2.0 h, 130.4 mg (89%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.67 (d, J = 17.2 Hz, 1H, CHHC=O), 4.06 (d, 
J = 17.2 Hz, 1H, CHHC=O), 5.74 (s, 1H, OH), 7.34-7.40 (m, 3H, ArH), 7.48-7.52 (m, 2H, 
ArH), 7.94-7.96 (m, 2 H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 40.2, 76.5 (q, JC,F = 
29 Hz), 124.6 (q, JC,F = 283 Hz), 126.3, 128.2, 128.4, 128.7, 128.9, 134.4, 136.2, 137.6, 199.7 
ppm.  
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DBU Catalyzed Aldol Reactions of -Keto Esters 12 with 10 
 
 General procedure for the DBU-catalyzed aldol reactions of -keto esters 12 with 
10 to give 13 (Scheme 2.10). To a mixture of -keto ester 12 (5.0 mmol) and 10 (0.5 mmol) 
was added DBU (0.1 mmol), and the mixture was stirred at rt (25 °C) until 10 was consumed 
(monitored by TLC). The reaction mixture was diluted with hexane-EtOAc and purified by 
silica gel flash column chromatography (hexane/EtOAc = 8:1 to 4:1) to give 13. 
 A 15 mmol-scale reaction to give 13a. To a mixture of ethyl acetoacetate (9.48 mL, 
75.0 mmol, 5.0 equiv) and 10a (2.11 mL, 15.0 mmol, 1.0 equiv) was added DBU (224 L, 
1.50 mmol, 0.1 equiv), and the mixture was stirred at rt (25 °C) for 4 days. The reaction 
mixture was diluted with hexane-EtOAc and purified by silica gel flash column 
chromatography (hexane/EtOAc = 15:1 to 8:1) to give 13a (3.29 g, 72%).  
 1
H NMR analyses during the progress of the reaction to form 13a. A reaction 
mixture to form 13a was prepared. At 5 min, 50 min, 130 min, and 220 min, an aliquot was 
taken from the mixture, diluted with CDCl3, and analyzed by 
1
H NMR. Formation of product 
13a was observed at each time point. But, no sign of the presence of the product with the 
bond formation at the -position of the -keto ester was detected.  
Ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-phenylhexanoate (13a) 
 
Synthesized by the general procedure, 24 h, 126.0 mg (83%). 
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Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.26 (t, J = 7.2 Hz, 3H, OCH2CH3), 3.36 (d, J 
= 17.6 Hz, 1H, C(OH)CHHC=O), 3.41 (d, J = 15.6 Hz, 1H, C(=O)CHHCOOEt), 3.45 (d, J = 
15.6 Hz, 1H, C(=O)CHHCOOEt), 3.59 (d, J = 17.6 Hz, 1H, C(OH)CHHC=O), 4.19 (q, J = 
7.2 Hz, 2H, OCH2CH3), 4.98 (s, 1H, OH), 7.34-7.42 (m, 3H, ArH), 7.56-7.58 (m, 2H, ArH) 
ppm; 
13
C NMR (100 MHz, CDCl3): δ = 14.0, 45.2, 50.6, 61.9, 76.0 (q, JC,F = 29 Hz), 124.4 (q, 
JC,F = 283 Hz), 126.2, 128.5, 128.9, 136.9, 166.1, 202.5 ppm; HRMS (ESI) calcd for 
C14H16O4F3 ([M + H]
+
) 305.0995, found 305.0981. 
Ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-3-oxohexanoate (13aa) 
 
Synthesized by the general procedure, 36 h, 105.3 mg (63%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.26 (t, J = 7.2 Hz, 3H, OCH2CH3), 3.31 (d, J 
= 17.6 Hz, 1H, C(OH)CHHC=O), 3.40 (d, J = 15.6 Hz, 1H, C(=O)CHHCOOEt), 3.44 (d, J = 
15.6 Hz, 1H, C(=O)CHHCOOEt), 3.56 (d, J = 17.6 Hz, 1H, C(OH)CHHC=O), 3.80 (s, 3H, 
OCH3) 4.19 (q, J = 7.2 Hz, 2H, OCH2CH3), 4.92 (brs, 1H, OH), 6.90 (d, J = 8.8 Hz, 2H, ArH), 
7.48 (d, J = 8.8 Hz, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 13.9, 45.2, 50.5, 55.2, 
61.8, 75.7 (q, JC,F = 29 Hz), 113.8 124.4 (q, JC,F = 283 Hz), 127.5, 128.7, 159.9, 166.2, 202.5 
ppm; HRMS (ESI) calcd for C15H16O5F3 ([M + H]
+
) 335.1101, found 335.1088. 
Ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-3-oxohexanoate (13ab)  
 
Synthesized by the general procedure, 24 h, 131.5 mg (78%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.26 (t, J = 7.2 Hz, 3H, OCH2CH3), 3.35 (d, J 
= 17.6 Hz, 1H, C(OH)CHHC=O), 3.41 (d, J = 15.6 Hz, 1H, C(=O)CHHCOOEt), 3.46 (d, J = 
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15.6 Hz, 1H, C(=O)CHHCOOEt), 3.56 (d, J = 17.6 Hz, 1H, C(OH)CHHC=O), 4.19 (q, J = 
7.2 Hz, 2H, OCH2CH3), 5.04 (s, 1H, OH), 7.36 (d, J = 8.4 Hz, 2H, ArH), 7.51 (d, J = 8.4 Hz, 
2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 13.9, 45.0, 50.4, 62.0, 75.7 (q, JC,F = 29 Hz), 
124.1 (q, JC,F = 283 Hz), 127.7, 128.7, 135.1, 135.5, 166.2, 202.3 ppm; HRMS (ESI) calcd for 
C14H15O4F3Cl ([M + H]
+
) 339.0605, found 339.0591.  
Ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-(thiophen-2-yl)hexanoate (13ac) 
 
Synthesized by the general procedure, 24 h, 130.4 mg (84%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.26 (t, J = 7.2 Hz, 3H, OCH2CH3), 3.32 (d, J 
= 17.2 Hz, 1H, C(OH)CHHC=O), 3.46 (s, 2H, C(=O)CH2COOEt), 3.52 (d, J = 17.6 Hz, 1H, 
C(OH)CHHC=O), 4.19 (q, J = 7.2 Hz, 2H, OCH2CH3), 5.42 (s, 1H, OH), 6.99-7.01 (m, 2H, 
ArH), 7.32-7.34 (m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 13.9, 45.8, 50.5, 61.9, 
75.3 (q, JC,F = 31 Hz), 123.7 (q, JC,F = 283 Hz), 126.0, 126.7, 127.2, 141.0, 166.1, 202.4 ppm; 
HRMS (ESI) calcd for C12H14O4F3S ([M + H]
+
) 311.0559, found 311.0549. 
Ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-phenylhexanoate (13b) 
 
Synthesized by the general procedure, 24 h, 127.5 mg (80%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.22-1.29 (m, 6H, OCH2CH3, CH3CHC=O), 
3.31-3.61 (m, 3H, CH3CHC=O, C(OH)CH2C=O), 4.11-4.24 (m, 2H, OCH2CH3), 5.20 (brs, 
1H 1/2, OH), 5.24 (brs, 1H 1/2, OH) 7.33-7.41 (m, 3H, ArH), 7.56-7.57 (m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 12.1, 12.2, 13.9, 43.8, 44.0, 53.9, 54.4, 61.8, 61.9, 75.69 (q, 
JC,F = 29 Hz), 76.01 (q, JC,F = 29 Hz), 124.37 (q, JC,F = 283 Hz), 124.44 (q, JC,F = 283 Hz), 
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126.05, 126.09, 128.3, 128.4, 128.79, 128.83, 137.05, 137.16, 169.21, 169.23, 205.7, 206.0 
ppm; HRMS (ESI) calcd for C15H18O4F3 ([M + H]
+
) 319.1152, found 319.1135.  
Ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-2-methyl-3-oxohexanoate (13ba) 
 
Synthesized by the general procedure, 26 h, 115.3 mg (66%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.23-1.29 (m, 6H, OCH2CH3, CH3CHC=O), 
3.27-3.59 (m, 3H, CH3CHC=O, C(OH)CH2C=O), 3.79 (s, 3H 1/2, OCH3), 3.80 (s, 3H 1/2, 
OCH3), 4.13-4.23 (m, 2 H, OCH2CH3), 5.08 (brs, 1H 1/2, OH), 5.16 (brs, 1H 1/2, OH), 
6.87-6.92 (m, 2H, ArH), 7.45-7.47 (m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 12.1, 
12.2, 13.9, 43.7, 44.0, 53.9, 54.4, 55.2, 61.8, 61.9, 75.7 (q, JC,F = 29 Hz), 75.8 (q, JC,F = 29 
Hz), 113.7, 113.8, 124.4 (q, JC,F = 283 Hz), 124.5 (q, JC,F = 283 Hz), 127.39, 127.44, 129.0, 
129.1, 159.87, 159.88, 169.29, 169.30, 205.7, 206.1 ppm; HRMS (ESI) calcd for C16H20O5F3 
([M + H]
+
) 349.1257, found 349.1250. 
Ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxohexanoate (13bb) 
 
Synthesized by the general procedure, 24 h, 132.3 mg (75%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.22-1.29 (m, 6H, OCH2CH3, CH3CHC=O), 
3.28-3.59 (m, 3H, CH3CHC=O, C(OH)CH2C=O), 4.12-4.23 (m, 2 H, OCH2CH3), 5.17 (brs, 
1H 1/2, OH), 5.28 (brs, 1H 1/2, OH), 7.33-7.37 (m, 2H, ArH), 7.48-7.50(m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 12.1, 12.2, 13.88, 13.89, 43.5, 43.9, 53.8, 54.3, 61.9, 62.0, 
75.73 (q, JC,F = 29 Hz), 75.74 (q, JC,F = 29 Hz), 124.17 (q, JC,F = 283 Hz), 124.20 (q, JC,F = 
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283 Hz), 127.6, 127.7, 128.5, 128.6, 135.00, 135.03 135.7, 135.8, 169.21, 169.22, 205.6, 
205.8 ppm; HRMS (ESI) calcd for C15H17O4F3Cl ([M + H]
+
) 353.0762, found 353.0747.  
Ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-(thiophen-2-yl)hexanoate (13bc) 
 
Synthesized by the general procedure, 26 h, 113.5 mg (70%). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 1.23-1.31 (m, 6H, OCH2CH3, CH3CHC=O), 
3.27-3.60 (m, 3H, CH3CHC=O, C(OH)CH2C=O), 4.13-4.23 (m, 2H, OCH2CH3), 5.59 (brs, 
1H 1/2, OH), 5.62 (brs, 1H 1/2, OH), 6.98-7.01 (m, 1 H, ArH), 7.07-7.10 (m, 1 H, ArH), 
7.32-7.33 (m, 1 H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 12.1, 12.2, 13.9, 44.5, 44.6, 
54.0, 54.4, 61.8, 61.9, 75.41 (q, JC,F = 30 Hz), 75.44 (q, JC,F = 31 Hz), 123.7 (q, JC,F = 283 Hz), 
123.8 (q, JC,F = 283 Hz), 125.7, 125.8, 126.5, 126.6, 127.1, 127.2, 141.2, 141.3, 169.12, 
169.15, 205.6, 206.0 ppm; HRMS (ESI) calcd for C13H16O4F3S ([M + H]
+
) 325.0716, found 
325.0703. 
 
DBU Catalyzed Vinylogous Aldol Reactions of Cyclic Enones 14 with 10 
 
 General procedure for the DBU-catalyzed vinylogous aldol reactions of cyclic 
enones 14 with 10 to give 15 (Scheme 2.11). To a mixture of cyclic enones 14 (2.5 mmol) 
and 10 (0.5 mmol) was added DBU (0.05 mmol), and the mixture was stirred at rt (25 °C) 
until 10 was consumed (monitored by TLC). The reaction mixture was diluted with hexane-
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EtOAc and purified by silica gel flash column chromatography (hexane/EtOAc = 8:1 to 4:1) 
to give 15. 
3-(3,3,3-Trifluoro-2-hydroxy-2-phenylpropyl)cyclohex-2-enone (15a) 
 
Synthesized by the general procedure, 1.0 h, 115.1 mg (81%). 
Colorless solid. 
1
H NMR (400 MHz, CDCl3): δ = 1.72-1.79 (m, 2H, CH2CH2CH2), 1.88 (dt, J 
= 18.3 Hz, 5.7 Hz, 1H, C=CCHHCH2), 2.12 (dt, J = 18.3 Hz, 5.7 Hz, 1H, C=CCHHCH2), 
2.19-2.23 (m, 2H, C(=O)CH2CH2), 2.99 (d, J = 14.1 Hz, 1H, C(OH)CHH), 3.05 (d, J = 14.1 
Hz, 1H, C(OH)CHH), 3.42 (s, 1H, OH), 5.82 (s, 1H, C=CHC=O), 7.36-7.42 (m, 3H, ArH), 
7.54-7.56 (m, 2H, ArH),  ppm; 
13
C NMR (100 MHz, CDCl3): δ = 22.5, 30.9, 37.0, 43.8, 76.8 
(q, JC,F = 28 Hz), 125.3 (q, JC,F = 285 Hz), 126.1, 128.5, 128.9, 129.6, 130.7, 136.0, 159.0, 
199.6 ppm; HRMS (ESI) calcd for C15H16O2F3 ([M + H]
+
) 285.1097, found 285.1110. 
3-(3,3,3-Trifluoro-2-hydroxy-2-(p-tolyl)propyl)cyclohex-2-enone (15b) 
 
Synthesized by the general procedure, 1.0 h, 119.3 mg (80%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 1.70-1.77 (m, 2H, CH2CH2CH2), 1.99-2.06 
(m, 1H, C=CCHHCH2), 2.14-2.18 (m, 2H, C(=O)CH2CH2), 2.21-2.29 (m, 1H, C=CCHHCH2), 
2.33 (s, 3H, ArCH3), 2.98 (d, J = 14.5 Hz, 1H, C(OH)CHH), 3.13 (d, J = 14.5 Hz, 1H, 
C(OH)CHH), 5.78 (s, 1H, C=CHC=O), 7.18 (d, J = 8.0 Hz, 2H, ArH) 7.46 (d, J = 8.0 Hz, 2H, 
ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 21.0, 23.6, 32.0, 37.8, 43.9, 77.7 (q, JC,F = 28 
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Hz), 127.1 (q, JC,F = 285 Hz), 127.8, 129.7, 130.7, 135.1, 139.4, 163.4, 202.3 ppm; HRMS 
(ESI) calcd for C16H18O2F3 ([M + H]
+
) 299.1253, found 299.1233.  
3-(3,3,3-Trifluoro-2-hydroxy-2-(4-methoxyphenyl)propyl)cyclohex-2-enone (15c) 
 
Synthesized by the general procedure, 1.0 h, 131.8 mg (84%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 1.70-1.77 (m, 2H, CH2CH2CH2), 1.99-2.06 
(m, 1H, C=CCHHCH2), 2.14-2.18 (m, 2H, C(=O)CH2CH2), 2.21-2.28 (m, 1H, C=CCHHCH2), 
2.97 (d, J = 14.4 Hz, 1H, C(OH)CHH), 3.12 (d, J = 14.4 Hz, 1H, C(OH)CHH), 3.78 (s, 3H, 
OCH3), 5.79 (s, 1H, C=CHC=O), 6.91 (d, J = 8.7 Hz, 2H, ArH), 7.50 (d, J = 8.7 Hz, 2H, 
ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 23.6, 32.0, 37.8, 43.9, 55.7, 77.5 (q, JC,F = 28 
Hz), 114.4, 127.1 (q, JC,F = 285 Hz), 129.1, 129.9, 130.7, 161.1, 163.4, 202.2 ppm; HRMS 
(ESI) calcd for C16H18O3F3 ([M + H]
+
) 315.1203, found 315.1191. 
3-(2-(4-Chlorophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone (15d) 
 
Synthesized by the general procedure, 1.0 h, 105.2 mg (66%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 1.73-1.80 (m, 2H, CH2CH2CH2), 2.01-2.09 
(m, 1H, C=CCHHCH2), 2.15-2.19 (m, 2H, C(=O)CH2CH2), 2.23-2.30 (m, 1H, C=CCHHCH2), 
3.01 (d, J = 14.1 Hz, 1H, C(OH)CHH), 3.16 (d, J = 14.1 Hz, 1H, C(OH)CHH), 5.78 (s, 1H, 
C=CHC=O), 7.38 (d, J = 8.5 Hz, 2H, ArH), 7.59 (d, J = 8.5 Hz, 2H, ArH) ppm; 
13
C NMR 
(100 MHz, CD3OD): δ = 23.6, 32.0, 37.8, 43.6, 77.6 (q, JC,F = 28 Hz), 126.9 (q, JC,F = 285 
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Hz), 129.2, 129.7, 130.8, 135.5, 137.0, 162.8, 202.1 ppm; HRMS (ESI) calcd for 
C15H15O2F3Cl ([M + H]
+
) 319.0707, found 319.0693. 
3-(2-(4-Bromophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone (15e) 
 
Synthesized by the general procedure, 1.0 h, 127.1 mg (70%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 1.72-1.79 (m, 2H, CH2CH2CH2), 2.01-2.09 
(m, 1H, C=CCHHCH2), 2.15-2.19 (m, 2H, C(=O)CH2CH2), 2.22-2.30 (m, 1H, C=CCHHCH2), 
3.00 (d, J = 14.6 Hz, 1H, C(OH)CHH), 3.15 (d, J = 14.6 Hz, 1H, C(OH)CHH), 5.78 (s, 1H, 
C=CHC=O), 7.53 (s, 4H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 23.6, 32.0, 37.8, 
43.6, 77.6 (q, JC,F = 278 Hz), 123.6, 126.8 (q, JC,F = 285 Hz), 129.9, 130.8, 132.3, 137.5, 
162.7, 202.1 ppm; HRMS (ESI) calcd. for C15H15O2F3Br ([M + H]
+
) 363.0202; found 
363.0174.  
3-(3,3,3-Trifluoro-2-hydroxy-2-(4-(trifluoromethyl)phenyl)propyl)cyclohex-2-enone 
(15f) 
 
Synthesized by the general procedure, 1.0 h, 107.4 mg (61%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 1.72-1.79 (m, 2H, CH2CH2CH2), 2.02-2.10 
(m, 1H, C=CCHHCH2), 2.13-2.18 (m, 2H, C(=O)CH2CH2), 2.24-2.31 (m, 1H, C=CCHHCH2), 
3.06 (d, J = 14.8 Hz, 1H, C(OH)CHH), 3.16 (d, J = 14.8 Hz, 1H, C(OH)CHH), 5.79 (s, 1H, 
C=CHC=O), 7.69 (d, J = 8.4 Hz, 2H, ArH), 7.82 (d, J = 8.4 Hz, 2H, ArH) ppm; 
13
C NMR 
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(100 MHz, CD3OD): δ = 23.6, 32.0, 37.8, 43.6, 77.6 (q, JC,F = 28 Hz), 125.5 (q, JC,F = 270 
Hz), 126.0 (q, JC,F = 4 Hz), 126.8 (q, JC,F = 285 Hz), 128.8, 130.8, 131.6 (q, JC,F = 32 Hz 
142.6, 162.7, 202.1 ppm; HRMS (ESI) calcd for C16H15O2F6 ([M + H]
+
) 353.0971, found 
353.0940.  
3-(3,3,3-Trifluoro-2-hydroxy-2-(thiophen-2-yl)propyl)cyclohex-2-enone (15g) 
 
Synthesized by the general procedure, 1.0 h, 110.3 mg (76%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 1.77-1.83 (m, 2H, CH2CH2CH2), 2.01-2.09 
(m, 1H, C=CCHHCH2), 2.19-2.22 (m, 2H, C(=O)CH2CH2), 2.33-2.40 (m, 1H, C=CCHHCH2), 
3.00 (s, 2H, C(OH)CH2), 5.81 (s, 1H, C=CHC=O), 7.02 (dd, J = 3.6 Hz, 5.1 Hz, 1H, ArH), 
7.14 (d, J = 3.6 Hz, 1H, ArH), 7.39 (dd, J = 1.2 Hz, 5.1 Hz, 1H, ArH) ppm; 
13
C NMR (100 
MHz, CD3OD): δ = 23.7, 32.0, 37.8, 45.3, 77.7 (q, JC,F = 29 Hz), 126.5 (q, JC,F = 284 Hz), 
126.9 (q, JC,F = 1 Hz), 127.0, 127.9, 130.8, 142.3, 162.7, 202.2 ppm; HRMS (ESI) calcd for 
C13H14O2F3S ([M + H]
+
) 291.0661, found 291.0650. 
3-(3,3,3-Trifluoro-2-hydroxy-2-phenylpropyl)cyclopent-2-enone (15h) 
  
Synthesized by the general procedure, 30 min, 109.4 mg (81%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 2.18 (t, J = 4.6 Hz, 2H, CH2C=O), 2.34-
2.42 (m, 1H, CHHCH2C=O), 2.49-2.57 (m, 1H, CHHCH2C=O), 3.21 (d, J = 15.7 Hz, 1H, 
C(OH)CHH), 3.51 (d, J = 15.7 Hz, 1H, C(OH)CHH), 5.81 (m, 1H, C=CHC=O), 7.31-7.40 (m, 
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3H, ArH), 7.62 (d, J = 7.5 Hz, 2H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ = 34.0, 35.9, 
39.2, 77.3 (q, JC,F = 28 Hz), 127.0 (q, JC,F = 285 Hz), 127.9, 129.2, 129.5, 133.9, 138.0, 179.3, 
212.9 ppm; HRMS (ESI) calcd for C14H14O2F3 ([M + H]
+
) 271.0940, found 271.0921.  
3-(3,3,3-Trifluoro-2-hydroxy-2-(4-methoxyphenyl)propyl)cyclopent-2-enone (15i) 
 
Synthesized by the general procedure, 30 min, 123.2 mg (82%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 2.19 (t, J = 4.4 Hz, 2H, CH2C=O), 2.36-
2.42 (m, 1H, CHHCH2C=O), 2.49-2.57 (m, 1H, CHHCH2C=O), 3.18 (d, J = 15.6 Hz, 1H, 
C(OH)CHH), 3.46 (d, J = 15.6 Hz, 1H, C(OH)CHH), 3.77 (s, 3H,  OCH3), 5.82 (s, 1H, 
C=CHC=O), 6.91(d, J = 8.8 Hz, 2H, ArH), 7.52 (d, J = 8.8 Hz, 2H, ArH) ppm; 
13
C NMR 
(100 MHz, CD3OD): δ = 34.0, 35.9, 39.1, 55.7, 77.1 (q, JC,F = 28 Hz), 114.5, 127.0 (q, JC,F = 
285 Hz), 129.2, 129.7, 133.9, 161.2, 179.6, 213.0 ppm; HRMS (ESI) calcd for C15H16O3F3 
([M + H]
+
) 301.1046, found 301.1030. 
3-(3,3,3-trifluoro-2-hydroxy-2-(4-(trifluoromethyl)phenyl)propyl)cyclopent-2-enone 
(15j) 
 
Synthesized by the general procedure, 30 min, 89.5 mg (53%). 
Colorless solid. 
1
H NMR (400 MHz, CD3OD): δ = 2.21 (t, J = 4.7 Hz, 2H, CH2C=O), 2.40-
2.46 (m, 1H, CHHCH2C=O), 2.53-2.60 (m, 1H, CHHCH2C=O), 3.25 (d, J = 16.0 Hz, 1H, 
C(OH)CHH), 3.58 (d, J = 16.0 Hz, 1H, C(OH)CHH), 5.82 (s, 1H, C=CHC=O), 7.70 (d, J = 
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8.4 Hz, 2H, ArH), 7.85 (d, J = 8.4 Hz, 2H, ArH) ppm; 
13
C NMR (100 MHz, CD3OD): δ =34.0, 
35.9, 38.9, 77.3 (q, JC,F = 28 Hz), 125.5 (q, JC,F = 270 Hz) 126.1 (q, JC,F = 4 Hz), 126.7 (q, JC,F 
= 285 Hz), 128.9, 131.8 (q, J = 32 Hz), 134.0, 142.5, 178.6, 212.7 ppm; HRMS (ESI) calcd 
for C15H13O2F6 ([M + H]
+
) 339.0814, found 339.0797. 
 
Resolution of the Aldol products 13  
 Synthesis of enamine 16a and the resolution to 16a-1 and 16a-2 (Scheme 2.12). To 
a solution of 13a (243.4 mg, 0.8 mmol) in toluene (1.5 mL), (R)-1-phenylethylamine (112 L, 
0.88 mmol) was added, and the mixture was stirred at rt (25 °C) for 12 h. The mixture was 
purified by silica gel flash column chromatography (hexane/EtOAc = 30:1 to 15:1) to give 
16a-1 (upper spot on TLC) (108.5 mg, 32%, dr 20:1), mixtures of 16a-1 and 16a-2 (81.7 mg, 
24%, dr 1:1), and 16a-2 (lower spot on TLC) (105.5 mg, 31%, dr 20:1); the dr values of 16a-1 
and 16a-2 were determined by 
1
H NMR analyses. Compound 16a-1 (dr 20:1) was crystallized 
from hexane-CH2Cl2 to give the essentially pure form (50.5 mg, dr >99:1). Compound 16a-2 
(dr 20:1) was also crystallized from hexane-CH2Cl2 to increase the purity (60.0 mg, dr 99:1). 
The absolute stereochemistry of 16a-1 was determined to be (R,R) by the X-ray structural 
analysis. Note that the fractions containing 16a-1 and 16a-2 were able to be purified further to 
give pure 16a-1 and also pure 16a-2. 
Compound 16a-1 
 
Colorless crystals, mp 126 C, Rf = 0.38 (hexane/EtOAc = 10:1). 
1
H NMR (400 MHz, 
CDCl3): δ = 0.67 (d, J = 6.4 Hz, 3H, NCH(CH3)Ph, 1.13 (t, J = 7.2 Hz, 3H, OCH2CH3), 2.58 
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(d, J = 13.6 Hz, 1H, C(OH)CHH), 3.52 (d, J = 5.6 Hz, 1H, C=CHCOOEt), 3.87-4.10 (m, 3H, 
NCH(CH3)Ph, OCH2CH3), 4.16 (d, J = 13.6 Hz, 1H, C(OH)CHH), 4.49 (s, 1H, OH), 6.89-
6.91 (m, 3H, ArH, NH), 7.12-7.21 (m, 3H, ArH),  7.32-7.41 (m, 3H, ArH), 7.65-7.67 (m, 2H, 
ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 14.4, 22.2, 38.7, 53.1, 59.9, 76.8 (q, JC,F = 25 
Hz), 87.6, 125.4, 125.8 (q, JC,F = 285 Hz), 126.1, 127.5, 128.6, 128.77, 128.80, 137.8, 142.4, 
155.2, 172.2 ppm; HRMS (ESI) calcd for C22H25NO3F3 ([M + H]
+
) 408.1781, found 408.1762. 
 
X-ray crystal structure of 16a-1 (CCDC 1401982). The analysis of the X-ray crystal structure 
of 16a-1 was performed using a custom anaysis service. 
Compound 16a-2 
 
Colorless solid, Rf = 0.28 (hexane/EtOAc = 10:1). 
1
H NMR (400 MHz, CDCl3): δ = 1.20-1.24 
(m, 6H, NCH(CH3)Ph, OCH2CH3), 2.80 (d, J = 13.6 Hz, 1H, C(OH)CHH), 3.85 (d, J = 5.6 
Hz, 1H, C=CHCOOEt), 4.04-4.23 (m, 4H, NCH(CH3)Ph, OCH2CH3, C(OH)CHH), 4.55 (s, 
1H, OH), 6.49-6.51 (m, 2H, ArH), 6.94 (s, 1H, NH), 7.15-7.17 (m, 3H, ArH),  7.36-7.46 (m, 
4H, ArH), 7.70-7.72 (m, 2H, ArH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 14.4, 23.4, 38.5, 
52.9, 60.0, 76.8 (q, JC,F = 28 Hz), 87.8, 125.4, 125.7 (q, JC,F = 286 Hz) 126.4, 127.2, 128.5, 
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128.5, 128.6, 128.7, 137.4, 141.9, 154.5, 172.1 ppm; HRMS (ESI) calcd for C22H25NO3F3 ([M 
+ H]
+
) 408.1781, found 408.1762. 
 Synthesis of enamine 16ac and the resolution to 16ac-1 and 16ac-2 (Scheme 2.11). 
To a solution of 13ac (248.2 mg, 0.8 mmol) in toluene (1.5 mL), (R)-1-phenylethylamine 
(112 L, 0.88 mmol) was added, and the mixture was stirred at rt (25 °C) for 12 h. The 
mixture was purified by silica gel flash column chromatography (hexane/EtOAc = 30:1 to 
15:1) to give 16ac-1 (upper spot on TLC) (169.0 mg, 41%), mixtures of 16ac-1 and 16ac-2 
(62.9 mg, 15%), and 16ac-2 (lower spot on TLC) (156.4 mg, 38%). Compound 16ac-1 was 
crystallized from hexane-CH2Cl2 to give the essentially pure form (72.4 mg, dr >99:1). 
Compound 16ac-2 was also crystallized from hexane-CH2Cl2 to give the pure form (65.6 mg, 
dr >99:1). 
Compound 16ac-1 
 
Colorless crystals, mp 133 C, Rf = 0.33 (hexane/EtOAc = 10:1). 
1
H NMR (400 MHz, 
CDCl3): δ = 0.86 (d, J = 6.8 Hz, 3H, NCH(CH3)Ph), 1.13 (t, J = 7.2 Hz, 3H, OCH2CH3), 2.45 
(d, J = 13.2 Hz, 1H, C(OH)CHH), 3.75 (d, J = 5.2 Hz, 1H, C=CHCOOEt), 3.93-4.09 (m, 3H, 
NCH(CH3)Ph, OCH2CH3), 4.16 (d, J = 13.2 Hz, 1H, C(OH)CHH), 4.53 (s, 1H, OH), 6.96-
7.05 (m, 3H, ArH), 7.13-7.18 (m, 2H, ArH), 7.23-7.26 (m, 2H, ArH), 7.30-7.31 (m, 1H, ArH), 
7.38 (s, 1H, NH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 14.3, 22.6, 40.1, 53.4, 60.1, 76.8 (q, 
JC,F = 30 Hz ), 87.8, 123.8, 125.1 (q, JC,F = 285Hz), 125.5, 126.1, 127.5, 127.6, 128.9, 142.4, 
143.2, 155.0, 172.4 ppm; HRMS (ESI) calcd for C20H23NO3F3S ([M + H]
+
) 414.1345, found 
414.1327. 
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Compound 16ac-2 
 
Colorless crystals, Rf = 0.24 (hexane/EtOAc = 10:1). 
1
H NMR (400 MHz, CDCl3): δ = 1.23 (t, 
J = 7.0 Hz, 3H, OCH2CH3), 1.31 (d, J = 6.8 Hz, 3H, NCH(CH3)Ph), 2.68 (d, J = 13.6 Hz, 1H, 
C(OH)CHH), 4.03-4.27 (m, 5H, NCH(CH3)Ph, OCH2CH3, C(OH)CHH, C=CHCOOEt), 4.64 
(s, 1H, OH), 6.69-6.72 (m, 2H, ArH), 7.00-7.02 (m, 1H, ArH),  7.17-7.26 (m, 4H, ArH), 7.29-
7.31 (m, 1H, ArH), 7.41 (s, 1H, NH) ppm; 
13
C NMR (100 MHz, CDCl3): δ = 14.3, 23.1, 40.0, 
53.2, 60.1, 76.7 (q, JC,F = 29 Hz ), 87.6, 124.5, 125.0 (q, JC,F = 285 Hz), 125.6, 126.2, 127.3, 
128.6, 141.9, 142.3, 154.2, 172.3 ppm; HRMS (ESI) calcd for C20H23NO3F3S ([M + H]
+
) 
414.1345, found 414.1327. 
 Hydrolysis of enamine 16a-1 to give (R)-13a (Scheme 2.12). A mixture of 16a-1 
(0.12 mmol, 50.0 mg, dr >99:1) and 10% HCl/(H2O/EtOH = 1:1) (1.0 mL) was stirred at rt 
(25 °C) for 4 h (note: when the mixture was stirred for 2 days, the decarboxylation product 17 
was obtained, see below). The reaction mixture was extracted with CH2Cl2 (3 mL   3). 
Organic layers were combined, washed with brine, dried over MgSO4, concentrated, and 
purified by flash column chromatography (hexane/EtOAc = 5:1) to give (R)-13a (31.5 mg, 
89%, >99%). The ee value was determined by HPLC analysis.  
 Resolution of (±)-13a (10 mmol-scale) to give (R)-13a. To a solution of (±)-13a 
(3.05g, 10.0 mmol) in toluene (15.0 mL), (R)-1-phenylethylamine (1.53 mL, 12.0 mmol) was 
added, and the mixture was stirred at rt (25 °C) for 16 h. The reaction mixture was directly 
purified by silica gel flash column chromatography (hexane/EtOAc = 40:1 to 20:1) to give 
16a-1 (1.40 g, 33%, the theoretical maximum yield 50%). This was crystallized from hexane-
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CH2Cl2 to give 16a-1 as the pure diastereomer (dr > 99:1 determined by 
1
H NMR). To the 
16a-1 crystals, 10% HCl/(H2O/EtOH = 1:1) (5.0 mL) was added at rt (25 °C), and the mixture 
was stirred at the same temperature for 4 h. The mixture was extracted with CH2Cl2 (15 mL   
3). Organic layers were combined, washed with brine, dried over MgSO4, concentrated, and 
purified by silica gel flash column chromatography (hexane/EtOAc = 5:1) to give (R)-13a 
(0.43 g, 14% from (±)-13a, 99% ee). Note that the fractions containing 16a-1 and 16a-2 were 
able to be purified further to give pure 16a-1 and also pure 16a-2. 
Compound (R)-13a 
 
Colorless oil. []D
26
  -34.2 (c = 0.67, CH2Cl2), >99% ee. HPLC (Daicel Chiralpak IA, 
hexane/2-PrOH = 98:2, 0.6 mL/min, λ = 254 nm): tR (major, (R)-13a) = 27.9 min, tR (miner, 
(S)-13a) = 31.8 min. 
 The absolute stereochemistry of 13a obtained from enamine 16a-1 (upper spot product 
on TLC) was determined to be R by converting to known ketone 17 and also by X-ray crystal 
structure analysis of enamine 16a-1 (see above).  
Compound (S)-13a  
 
Compound (S)-13a (39.0 mg, 87%) was obtained from the hydrolysis of 16a-2 (60.0 mg, 0.15 
mmol) by the same method used for the hydrolysis of 16a-1.  
Colorless oil. []D
26
  +30.5 (c = 0.37, CH2Cl2), 98 % ee. HPLC (Daicel Chiralpak IA, 
hexane/2-PrOH = 98:2, 0.6 mL/min, λ = 254 nm): tR (miner, (R)-13a) = 27.8 min, tR (major, 
(S)-13a) = 31.6 min. 
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Compound (S)-13ac  
 
Compound (S)-13ac (40.6 mg, 78%) was obtained from the hydrolysis of 16ac-1 (69.5 mg, 
0.17 mmol). Absolute stereochemistry was determined by analogy.  
Colorless oil. []D
25
 –40.9 (c = 0.53, CH2Cl2), >99% ee. HPLC (Daicel Chiralpak AS, 
hexane/2-PrOH = 98:2, 0.6 mL/min, λ = 254 nm): tR (major, (S)-13ac) = 39.7 min, tR (miner, 
(R)-13ac) = 53.0 min. 
Compound (R)-13ac 
 
Compound (R)-13ac (41.8 mg, 91%) was obtained from the hydrolysis of 16ac-2 (61.0 mg, 
0.15 mmol). 
Colorless oil. []D
25
  +40.5 (c = 0.74, CH2Cl2), >99% ee. HPLC (Daicel Chiralpak AS, 
hexane/2-PrOH = 98:2, 0.6 mL/min, λ = 254 nm): tR (miner, (S)-13ac) =40.8 min, tR (major, 
(R)-13ac) = 50.5 min. 
 Formation of (R)-17 (Scheme 2.11). A mixture of (R)-13a (30.0 mg, 0.10 mmol, 
99% ee) and 10% HCl/(H2O/EtOH = 1:1) (1.0 mL) was stirred at rt (25 °C) for 2 days. The 
mixture was extracted with CH2Cl2 (3 mL   3). Organic layers were combined, washed with 
brine, dried over MgSO4, concentrated and purified by silica gel flash column 
chromatography (hexane/EtOAc = 5:1) to give (R)-17 (17 mg, 74%, 99% ee).  
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(R)-5,5,5-Trifluoro-4-hydroxy-4-phenylpentan-2-one ((R)-17)
89
 
 
[]D
25
 –20.8 (c = 0.40, CHCl3, 99% ee). Lit. []D
20
 +24.1 (c = 1.0, CHCl3, 92% ee) for (S)-17. 
1
H NMR (400 MHz, CDCl3): δ = 2.20 (s, 3H, CH3), 3.20 (d, J = 17.2 Hz, 1H, C(OH)CHH), 
3.37 (d, J = 17.2 Hz, 1H, C(OH)CHH), 5.43 (s, 1H, OH), 7.34-7.42 (m, 3H, ArH), 7.55-7.57 
(m, 2H, ArH) ppm. HPLC (Daicel Chiralpak IB, hexane/2-PrOH = 95:5, 0.6 mL/min, λ = 220 
nm): tR (major, (R)-17) =11.4 min, tR (miner, (S)-17) =13.5 min. 
 
Formation of 19 from 13a and 18  
 Synthesis of 19. To a solution of (±)-13a (30.4 mg, 0.1 mmol) in toluene (150 L), 
amine 18 (0.11 mmol) was added, and the mixture was stirred at rt (25 °C) until 13a was 
consumed (monitored by TLC). The reaction mixture was diluted with hexane-EtOAc and 
purified by silica gel flash column chromatography to give 19 as diastereomer mixtures in 
quantative yield.  
 Synthesis of single diasteromer of 19. To a solution of (R)-13a (15.2 mg, 0.05 mmol) 
in toluene (100 L), amine 18 (0.055 mmol) was added, and the mixture was stirred at rt 
(25 °C) until 13a was consumed (monitored by TLC). The reaction mixture was diluted with 
hexane-EtOAc and purified by silica gel flash column chromatography to give 19 as mostly 
single diastereomer in quantative yield.  
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Scheme 6.1. Amines 18 tested to form enamines 19. 
 
Compound 19a 
 
Compound 19a (dr 1:1). 
1
H NMR (400 MHz, CDCl3): 0.90 (d, J = 6.8 Hz, 3H 1/2, 
PhCHCH3), 0.99 (d, J = 6.8 Hz, 3H 1/2, PhCHCH3), 1.27 (t, J = 7.2 Hz, 3H 1/2, OCH2CH3), 
1.28 (t, J = 7.2 Hz, 3H 1/2, OCH2CH3), 2.16-2.25 (m, 1H 1/2, PhCHCH3), 2.50 (d, J = 13.6 
Hz, 1H 1/2, C(OH)CHH), 2.54-2.64 (m, 2H 1/2, CHCH3, C(OH)CHH), 2.73-2.81 (m, 1H, 
NCHHCH), 2.87-2.97 (m, 1H, NCHHCH), 3.22-3.28 (m, 1H 1/2, C=CHCOOEt), 3.45-3.51 
(m, 1H 1/2, C=CHCOOEt), 4.04-4.22 (m, 3H, C(OH)CHH, OCH2CH3), 4.68 (s, 1H 1/2, 
OH), 4.73 (s, 1H 1/2, OH), 6.87 (s, 1H 1/2, NH), 6.92-6.98 (m, 2H, ArH; 1H 1/2, NH), 
7.22-7.36 (m, 3H+3H 1/2, ArH), 7.40-7.44 (m, 3H 1/2, ArH), 7.57-7.61 (m, 2H, ArH). 13C 
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NMR (100 MHz, CDCl3): 14.4, 18.8, 19.9, 38.0, 38.7, 38.8, 38.9, 50.0, 50.2, 59.86, 59.90, 
76.8 (q, JC,F = 28 Hz), 86.29, 86.33, 125.7 (q, JC,F = 285 Hz), 125.8, 125.9, 126.76, 126.84, 
126.9, 127.1, 128.4, 128.5, 128.56, 128.63, 128.8, 137.5, 137.8, 143.0, 143.1, 156.2, 156.3, 
172.1, 172.2. HRMS (ESI) calcd for C23H27NO3F3 ([M + H]
+
) 422.1938, found 422.1917. 
 
Single diastereomer: 
1
H NMR (400 MHz, CDCl3): 0.99 (d, J = 6.8 Hz, 3H, PhCHCH3), 1.27 
(t, J = 7.2 Hz, 3H, OCH2CH3), 2.16-2.25 (m, 1H, PhCHCH3), 2.50 (d, J = 13.6 Hz, 1H, 
C(OH)CHH), 2.72-2.78 (m, 1H, NCHHCH), 2.87-2.94 (m, 1H, NCHHCH), 3.22-3.28 (m, 1H, 
C=CHCOOEt), 4.08 (d, J = 13.6 Hz, 1H, C(OH)CHH), 4.10-4.22 (m, 2H, OCH2CH3), 4.68 (s, 
1H, OH), 6.87 (s, 1H, NH), 6.91-6.95 (m, 2H, ArH), 7.21-7.32 (m, 3H, ArH), 7.40-7.45 (m, 
3H, ArH), 7.57-7.62 (m, 2H, ArH). 
13
C NMR (100 MHz, CDCl3): 14.4, 19.9, 38.6, 38.8, 49.9, 
59.9, 76.8 (q, JC,F = 29 Hz), 86.2, 125.7 (q, JC,F = 285 Hz), 125.9, 126.8, 127.1, 128.4, 128.6, 
128.8, 137.8, 143.0, 156.2, 172.1.  
Compound 19b 
 
Compound 19b (dr 1:1). 
1
H NMR (400 MHz, CDCl3): 1.23-1.32 (m, 1H), 1.26 (t, J = 7.2 Hz, 
3H 1/2), 1.27 (t, J = 7.2 Hz, 3H 1/2), 1.57-1.82 (m, 3H), 2.56-2.75 (m, 2H+1H 1/2), 2.93 
(dt, J = 12.8 Hz, 4.4 Hz, 1H 1/2), 3.20-3.27 (m, 1H 1/2), 3.47-3.51 (m, 1H 1/2), 3.56-3.62 
(m, 1H), 3.67-3.81 (m, 1H+1H 1/2), 3.90-3.95 (m, 1H 1/2), 4.11-4.21 (m, 3H), 4.64 (s, 1H), 
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4.68 (s, 1H 1/2), 6.97 (s, 1H 1/2), 6.99 (s, 1H 1/2), 7.32-7.36 (m, 1H), 7.38-7.42 (m, 2H), 
7.64-7.67 (m, 2H). 
13
C NMR (100 MHz, CDCl3): 14.4, 25.4, 28.3, 28.9, 38.7, 38.9, 46.0, 47.2, 
59.8, 59.9, 67.7, 67.8, 75.4, 76.0, 77.0 (q, JC,F = 28 Hz), 86.0, 86.2, 125.8 (q, JC,F = 285 Hz), 
125.95, 125.96, 126.00, 126.01, 128.2, 128.3, 128.5, 128.6, 137.6, 137.7, 156.6, 172.20, 
172.23. HRMS (ESI) calcd for C19H25NO4F3 ([M + H]
+
) 388.1730, found 388.1714. 
 
Single diastereomer: 
1
H NMR (400 MHz, CDCl3): 1.27 (t, J = 7.2 Hz, 3H), 1.72-1.82 (m, 3H), 
2.61-2.75 (m, 3H), 3.20-3.27 (m, 1H), 3.56-3.63 (m, 1H), 3.67-3.73 (m, 1H), 3.77-3.82 (m, 
1H), 4.09-4.22 (m, 3H), 4.65 (s, 1H), 6.98 (s, 1H), 7.32-7.42 (m, 3H), 7.65 (d, J = 7.6 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): 14.4, 25.4, 28.8, 38.9, 47.2, 59.9, 67.8, 76.0, 76.9 (q, JC,F = 28 
Hz), 86.0, 125.8 (q, JC,F = 285 Hz), 125.91, 125.92, 128.3, 128.5, 137.7, 156.6, 172.2. 
Compound 19c 
 
Compound 19c (dr 1:1). 
1
H NMR (400 MHz, CDCl3): 0.70 (d, J = 6.8 Hz, 3H 1/2), 0.75 (d, J 
= 6.8 Hz, 3H 1/2), 0.85-1.23 (m, 3H), 1.27 (t, J = 7.2 Hz, 3H), 2.56-2.86 (m, 3H), 3.21-3.33 
(m, 2H), 3.58-3.65 (m, 1H), 4.09-4.22 (m, 3H), 4.66 (s, 1H 1/2), 4.67 (s, 1H 1/2), 7.03 (s, 
1H 1/2), 7.04 (s, 1H 1/2), 7.33-7.42 (m, 3H), 7.65-7.67 (m, 2H). 13C NMR (100 MHz, 
CDCl3): 14.4, 16.3, 16.5, 31.3, 31.4, 32.9, 33.1, 38.9, 41.0, 41.3, 59.9, 67.3, 67.5, 76.9 (q, JC,F 
= 28 Hz), 85.78, 85.83, 125.8 (q, JC,F = 285 Hz), 126.06, 126.08, 128.3, 128.4, 128.5, 137.87, 
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137.91, 156.4, 156.5, 172.29, 172.31. HRMS (ESI) calcd for C19H27NO4F3 ([M + H]
+
) 
390.1887, found 390.1869. 
Compound 19c (dr 1:1).  
1
H NMR (400 MHz, CD3CN): 0.65 (d, J = 6.4 Hz, 3H 1/2), 0.70 (d, 
J = 6.4 Hz, 3H 1/2), 0.84-0.96 (m, 1H), 1.03-1.23 (m, 2H), 1.27 (t, J = 7.2 Hz, 3H), 2.52-
2.54 (m, 1H), 2.56-2.83 (m, 2H), 2.97 (d, J = 14.0 Hz, 1H 1/2), 2.99 (d, J = 14.0 Hz, 
1H 1/2),  3.13-3.18 (m, 2H), 3.90 (d, J = 14.0 Hz, 1H 1/2), 3.92 (d, J = 14.0 Hz, 1H 1/2),  
4.04-4.16 (m, 2H), 4.56 (s, 1H 1/2), 4.57 (s, 1H 1/2), 4.58 (br, 1H), 7.34-7.43 (m, 3H), 
7.62-7.64 (m, 2H). 
 
Single diastereomer: 
1
H NMR (400 MHz, CDCl3): 0.70 (d, J = 6.4 Hz, 3H), 0.83-1.24 (m, 
3H), 1.28 (t, J = 7.4 Hz, 3H), 2.57-2.65 (m, 2H), 2.79-2.87 (m, 1H), 3.21-3.31 (m, 2H), 3.58-
3.63 (m, 1H), 4.10-4.22 (m, 3H), 4.67 (s, 1H), 7.03 (s, 1H), 7.33-7.43 (m, 3H), 7.66 (d, J = 
7.6 Hz, 2H). 
13
C NMR (100 MHz, CDCl3): 14.4, 16.3, 31.2, 32.8, 38.9, 41.0, 59.9, 67.5, 76.9 
(q, JC,F = 28 Hz), 85.7, 125.8 (q, JC,F = 285 Hz), 126.1, 128.3, 128.5, 137.9, 156.4, 172.3. 
 1
H NMR analyses during the progress of the reaction to form 19. To a solution of 
(±)-13a (30.4 mg, 0.1 mmol) in CDCl3 (300 L), enantiomerically pure amine 18 (0.11 
mmol) was added, and the mixture was stirred at rt (25 °C). At 5 min, 30 min, 60 min, and 
120 min, 360 min an aliquot was taken from the mixture, diluted with CDCl3 or CD3CN, and 
analyzed by 
1
H NMR. Conversion of 18 at different time points was summarized in Table 6.2. 
In all cases, both of the enamine diastereomers were seen clearly within 30 min to 1 h. The dr 
of the formed enamine 19 was 1:1 at all of the time points analyzed with each of 18a, 18b and 
18c. 
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Table 6.2. Conversion of 18 at different time points during the formation of 19. 
Time (min) Conversion of 18a Conversion of 18b Conversion of 18c 
5 -- -- -- 
30 -- -- 46% 
60 25% 13 % 67% 
120 45% 22% 83% 
360 65% 54% 100% 
 
 
6.3 Experimental Section for Chapter 3 
Deuteration of Pyruvic Aldehyde Derivative 1 
 
 Deuteration of pyruvic aldehyde derivative 1 in the presence of DBU: To a solution of 
1 (212.7 L, 1.80 mmol) in CDCl3 (8.25 mL), D2O (144.0 L, 8.0 mmol) was added at room 
temperature (25 C). The mixture was stirred at the same temperature for 5 min before adding 
premade DBU solution in CDCl3 (0.24 mmol/mL, 0.75 mL, 0.18 mmol). At time points 
indicated, a portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H NMR. The 
experiments were performed twice. 
Table 6.3. Deuteration of pyruvic aldehyde derivative 1 in the presence of DBU. 
Experiment 1: 
Time (min) 1 6 10 16 24 30.5 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.89 2.79 2.74 2.63 2.48 2.37 
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Integration of CH3 at A/3 0.963 0.930 0.913 0.877 0.826 0.790 
       
Time (min) 51 67 
Integration of the 
dimethoxy group 
6.00 6.00 
Integration of CH3 at A 2.02 1.85 
Integration of CH3 at A/3 0.673 0.617 
 
Experiment 2: 
Time (min) 1 7 12 18 24 31 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.83 2.71 2.62 2.53 2.44 2.33 
Integration of CH3 at A/3 0.943 0.903 0.873 0.843 0.813 0.777 
       
Time (min) 65 110 240 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 
Integration of CH3 at A 1.81 1.39 0.78 
Integration of CH3 at A/3 0.603 0.463 0.26 
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Figure 6.2. NMR spectra of pyruvic aldehyde derivative 1 in the presence of DBU at 
different time points. 
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 Deuteration of pyruvic aldehyde derivative 1 in the presence of L-proline: To a 
solution of L-proline (20.7 mg, 0.18 mmol) in deuterated DMSO (9.0 mL), D2O (144.0 L, 
8.0 mmol) was added at room temperature (25 C). The mixture was stirred at the same 
temperature for 30 min before adding 1 (212.7 L, 1.80 mmol). At time points indicated, a 
portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H NMR. The experiments 
were performed twice. 
Table 6.4. Deuteration of pyruvic aldehyde derivative 1 in the presence of L-proline. 
Experiment 1: 
Time (min) 3 40 63 96 175 
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Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.8455 2.8303 2.8239 2.8117 2.7847 
Integration of CH3 at A/3 0.9485 0.9434 0.9413 0.9372 0.928 
      
Time (min) 245 760 2184 3635 5084 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.7626 2.6268 2.3715 2.1508 2.0298 
Integration of CH3 at A/3 0.9209 0.8756 0.7905 0.7169 0.6766 
 
Experiment 2: 
Time (min) 15 35 61 129 165 689 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.8345 2.8294 2.8173 2.7956 2.7828 2.6365 
Integration of CH3 at A/3 0.9448 0.9431 0.9391 0.9319 0.9276 0.8788 
       
Time (min) 2105 3556 5005 6447 10090 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.352 2.1451 2.0312 1.9453 1.8642 
Integration of CH3 at A/3 0.784 0.7150 0.6771 0.6484 0.6214 
 
 
 Deuteration of pyruvic aldehyde derivative 1 in the presence of (S)-(+)-pyrrolidine-3-
carboxylic acid: To a solution of (S)-(+)-pyrrolidine-3-carboxylic acid (20.7 mg, 0.18 mmol) 
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in deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added at room temperature (25 
C). The mixture was stirred at the same temperature for 30 min before adding 1 (212.7 L, 
1.80 mmol). At time points indicated, a portion (0.5 mL) of the mixture was taken out and 
analyzed by
 1
H NMR. The experiments were performed twice. 
Table 6.5. Deuteration of pyruvic aldehyde derivative 1 in the presence of (S)-(+)-
pyrrolidine-3-carboxylic acid.  
Experiment 1: 
Time (min) 1 6 11 16 21 38 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.8341 2.678 2.5096 2.3477 2.2405 1.8291 
Integration of CH3 at A/3 0.9447 0.8927 0.8365 0.7826 0.7468 0.6097 
       
Time (min) 86 327 
Integration of the 
dimethoxy group 
6.00 6.00 
Integration of CH3 at A 1.2162 0.8596 
Integration of CH3 at A/3 0.4054 0.2865 
 
Experiment 2: 
Time (min) 1 6 10 18 23 35 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.8696 2.6936 2.6084 2.3293 2.1989 1.9396 
Integration of CH3 at A/3 0.9565 0.8979 0.8695 0.7764 0.7330 0.6465 
       
Time (min) 85 308 
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Integration of the 
dimethoxy group 
6.00 6.00 
Integration of CH3 at A 1.308 0.9089 
Integration of CH3 at A/3 0.436 0.3030 
 
 
 Deuteration of pyruvic aldehyde derivative 1 in the presence of pyrrolidine-
CH3COOH: To a solution of pyrrolidine (14.8 L, 0.18 mmol) and CH3COOH (10.3 L, 0.18 
mmol) in deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added at room 
temperature (25 C). The mixture was stirred at the same temperature for 30 min before 
adding 1 (212.7 L, 1.80 mmol). At time points indicated, a portion (0.5 mL) of the mixture 
was taken out and analyzed by
 1
H NMR. The experiments were performed twice. 
Table 6.6. Deuteration of pyruvic aldehyde derivative 1 in the presence of pyrrolidine-
CH3COOH. 
Experiment 1: 
Time (min) 5 23 44 60 81 144 333 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 6.00 6.00 
Integration of CH3 at A 2.6170 2.1945 1.7857 1.5735 1.3632 1.0706 0.8969 
Integration of CH3 at A/3 0.8723 0.7315 0.5952 0.5245 0.4544 0.3569 0.2990 
 
Experiment 2: 
Time (min) 6 23 44 60 81 145 333 
Integration of the 
dimethoxy group 
6.00 6.00 6.00 6.00 6.00 6.00 6.00 
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Integration of CH3 at A 2.6611 2.1897 1.7655 1.5379 1.3318 1.0111 0.8532 
Integration of CH3 at A/3 0.8870 0.7299 0.5885 0.5126 0.4439 0.3370 0.2844 
 
 
 
 Deuteration of pyruvic aldehyde derivative 1 in the presence of triethylamine: To a 
solution of 1 (212.7 L, 1.80 mmol) in CDCl3 (9.0 mL), D2O (144.0 L, 8.0 mmol) was 
added at room temperature (25 C). The mixture was stirred at the same temperature for 5 min 
before adding triethyl amine (25.1 L, 0.18 mmol). At time points indicated, a portion (0.5 
mL) of the mixture was taken out and analyzed by
 1
H NMR.  
 
Deuteration of Methyl Ethyl Ketone  
 
 Deuteration of methyl ethyl ketone in the presence of DBU: To a solution of methyl 
ethyl ketone (161.2 L, 1.80 mmol) in CDCl3 (8.25 mL), D2O (144.0 L, 8.0 mmol) was 
added at room temperature (25 C). The mixture was stirred at the same temperature for 5 min 
before adding premade DBU solution in CDCl3 (0.24 mmol/mL, 0.75 mL, 0.18 mmol). At 
time points indicated, a portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H 
NMR. The experiments were performed twice. 
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Table 6.7. Deuteration of methyl ethyl ketone in the presence of DBU.   
Experiment 1: 
Time (min) 5* 30 90 147 229 297 359 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at C 2.9868 2.9623 2.9272 2.8981 2.8570 2.8257 2.7962 
Integration of CH3 at C/3 0.9956 0.9874 0.9757 0.9660 0.9523 0.9419 0.9321 
Integration of CH2 at D 1.9435 1.9493 1.9268 1.9039 1.8751 1.8472 1.8242 
Integration of CH2 at D/2 0.9718 0.9747 0.9634 0.9520 0.9376 0.9236 0.9121 
*Not included in the graph. 
Experiment 2: 
Time (min) 34 92 151 232 299 362 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at C 2.9568 2.9212 2.8875 2.8516 2.8184 2.7918 
Integration of CH3 at C/3 0.9856 0.9737 0.9625 0.9505 0.9395 0.9306 
Integration of CH2 at D 1.9434 1.9245 1.8982 1.8705 1.8439 1.8253 
Integration of CH2 at D/2 0.9717 0.9623 0.9491 0.9353 0.9220 0.9127 
 
 
 Deuteration of methyl ethyl ketone in the presence of L-proline: To a solution of L-
proline (20.7 mg, 0.18 mmol) in deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was 
added at room temperature (25 C). The mixture was stirred at the same temperature for 30 
min before adding methyl ethyl ketone (161.2 L, 1.80 mmol). At time points indicated, a 
portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H NMR. The experiments 
were performed twice. 
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Table 6.8. Deuteration of methyl ethyl ketone in the presence of L-proline.  
Experiment 1: 
Time (min) 5* 40 130 180 268 354 433 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at C 3.0730 3.0723 3.032 3.0157 2.9738 2.9413 2.8978 
Integration of CH3 at C/3 1.0238 1.0241 1.0107 1.0052 0.9913 0.9804 0.9659 
      
Time (min) 593 1472 2930 4360 8900 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at C 2.8397 2.6209 2.3926 2.2816 2.1661 
Integration of CH3 at C/3 0.9466 0.8736 0.7975 0.7605 0.7220 
* Not included in the graph. There may be a lag for enamine formation. 
Time (min) 40* 180* 268* 593 1472 2930 4360 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at D 1.9929 2.0047 1.9909 1.9386 1.9111 1.8302 1.7968 
Integration of CH2 at D/2 0.9965 1.0023 0.9955 0.9693 0.9556 0.9151 0.8984 
* Not included in the graph. There may be a lag for enamine formation. 
Experiment 2: 
Time (min) 44 134 184 285.5 370 600 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at C 3.0784 3.0365 3.0126 2.9752 2.9352 2.8324 
Integration of CH3 at C/3 1.0261 1.0122 1.0042 0.9917 0.9784 0.9441 
       
Time (min) 1477 2899 4330 
Integration of CH2CH3 3.00 3.00 3.00 
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Integration of CH3 at C 2.5882 2.3438 2.2392 
Integration of CH3 at C/3 0.8627 0.7813 0.7464 
    
Time (min) 44* 134* 184* 600 1477 2889 4330 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at D 2.0143 1.9982 1.9993 1.9443 1.9051 1.8252 1.7784 
Integration of CH2 at D/2 1.007 0.9991 0.9997 0.9722 0.9526 0.9126 0.8892 
* Not included in the graph. There may be a lag for enamine formation. 
 
 
 Deuteration of methyl ethyl ketone in the presence of (S)-(+)-pyrrolidine-3-carboxylic 
acid: To a solution of (S)-(+)-pyrrolidine-3-carboxylic acid (20.7 mg, 0.18 mmol) in 
deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added at room temperature (25 
C). The mixture was stirred at the same temperature for 30 min before adding methyl ethyl 
ketone (161.2 L, 1.80 mmol). At time points indicated, a portion (0.5 mL) of the mixture 
was taken out and analyzed by
 1
H NMR. The experiments were performed twice. 
Table 6.9. Deuteration of methyl ethyl ketone in the presence of (S)-(+)-pyrrolidine-3-
carboxylic acid.  
Experiment 1: 
Time (min) 6 21 41 55 70 91 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at C 2.6979 2.4299 2.086 1.8943 1.7431 1.5603 
Integration of CH3 at C/3 0.8993 0.8100 0.6953 0.6314 0.5810 0.5201 
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Time (min) 133 240 
Integration of CH2CH3 3.00 3.00 
Integration of CH3 at C 1.3287 1.1607 
Integration of CH3 at C/3 0.4429 0.3869 
 
Time (min) 6 21 41 55 70 91 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at D 1.8464 1.7732 1.606 1.5131 1.4656 1.353 
Integration of CH2 at D/2 0.9232 0.8866 0.803 0.7566 0.7328 0.6765 
       
Time (min) 133 240 370 
Integration of CH2CH3 3.00 3.00 3.00 
Integration of CH2 at D 1.1981 1.0296 0.8975 
Integration of CH2 at D/2 0.5991 0.5148 0.4488 
 
Experiment 2: 
Time (min) 7 27 43 57 72 92 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at C 2.6988 2.3072 2.0482 1.8661 1.7077 1.5625 
Integration of CH3 at C/3 0.8996 0.76907 0.6827 0.6220 0.5692 0.5208 
       
Time (min) 134 241 
Integration of CH2CH3 3.00 3.00 
Integration of CH3 at C 1.3325 1.1677 
Chapter 6                                                                                                                                                               124   
 
 
Integration of CH3 at C/3 0.4442 0.3892 
 
Time (min) 7 27 43 57 72 92 
Integration of CH2CH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at D 1.8377 1.7006 1.5959 1.5091 1.4271 1.3577 
Integration of CH2 at D/2 0.9189 0.8503 0.7980 0.7546 0.7136 0.6789 
       
Time (min) 134 241 371 
Integration of CH2CH3 3.00 3.00 3.00 
Integration of CH2 at D 1.1933 1.0246 0.9037 
Integration of CH2 at D/2 0.5967 0.5123 0.4519 
 
 
 
Deuteration of Methoxyacetone  
 
 Deuteration of methoxyacetone in the presence of DBU: To a solution of 
methoxyacetone (167.0 L, 1.80 mmol) in CDCl3 (8.25 mL), D2O (144.0 L, 8.0 mmol) was 
added at room temperature (25 C). The mixture was stirred at the same temperature for 5 min 
adding premade DBU solution in CDCl3 (0.24 mmol/mL, 0.75 mL, 0.18 mmol). At time 
points indicated, a portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H NMR. 
The experiments were performed twice.  
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Table 6.10. Deuteration of methoxyacetone 3 in the presence of DBU.   
Experiment 1: 
Time (min) 2 9 16 24 32 41 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at E 2.84 2.79 2.73 2.67 2.62 2.55 
Integration of CH3 at E/3 0.947 0.93 0.91 0.89 0.873 0.85 
   
   
 
Time (min) 58 76 106 147 720 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at E 2.44 2.34 2.19 2.03 1.03 
Integration of CH3 at E/3 0.814 0.78 0.73 0.678 0.344 
 
Time (min) 2 9 16 32 41 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at F 1.9068 1.8909 1.8784 1.8493 1.8321 
Integration of CH2 at F/2 0.9534 0.9455 0.9392 0.9247 0.9161 
 
Time (min) 76 106 147 720 
Integration of OCH3 3.00 3.00 3.00 3.00 
Integration of CH2 at F 1.7774 1.7393 1.6949 1.2653 
Integration of CH2 at F/2 0.8887 0.8697 0.8475 0.6327 
 
Experiment 2:  
Time (min) 2 9 19 27 37 45 
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Integration of OCH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at E 2.84 2.77 2.69 2.63 2.56 2.51 
Integration of CH3 at E/3 0.947 0.923 0.897 0.877 0.853 0.837 
   
   
 
Time (min) 55 78 111 682 
Integration of OCH3 3.00 3.00 3.00 3.00 
Integration of CH3 at E 2.45 2.32 2.17 1.09 
Integration of CH3 at E/3 0.815 0.772 0.723 0.363 
 
Time (min) 2 27 37 45 55 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at F 1.9015 1.8596 1.8408 1.8265 1.8057 
Integration of CH2 at F/2 0.9508 0.9298 0.9204 0.9133 0.9029 
 
Time (min) 78 111 682 
Integration of OCH3 3.00 3.00 3.00 
Integration of CH2 at F 1.7735 1.7351 1.3079 
Integration of CH2 at F/2 0.8868 0.9676 0.6540 
 
 
 Deuteration of methoxyacetone in the presence of L-proline: To a solution of L-proline 
(20.7 mg, 0.18 mmol) in deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added 
at room temperature (25 C). The mixture was stirred at the same temperature for 30 min 
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before adding internal standard CH2Br2 (62.6 L, 0.9 mmol) and methoxyacetone (167.0L, 
1.80 mmol). At time points indicated, a portion (0.5 mL) of the mixture was taken out and 
analyzed by
 1
H NMR. The experiments were performed twice. 
Table 6.11. Deuteration of methoxyacetone in the presence of L-proline. 
Experiment 1: 
Time (min) 5* 46 113 172 251 310 
Integration of internal 
standard CH2Br2 
1.158 1.158 1.158 1.158 1.158 1.158 
Integration of CH3 at E 3.00 2.9916 2.9023 2.8478 2.7500 2.7040 
Integration of CH3 at E/3 1.00 0.9972 0.9674 0.9493 0.9167 0.9013 
 
  
    
Time (min) 360 421 566 661 2202 3752 
Integration of internal 
standard CH2Br2 
1.158 1.158 1.158 1.158 1.158 1.158 
Integration of CH3 at E 2.6526 2.5894 2.5015 2.4681 1.9115 1.7233 
Integration of CH3 at E/3 0.8842 0.8631 0.8338 0.8227 0.6372 0.5744 
* Not included in the graph. There may be a lag for enamine formation. 
Time (min) 46 78 172 310 
Integration of internal 
standard CH2Br2 
1.158 1.158 1.158 1.158 
Integration of CH2 at F 1.9482 1.945 1.9242 1.8953 
Integration of CH2 at F/2 0.9471 0.9725 0.9621 0.9476 
 
Time (min) 360 661 2202 3752 
Integration of internal 
standard CH2Br2 
1.158 1.158 1.158 1.158 
Integration of CH2 at F 1.8823 1.8279 1.6994 1.5687 
Integration of CH2 at F/2 0.9411 0.9139 0.8497 0.7844 
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Experiment 2: 
Time (min) 3* 35 105 165 242 302 
Integration of internal 
standard CH2Br2 
1.1486 1.1486 1.1486 1.1486 1.1486 1.1486 
Integration of CH3 at E 3.00 2.9941 2.9219 2.8426 2.7838 2.7045 
Integration of CH3 at E/3 1.00 0.9980 0.9740 0.9475 0.9279 0.9015 
       
Time (min) 353 413 556 
Integration of internal 
standard CH2Br2 
1.1486 1.1486 1.1486 
Integration of CH3 at E 2.6593 2.6050 2.5171 
Integration of CH3 at E/3 0.8864 0.9683 0.8390 
* Not included in the graph. There may be a lag for enamine formation. 
Time (min) 35 105 242 302 353 556 
Integration of internal 
standard CH2Br2  
1.1486 1.1486 1.1486 1.1486 1.1486 1.1486 
Integration of CH2 at F 1.9523 1.9395 1.9115 1.8937 1.8803 1.8445 
Integration of CH2 at F/2 0.9762 0.9698 0.9557 0.9468 0.9402 0.9223 
 
 
 Deuteration of methoxyacetone in the presence of (S)-(+)-pyrrolidine-3-carboxylic 
acid : To a solution of (S)-(+)-pyrrolidine-3-carboxylic acid (20.7 mg, 0.18 mmol) in 
deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added at room temperature (25 
C). The mixture was stirred at the same temperature for 30 min before adding 
methoxyacetone 3 (167.0L, 1.80 mmol). At time points indicated, a portion (0.5 mL) of the 
mixture was taken out and analyzed by
 1
H NMR. The experiments were performed twice. 
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Table 6.12. Deuteration of methoxyacetone in the presence of (S)-(+)-pyrrolidine-3-
carboxylic acid.  
Experiment 1: 
Time (min) 1 6 19 27 37 57 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at E 2.9075 2.6671 2.1099 1.8865 1.6187 1.3431 
Integration of CH3 at E/3 0.9692 0.88903 0.7033 0.6288 0.5396 0.4477 
       
Time (min) 145 
Integration of OCH3 3.00 
Integration of CH3 at E 1.1374 
Integration of CH3 at E/3 0.3791 
 
Time (min) 1 6 19 27 37 57 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at F 2.0485 1.9835 1.7913 1.7528 1.5875 1.4417 
Integration of CH2 at F/2 1.0243 0.9918 0.8957 0.9864 0.7938 0.7209 
       
Time (min) 145 268 
Integration of OCH3 3.00 3.00 
Integration of CH2 at F 1.0427 0.8862 
Integration of CH2 at F/2 0.5214 0.4431 
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Experiment 2: 
Time (min) 1.5 6 14 23 33 57 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH3 at E 2.9015 2.6522 2.2763 1.9524 1.6923 1.3456 
Integration of CH3 at E/3 0.9672 0.8841 0.7588 0.6508 0.5641 0.4485 
       
Time (min) 142 
Integration of OCH3 3.00 
Integration of CH3 at E 1.1442 
Integration of CH3 at E/3 0.3814 
  
Time (min) 1.5 6 14 23 33 57 
Integration of OCH3 3.00 3.00 3.00 3.00 3.00 3.00 
Integration of CH2 at F 2.0604 1.9726 1.8453 1.7278 1.6294 1.4397 
Integration of CH2 at F/2 1.0302 0.9863 0.9227 0.8639 0.8147 0.7199 
       
Time (min) 142 264 
Integration of OCH3 3.00 3.00 
Integration of CH2 at F 1.053 0.9035 
Integration of CH2 at F/2 0.5265 0.4518 
 
 
 
 
Chapter 6                                                                                                                                                               131   
 
 
Deuteration of Hydroxyacetone  
 
 Deuteration of hydroxyacetone in the presence L-proline: To a solution of L-proline 
(20.7 mg, 0.18 mmol) in deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added 
at room temperature (25 C). The mixture was stirred at the same temperature for 30 min 
before adding internal standard CH2Br2 (62.6 L, 0.9 mmol) and hydroxyacetone (125.8 L, 
1.80 mmol). At time points indicated, a portion (0.5 mL) of the mixture was taken out and 
analyzed by
 1
H NMR. The experiments were performed twice. 
Table 6.13. Deuteration of hydroxyacetone in the presence of L-proline. 
Experiment 1: 
Time (min) 3* 39 177 248 791 
Integration of internal standard 
CH2Br2 
0.982 0.982 0.982 0.982 0.982 
Integration of CH3 at G 3.00 3.0019 2.9681 2.9420 2.7742 
Integration of CH3 at G/3 1.00 1.001 0.9894 0.9807 0.9247 
      
Time (min) 1222 2421 2784 4200 
Integration of internal standard 
CH2Br2 
0.982 0.982 0.982 0.982 
Integration of CH3 at G 2.6550 2.4764 2.4468 2.3489 
Integration of CH3 at G/3 0.885 0.8255 0.8156 0.7830 
* Integration of CH3 at position G was adjusted to be 3.00. Not included in the graph. There may be a lag for 
enamine formation. 
 
Time (min) 117 1222 2421 4200 
Integration of internal standard 
CH2Br2 
0.982 0.982 0.982 0.982 
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Integration of CH2 at H 2.0314 2.0276 1.9795 1.9157 
Integration of CH2 at H/2 1.0157 1.0138 0.9898 0.9579 
 
Experiment 2: 
Time (min) 3* 47 113 191 251 795 
Integration of internal 
standard CH2Br2 
0.9568 0.9568 0.9568 0.9568 0.9568 0.9568 
Integration of CH3 at G 3.00 2.9996 2.9780 2.9611 2.9282 2.7492 
Integration of CH3 at G/3 1.00 0.9999 0.9927 0.9870 0.9761 0.9164 
       
Time (min) 2431 2795 4205 
Integration of internal 
standard CH2Br2 
0.9568 0.9568 0.9568 
Integration of CH3 at G 2.4821 2.4362 2.3752 
Integration of CH3 at G/3 0.8274 0.8121 0.7917 
* Integration of CH3 at position G was adjusted to be 3.00. Not included in the graph. There may be a lag for 
enamine formation. 
 
 
Time (min) 113 795 2431 4205 
Integration of internal standard 
CH2Br2 
0.982 0.982 0.982 0.982 
Integration of CH2 at H 2.0443 2.0237 1.9830 1.9475 
Integration of CH2 at H/2 1.0222 1.0119 0.9915 0.9738 
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 Deuteration of hydroxyacetone in the presence of (S)-(+)-pyrrolidine-3-carboxylic 
acid: To a solution of (S)-(+)-pyrrolidine-3-carboxylic acid (20.7 mg, 0.18 mmol) in 
deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added at room temperature (25 
C). The mixture was stirred at the same temperature for 30 min before adding internal 
standard CH2Br2 (62.6 L, 0.9 mmol) and hydroxyacetone (125.8 L, 1.80 mmol). At time 
points indicated, a portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H NMR. 
The experiments were performed twice. 
Table 6.14. Deuteration of hydroxyacetone in the presence of (S)-(+)-pyrrolidine-3-
carboxylic acid.  
Experiment 1:  
Time (min) 1* 6 11 19 29 40 
Integration of internal 
standard CH2Br2 
0.9879 0.9879 0.9879 0.9879 0.9879 0.9879 
Integration of CH3 at G 2.6838 2.4935 2.2923 1.9635 1.7089 1.5055 
Integration of CH3 at G/3 0.8946 0.8312 0.7641 0.6545 0.5696 0.5018 
       
Time (min) 62 111 219 
Integration of internal 
standard CH2Br2 
0.9879 0.9879 0.9879 
Integration of CH3 at G 1.301 1.2372 1.2038 
Integration of CH3 at G/3 0.4337 0.4124 0.4013 
* Integration of CH2 at position H was adjusted to be 2.00. 
Time (min) 1* 6 11 19 29 40 
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Integration of internal 
standard CH2Br2 
0.9879 0.9879 0.9879 0.9879 0.9879 0.9879 
Integration of CH2 at H 2 1.9966 1.9522 1.901 1.8657 1.7691 
Integration of CH2 at H/2 1 0.9983 0.9761 0.9505 0.9329 0.8846 
       
Time (min) 62 111 219 342 
Integration of internal 
standard CH2Br2 
0.9879 0.9879 0.9879 0.9879 
Integration of CH2 at H 1.6859 1.5557 1.4645 1.4394 
Integration of CH2 at H/2 0.8430 0.7779 0.7323 0.7197 
* Integration of CH2 at position H was adjusted to be 2.00. Not included in the graph. There may be a lag for 
enamine formation. 
 
Experiment 2:  
Time (min) 1* 5.5 14 24 35 58 
Integration of internal 
standard CH2Br2 
1.0121 1.0121 1.0121 1.0121 1.0121 1.0121 
Integration of CH3 at G 2.6878 2.5001 2.1354 1.8316 1.6078 1.3261 
Integration of CH3 at G/3 0.8959 0.8334 0.7118 0.6105 0.5359 0.4420 
       
Time (min) 96 214 
Integration of internal 
standard CH2Br2 
1.0121 1.0121 
Integration of CH3 at G 1.2365 1.2194 
Integration of CH3 at G/3 0.4122 0.4065 
* Integration of CH2 at position H was adjusted to be 2.00. 
Time (min) 1* 5.5 14 24 35 58 
Integration of internal 
standard CH2Br2 
1.0121 1.0121 1.0121 1.0121 1.0121 1.0121 
Integration of CH2 at H 2 2.0165 1.942 0.9213 1.8158 1.7006 
Chapter 6                                                                                                                                                               135   
 
 
Integration of CH2 at H/2 1 1.0083 0.971 0.9607 0.9229 0.8503 
       
Time (min) 96 214 337 
Integration of internal 
standard CH2Br2 
1.0121 1.0121 1.0121 
Integration of CH2 at H 1.5725 1.4996 1.4489 
Integration of CH2 at H/2 0.7863 0.7498 0.7245 
* Integration of CH2 at position H was adjusted to be 2.00. Not included in the graph. There may be a lag for 
enamine formation. 
 
 
 
Deuteration of Ethyl Acetoacetate 
 
 Deuteration of ethyl acetoacetate in the presence of DBU: To a solution of ethyl 
acetoacetate (227.4 L, 1.80 mmol) in CDCl3 (8.25 mL), D2O (144.0 L, 8.0 mmol) was 
added at room temperature (25 C). The mixture was stirred at the same temperature for 5 min 
before adding premade DBU solution in CDCl3 (0.24 mmol/mL, 0.75 mL, 0.18 mmol). At 
time points indicated, a portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H 
NMR. The experiments were performed twice. 
Table 6.15. Deuteration of ethyl acetoacetate in the presence of DBU.  
Experiment 1: 
Time (min) 1 7 12.5 18 25 31 
Integration of OCH2CH3 2.00 2.00 2.00 2.00 2.00 2.00 
Integration of CH3 at I 2.66 2.60 2.54 2.49 2.43 2.38 
Integration of CH3 at I/3 0.887 0.867 0.847 0.83 0.81 0.793 
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Experiment 2: 
Time (min) 1 6.5 12 18 25 32 
Integration of OCH2CH3 2.00 2.00 2.00 2.00 2.00 2.00 
Integration of CH3 at I 2.68 2.62 2.55 2.50 2.43 2.38 
Integration of CH3 at I/3 0.893 0.873 0.85 0.833 0.81 0.793 
 
Figure 6.3. NMR spectra of ethyl acetoacetate in the presence of DBU at different time points. 
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 Deuteration of ethyl acetoacetate in the presence of L-proline: To a solution of L-
proline (20.7 mg, 0.18 mmol) in deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was 
added at room temperature (25 C). The mixture was stirred at the same temperature for 30 
min before adding ethyl acetoacetate (227.4 L, 1.80 mmol). At time points indicated, a 
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portion (0.5 mL) of the mixture was taken out and analyzed by
 1
H NMR. The experiments 
were performed twice. 
 
 Deuteration of ethyl acetoacetate in the presence of (S)-(+)-pyrrolidine-3-carboxylic 
acid: To a solution of (S)-(+)-pyrrolidine-3-carboxylic acid (20.7 mg, 0.18 mmol) in 
deuterated DMSO (9.0 mL), D2O (144.0 L, 8.0 mmol) was added at room temperature (25 
C). The mixture was stirred at the same temperature for 30 min before adding ethyl 
acetoacetate (227.4 L, 1.80 mmol). At time points indicated, a portion (0.5 mL) of the 
mixture was taken out and analyzed by
 1
H NMR. The experiments were performed twice. 
 
6.4 Experimental Section for Chapter 4 
6.4.1. Experimental Section for Chapter 4.2 
Synthesis of Catalysts and Enones 
 Amine catalysts IX
53, 128
 and XVIII
129
 were synthesized by reported 
procedures.
53,128,129
  Enones were purchased or synthesized by reported procedures
53
 or by 
modified methods of the reported procedures.
130
   
 
4-(4-Bromophenyl)but-3-en-2-one 
 To a mixture of water (10.0 mL), acetone (8.0 mL), and 4-bromobenzaldehyde (3.7 g, 
20 mmol), NaOH solution (10% in water, 5 mL) was added at room temperature (25 
o
C), and 
the mixture was stirred at the same temperature for 1 h.
130
 Generated precipitate was collected 
by filtration, washed with hexane, dried under vacuum to give 4-(4-bromophenyl)but-3-en-2-
one (4.3g, 95%). The 
1
H and 
13
C NMR of this product matched to the reported data.
131 
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Oxa-Hetero-Diels-Alder Reactions 
 
 General procedure for the catalytic enantioselective oxa-hetero-Diels-Alder 
reactions (Table 4.2) To a solution of enone 20 (1.0 mmol) and aryl trifluomethyl ketone 10 
(0.2 mmol) in toluene (super dehydrated, 0.4 mL), (2S,4R)-4-(tert-
butyldiphenylsilyloxy)pyrrolidine-2-carboxylic acid (XXI) (7.4 mg, 0.02 mmol) and DABCO 
(XV) (4.49 mg, 0.04 mmol) were added at room temperature (25 
o
C), and the mixture was 
stirred at the same temperature until 10 was consumed (monitored by TLC and crude 
1
H 
NMR). The mixture was purified by flash column chromatography (hexane/CH2Cl2 = 3:1 to 
2:1) to give product 3 (3-1 and 3-2). For all the cases using catalyst system XXI-XV, isomer 
21-2 was the major diastereomer and 21-1 was the minor diastereomer. Rf values of 21-1 and 
21-2 were the same or similar. The dr was determined by 
1
H NMR analysis before 
purification, and the value was retained after purification except a large-scale reaction (i.e., a 
1.0 mmol-scale reaction to afford 3j-2). The ee was determined by chiral-phase HPLC 
analysis after purification. The ratio of 21/22 (21 = 21-1 and 21-2, 22 = aldol product) was 
determined by 
1
H NMR analysis before purification. 
 Relative stereochemistries of 21a (21a-1 and 21a-2) were deduced from the relative 
stereochemistries of 25-1 and 25-2, which were determined by 
1
H NMR J values and NOESY 
experiments (see compounds 25-1 and 25-2). Relative stereochemistries of 21g (21g-1 and 
21g-2) were determined by 
1
H NMR J values and NOESY experiments (see compound 21g). 
Relative stereochemistries of compound 21 other than 21a and 21g were determined by 
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analogy. The absolute stereochemistry of 21 was tentatively assigned by the deduction from 
the previously suggested transition states
54
 and the product
53
 of the [4+2] cycloaddition of the 
in situ-formed enamine of 20a with isatin under catalyst system IX-X. 
 
 General procedure for the synthesis of racemic standards of 3. To a solution of 
enone 20 (1.0 mmol) and aryl trifluomethyl ketone 10 (0.2 mmol) in toluene (super 
dehydrated, 0.4 mL), pyrrolidine (3.2 L, 0. 04 mmol) and acetic acid (XIV) (4.6 L, 0.08 
mmol) were added at room temperature (25 
o
C), and the reaction mixture was stirred at the 
same temperature until 10 was consumed (monitored by TLC and crude 
1
H NMR). The 
mixture was purified by flash column chromatography (hexane/CH2Cl2 = 3:1 to 2:1) to give 
racemic product 21-1 and 21-2 as a diastereomer mixture. Among all the products except 21i 
and 21j, isomer 21-1 was the major diastereomer and 21-2 was the minor diastereomer. 21:22 > 
95:5.  
 
 Synthesis of compound 22a with 21a. To a solution of enone 20a (56.0 µL, 0.5 
mmol) and 4-chlorophenyl trifluoromethyl ketone (10b) (15.0 µL, 0.1 mmol) in toluene 
(super dehydrated, 0.2 mL), amine catalyst IX (5.87 mg, 0.02 mmol) and acetic acid (XIV) 
(2.3 L, 0.04 mmol) were added at room temperature (25 oC), and the mixture was stirred at 
the same temperature until 10b was consumed (monitored by TLC and crude 
1
H NMR). The 
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mixture was purified by flash column chromatography (hexane/CH2Cl2 = 3:1 to 2:1) to give 
21a and 22a (21.0 mg, 21a-1:21a-2:22a = 62:8:30). Compound 22a was eluted with 21a in 
usual silica gel flash column chromatography. The ratio of 21a/22a and the dr of 21a were 
determined by 
1
H NMR analysis. 
 A 2 mmol-scale reaction to afford 21a. To a solution of 20a (1.3 mL, 10.0 mmol) 
and 10b (417.0 mg, 2.0 mmol) in toluene (super dehydrated, 2.0 mL), (2S,4R)-4-(tert-
butyldiphenylsilyloxy)pyrrolidine-2-carboxylic acid (XXI) (74.0 mg, 0.2 mmol,) and 
DABCO (XV) (44.8 mg, 0.4 mmol) were added at room temperature (25 
o
C) and the reaction 
mixture was stirred at the same temperature for 24 h. The reaction mixture was purified by 
flash column chromatography (hexane/CH2Cl2 = 3:1 to 2:1) to give product 21a-1 and 21a-2 
as a diastereomer mixture (320.0 mg, 50%, 21a-1:21a-2 =1:1.9, 21a-2 er 96:4).  
2-(4-Chlorophenyl)-6-propyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21a) 
  
Synthesized by the general procedure; 24 h, 37.6 mg (59%), dr 21a-1:21a-2 = 1:1.9, 21a-2 er 
97:3. 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.94 (t, J = 7.2 Hz, 3H × 1.9/2.9, CH3), 1.01 (t, J 
= 7.2 Hz, 3H × 1/2.9, CH3), 1.35-1.81 (m, 4H, CH2CH2CH3), 2.21 (dd, J = 11.6 Hz, 16.0 Hz, 
1H × 1/2.9, CHCHHC=O), 2.26 (ddd, J = 1.6 Hz, 2.4 Hz, 14.7 Hz, 1H × 1.9/2.9, 
CHCHHC=O), 2.39 (dd, J = 11.6 Hz, 14.7 Hz, 1H × 1.9/2.9, CHCHHC=O), 2.49 (dd, J = 2.4 
Hz, 16.0 Hz, 1H × 1/2.9, CHCHHC=O), 2.85 (d, J = 15.6 Hz, 1H × 1/2.9, CF3CCHHC=O), 
3.01 (d, J = 14.3 Hz, 1H × 1.9/2.9, CF3CCHHC=O), 3.19 (d, J = 14.3 Hz, 1H × 1.9/2.9, 
CF3CCHHC=O), 3.29 (d, J = 15.6 Hz, 1H × 1/2.9, CF3CCHHC=O), 3.65-3.71 (m, 1H × 
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1.9/2.9, OCH), 4.39-4.44 (m, 1H × 1/2.9, OCH), 7.35-7.49 (m, 4H, ArH). 
13
C NMR (100 
MHz, CDCl3): δ 13.8, 13.9, 18.4, 38.1, 38.4, 42.7, 43.8, 45.7, 46.8, 72.1, 73.2, 78.5 (q, JC,F = 
28 Hz), 80.5 (q, JC,F = 30 Hz), 123.6 (q, JC,F = 282 Hz), 124.9 (q, JC,F = 287 Hz), 127.8, 128.6, 
129.1, 129.8, 132.0, 135.3, 135.9, 136.2, 202.9, 203.1. HRMS (ESI): calcd for C15H15O2ClF3 
([M - H]
-
) 319.0707, found 319.0713. HPLC (Daicel Chiralpak AS, hexane/i-PrOH = 99:1, 
0.6 mL/min, λ = 220 nm): tR (major diastereomer, major enantiomer) = 11.6 min, tR (major 
diastereomer, minor enantiomer) = 13.5 min. tR (minor diastereomer) = 19.4 min and 20.3 
min.  
Compound 22a 
 
Data of 22a extracted from the data of a mixture of 22a with 21a (21a-1:21a-2:22a = 62:8:30 
and 64:18:18): 
1
H NMR (400 MHz, CDCl3): peaks separated from 21a: δ 3.23 (d, J = 16.8 Hz, 
1H, CF3CCHHC=O), 3.46 (d, J = 16.8 Hz, 1H, CF3CCHHC=O), 6.08 (dd, J = 4.0 Hz, 16.0 
Hz, 1H, CH=CHCH2), 6.95 (dt, J = 6.8 Hz, 16.0 Hz, 1H, CH=CHCH2). 
13
C NMR (100 MHz, 
CDCl3): δ 13.5, 21.1, 34.6, 41.3, 76.1 (q, JC,F = 29 Hz), 124.4 (q, JC,F = 283 Hz), 127.9, 128.7, 
130.4, 134.9, 136.3, 151.4, 199.3. 
2-Phenyl-6-propyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21b) 
 
Synthesized by the general procedure; 48 h, 31.4 mg (55%), dr 21b-1:21b-2 = 1:1.3, 21b-2 er 
96:4.   
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Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.94 (t, J = 7.2 Hz, 3H × 1.3/2.3, CH3), 1.02 (t, J 
= 7.2 Hz, 3H × 1/2.3, CH3), 1.34-1.82 (m, 4H, CH2CH2CH3), 2.22 (dd, J = 12.0 Hz, 16.4 Hz, 
1H × 1/2.3, CHCHHC=O), 2.25 (ddd, J = 1.6 Hz, 2.8 Hz, 14.9 Hz, 1H × 1.3/2.3, 
CHCHHC=O), 2.38 (ddd, J = 0.8 Hz, 11.5 Hz, 14.9 Hz, 1H × 1.3/2.3, CHCHHC=O), 2.48 
(ddd, J = 0.8 Hz, 2.8 Hz, 16.4 Hz, 1H × 1/2.3, CHCHHC=O), 2.90 (d, J = 15.6 Hz, 1H × 1/2.3, 
CF3CCHHC=O), 3.01 (dd, J = 0.8 Hz, 14.8 Hz, 1H × 1.3/2.3, CF3CCHHC=O), 3.26 (dd, J = 
0.8 Hz, 14.8 Hz, 1H × 1.3/2.3, CF3CCHHC=O), 3.31 (dd, J = 0.8 Hz, 15.6 Hz, 1H × 1/2.3, 
CF3CCHHC=O), 3.68-3.75 (m, 1H × 1.3/2.3, OCH), 4.39-4.44 (m, 1H × 1/2.3, OCH), 7.36-
7.56 (m, 5H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 13.8, 13.9, 18.4, 18.5, 38.2, 38.5, 42.8, 
44.0, 45.8, 46.8, 71.9, 73.1, 78.7 (q, JC,F = 28 Hz), 80.8 (q, JC,F = 29 Hz), 123.9 (q, JC,F = 282 
Hz), 125.1 (q, JC,F = 287 Hz), 126.3, 128.3, 128.8, 129.0, 129.5, 133.4, 137.7, 203.4, 203.6 
ppm; HRMS (ESI): calcd for C15H18O2F3 ([M + H]
+
) 287.1253, found 287.1258. HPLC 
(Daicel Chiralpak AS, hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR (major 
diastereomer, major enantiomer) = 11.7 min, tR (major diastereomer, minor enantiomer) = 
18.9 min. tR (minor diastereomer) = 20.6 min and 21.4 min.  
6-Propyl-2-(thiophen-2-yl)-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21c) 
 
Synthesized by the general procedure; 28 h, 30.1 mg (52%), dr 21c-1:21c-2 = 1:1.4, 21c-2 er 
91:9.   
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.92 (t, J = 7.2 Hz, 3H × 1.4/2.4, CH3), 0.99 (t, J 
= 7.2 Hz, 3H × 1/2.4, CH3), 1.34-1.80 (m, 4H, CH2CH2CH3), 2.27-2.40 (m, 1H × 1/2.4, 
CHCHHC=O, 2H × 1.4/2.4, CHCHHC=O), 2.48 (dd, J = 2.7 Hz, 17.3 Hz, 1H × 1/2.4, 
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CHCHHC=O), 2.96 (d, J = 15.6 Hz, 1H × 1/2.4, CF3CCHHC=O), 2.99 (d, J = 14.7 Hz, 1H × 
1.4/2.4, CF3CCHHC=O), 3.14 (dd, J = 0.7 Hz, 14.7 Hz, 1H × 1.4/2.4, CF3CCHHC=O), 3.29 
(d, J = 15.6 Hz, 1H × 1/2.4, CF3CCHHC=O), 3.76-3.82 (m, 1H × 1.4/2.4, OCH), 4.39-4.44 
(m, 1H × 1/2.4, OCH), 6.99-7.05 (m, 1H × 1.4/2.4, 2H × 1/2.4, ArH), 7.13 (dd, J = 1.2 Hz, 
3.7 Hz, 1H × 1.4/2.4, ArH), 7.34 (dd, J = 1.2 Hz, 5.2 Hz, 1H × 1/2.4, ArH), 7.44 (dd, J = 1.2 
Hz, 5.2 Hz, 1H × 1.4/2.4, ArH). 
13
C NMR (100 MHz, CDCl3): δ 13.8, 13.9, 18.2, 18.3, 38.0, 
43.9, 44.6, 45.4, 46.9, 72.2, 73.5, 78.1 (q, JC,F = 30 Hz), 79.4 (q, JC,F = 31 Hz), 123.4 (q, JC,F = 
282 Hz), 124.5 (q, JC,F = 286 Hz), 125.5, 126.8, 127.0, 127.2, 128.7, 130.0, 137.1, 141.8, 
202.9, 203.0. HRMS (ESI): calcd for C13H14O2F3S ([M - H]
-
) 291.0661, found 291.0663. 
HPLC (Daicel Chiralpak AS, hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR (major 
diastereomer, major enantiomer) = 13.49 min, tR (major diastereomer, minor enantiomer) = 
20.6 min. tR (minor diastereomer) = 23.1 min and 25.4 min. 
6-Propyl-2-(trifluoromethyl)-2-(4-(trifluoromethyl)phenyl)dihydro-2H-pyran-4(3H)-one 
(21d) 
 
Synthesized by the general procedure; 18 h, 30.2 mg (43%), dr 21d-1:21d-2 = 1:1.7, 21d-2 er 
97:3.   
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.96 (t, J = 7.2 Hz, 3H × 1.7/2.7, CH3), 1.02 (t, J 
= 7.1 Hz, 3H × 1/2.7, CH3), 1.37-1.83 (m, 4H, CH2CH2CH3), 2.17-2.31 (m, 1H, 
CHCHHC=O), 2.42 (dd, J = 11.5 Hz, 15.0 Hz, 1H × 1.7/2.7, CHCHHC=O), 2.52 (dd, J = 2.1 
Hz, 16.6 Hz, 1H × 1/2.7, CHCHHC=O), 2.88 (d, J = 15.6 Hz, 1H × 1/2.7, CF3CCHHC=O), 
3.08 (dd, J = 0.7 Hz, 14.7 Hz, 1H × 1.7/2.7, CF3CCHHC=O), 3.24 (d, J = 14.7 Hz, 1H × 
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1.7/2.7, CF3CCHHC=O), 3.34 (dd, J = 0.6 Hz, 15.6 Hz, 1H × 1/2.7, CF3CCHHC=O), 3.65-
3.72 (m, 1H × 1.7/2.7, OCH), 4.42-4.47 (m, 1H × 1/2.7, OCH), 7.63-7.71 (m, 4H, ArH). 
13
C 
NMR (100 MHz, CDCl3): δ 13.8, 13.9, 18.4, 38.1, 38.4, 42.8, 43.9, 45.8, 46.7, 72.4, 73.4, 
78.6 (q, JC,F = 28 Hz), 80.6 (q, JC,F = 30 Hz), 123.57 (q, JC,F = 282 Hz), 123.66 (q, JC,F = 271 
Hz), 123.8 (q, JC,F = 271 Hz), 124.8 (q, JC,F = 287 Hz), 125.4 (q, JC,F = 4 Hz), 125.8 (q, JC,F = 
4 Hz), 126.9, 128.8, 131.3 (q, JC,F = 33 Hz), 131.8 (q, JC,F = 32 Hz), 137.6, 141.5, 202.6, 
202.8. HRMS (ESI): calcd for C16H15O2F6 ([M - H]
-
) 353.0971, found 353.0990. HPLC 
(Daicel Chiralpak IB, hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR (major 
diastereomer, minor enantiomer) = 13.4 min, tR (major diastereomer, major enantiomer) = 
14.1 min. tR (minor diastereomer) = 15.8 min and 20.4 min. 
2-(4-Bromophenyl)-6-propyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21e) 
 
Synthesized by the general procedure; 24 h, 44.0 mg (59%), dr 21e-1:21e-2 = 1:2.4, er of 21e-
2 97:3.   
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.94 (t, J = 7.2 Hz, 3H × 2.4/3.4, CH3), 1.01 (t, J 
= 7.1 Hz, 3H × 1/3.4, CH3), 1.35-1.81 (m, 4H × 3.4/3.4, CH2CH2CH3), 2.17-2.29 (m, 1H, 
CHCHHC=O), 2.39 (dd, J = 11.5 Hz, 14.8 Hz, 1H × 2.4/3.4, CHCHHC=O), 2.49 (dd, J = 2.3 
Hz, 16.4 Hz, 1H × 1/3.4, CHCHHC=O), 2.85 (d, J = 15.6 Hz, 1H × 1/3.4, CF3CCHHC=O), 
3.01 (d, J = 14.8 Hz, 1H × 2.4/3.4, CF3CCHHC=O), 3.19 (d, J = 14.8 Hz, 1H × 2.4/3.4, 
CF3CCHHC=O), 3.28 (d, J = 15.6 Hz, 1H × 1/3.4, CF3CCHHC=O), 3.65-3.71 (m, 1H × 
2.4/3.4, OCH), 4.39-4.43 (m, 1H × 1/3.4, OCH), 7.35-7.58 (m, 4H, ArH). 
13
C NMR (100 
MHz, CDCl3): δ 13.8, 13.9, 18.4, 38.1, 38.4, 42.7, 43.8, 45.7, 46.8, 72.1, 73.3, 78.5 (q, JC,F = 
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28 Hz), 80.6 (q, JC,F = 30 Hz), 123.5, 123.6 (q, JC,F = 282 Hz), 124.2, 124.8 (q, JC,F = 287 Hz), 
128.1, 130.1, 131.6, 132.1, 132.5, 136.8, 202.9, 203.1. HRMS (ESI): calcd for C15H15O2BrF3 
([M - H]
-
) 363.0202, found 363.0208. HPLC (Daicel Chiralpak AS, hexane/i-PrOH = 99:1, 
0.6 mL/min, λ = 220 nm): tR (major diastereomer, major enantiomer) = 11.5 min, tR (major 
diastereomer, minor enantiomer) = 12.6 min. tR (minor diastereomer) = 18.2 min and 19.7 
min. 
6-Propyl-2-(p-tolyl)-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21f) 
 
Synthesized by the general procedure; 72 h (2 was not consumed), 17.6 mg (29%), dr 21f-
1:21f-2 = 1:1.3, 21f-2 er 94:6.   
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.94 (t, J = 7.2 Hz, 3H × 1.3/2.3, CH3), 1.01 (t, J 
= 7.2 Hz, 3H × 1/2.3, CH3), 1.36-1.82 (m, 4H, CH2CH2CH3), 2.18-2.26 (m, 1H, 
CHCHHC=O), 2.32-2.39 (m, 1H×1.3/2.3, CHCHHC=O), 2.36 (s, 3H, ArCH3), 2.47 (ddd, J = 
0.8 Hz, 2.4 Hz, 16.4 Hz, 1H × 1/2.3, CHCHHC=O), 2.89 (d, J = 15.6 Hz, 1H × 1/2.3, 
CF3CCHHC=O), 2.98 (dd, J = 0.8 Hz, 14.6 Hz, 1H × 1.3/2.3, CF3CCHHC=O), 3.25 (dd, J = 
0.8 Hz, 14.6 Hz, 1H × 1.3/2.3, CF3CCHHC=O), 3.29 (dd, J = 0.8 Hz, 15.6 Hz, 1H × 1/2.3, 
CF3CCHHC=O), 3.67-3.74 (m, 1H × 1.3/2.3, OCH), 4.37-4.42 (m, 1H × 1/2.3, OCH), 7.18-
7.23 (m, 2H, ArH), 7.36-7.44 (m, 2H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 13.8, 13.9, 18.4, 
18.5, 21.0, 21.1, 38.2, 38.5, 42.9, 44.0, 45.8, 46.9, 71.7, 73.0, 78.7 (q, JC,F = 28 Hz), 80.7 (q, 
JC,F = 29 Hz), 123.9 (q, JC,F = 282 Hz), 125.2 (q, JC,F = 287 Hz), 126.2, 128.3, 129.0, 129.5, 
130.2, 134.8, 139.0, 139.6, 203.65, 203.73. HRMS (ESI): calcd for C16H20O2F3 ([M + H]
+
) 
301.1410, found 301.1408. HPLC (Daicel Chiralpak IB, hexane/i-PrOH = 99.5:0.5, 0.6 
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mL/min, λ = 220 nm): tR (major diastereomer, minor enantiomer) = 13.3 min, tR (major 
diastereomer, major enantiomer) = 13.9 min. tR (minor diastereomer) = 15.3 min and 18.5 min. 
2-(4-Fluorophenyl)-6-propyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21g) 
 
Synthesized by the general procedure; 26 h, 33.4 mg (55%), dr 21g-1:21g-2 = 1:2.2, 21g-2 er 
96:4.   
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.94 (t, J = 7.2 Hz, 3H × 2.2/3.2, CH3), 1.01 (t, J 
= 7.2 Hz, 3H × 1/3.2, CH3), 1.35-1.81 (m, 4H, CH2CH2CH3), 2.22 (dd, J = 11.6 Hz, 16.6 Hz, 
1H × 1/3.2, CHCHHC=O), 2.27 (ddd, J = 1.6 Hz, 2.8 Hz, 14.8 Hz, 1H × 2.2/3.2, 
CHCHHC=O), 2.39 (ddd, J = 0.7 Hz, 11.4 Hz, 14.8 Hz, 1H × 2.2/3.2, CHCHHC=O), 2.49 
(ddd, J = 0.6 Hz, 2.8 Hz, 16.6 Hz, 1H × 1/3.2, CHCHHC=O), 2.86 (d, J = 15.6 Hz, 1H × 1/3.2, 
CF3CCHHC=O), 3.02 (dd, J = 0.8 Hz, 14.6 Hz, 1H × 2.2/3.2, CF3CCHHC=O), 3.21 (dd, J = 
0.7 Hz, 14.6 Hz, 1H × 2.2/3.2, CF3CCHHC=O), 3.30 (dd, J = 0.6 Hz, 15.6 Hz, 1H × 1/3.2, 
CF3CCHHC=O), 3.65-3.71 (m, 1H × 2.2/3.2, OCH), 4.38-4.44 (m, 1H × 1/3.2, OCH), 7.05-
7.14 (m, 2H, ArH), 7.46-7.54 (m, 2H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 13.8, 13.9, 18.4, 
38.1, 38.5, 42.9, 44.0, 45.8, 46.8, 72.0, 73.2, 78.5 (q, JC,F = 28 Hz), 80.5 (q, JC,F = 30 Hz), 
115.3 (d, JC,F = 21 Hz), 115.9 (d, JC,F = 22 Hz), 123.7 (q, JC,F = 282 Hz), 125.0 (q, JC,F = 287 
Hz), 128.3 (d, JC,F = 8 Hz), 129.2 (d, JC,F = 3 Hz), 130.4 (d, JC,F = 9 Hz), 133.5, 163.0 (d, JC,F 
= 247 Hz), 163.3 (d, JC,F = 248 Hz), 203.1, 203.3. HRMS (ESI): calcd for C15H15O2F4 ([M - 
H]
-
) 303.1003, found 303.1013. HPLC (Daicel Chiralpak AS, hexane/i-PrOH = 99:1, 0.6 
mL/min, λ = 220 nm): tR (major diastereomer, major enantiomer) = 10.6 min, tR (major 
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diastereomer, minor enantiomer) = 13.4 min. tR (minor diastereomer) = 19.3 min and 20.9 
min. The relative stereochemistry was determined by the NOESY experiment as shown below. 
 
 The inter-proton distance H5-H6 was estimated by the reported method.
127
 The proton 
distance of the geminal protons H2a-H2b was used as the reference to be 1.75 Å.127 Only F2-
slices were usded to determine the NOE intensity.
127 
 Relative NOE Intensity Proton distance
127 
H2a-H2b 49.84 (aref) 1.75 Å (rref) 
H5-H6 2.16 (a5-6) 2.95 Å (r5-6) 
 
2-(3-Fluorophenyl)-6-propyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21h) 
 
Synthesized by the general procedure; 24 h, 33.0 mg (54%), dr 21h-1:21h-2 = 1:2.2, 21h-2 er 
95:5.  
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.95 (t, J = 7.2 Hz, 3H × 2.2/3.2, CH3), 1.02 (t, J 
= 7.0 Hz, 3H × 1/3.2, CH3), 1.36-1.82 (m, 4H, CH2CH2CH3), 2.23 (dd, J = 11.6 Hz, 16.6 Hz, 
1H × 1/3.2, CHCHHC=O), 2.28 (ddd, J = 1.6 Hz, 2.7 Hz, 15.0 Hz, 1H × 2.2/3.2, 
CHCHHC=O), 2.40 (ddd, J = 0.6 Hz, 11.5 Hz, 15.0 Hz, 1H × 2.2/3.2, CHCHHC=O), 2.50 
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(ddd, J = 0.7 Hz, 2.7 Hz, 16.6 Hz, 1H × 1/3.2, CHCHHC=O), 2.86 (d, J = 15.6 Hz, 1H × 1/3.2, 
CF3CCHHC=O), 3.02 (dd, J = 0.8 Hz, 14.8 Hz, 1H × 2.2/3.2, CF3CCHHC=O), 3.10 (dd, J = 
0.6 Hz, 14.8 Hz, 1H × 2.2/3.2, CF3CCHHC=O), 3.29 (dd, J = 0.7 Hz, 15.6 Hz, 1H × 1/3.2, 
CF3CCHHC=O), 3.69-3.75 (m, 1H × 2.2/3.2, OCH), 4.39-4.45 (m, 1H × 1/3.2, OCH), 7.05-
7.42 (m, 4H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 13.8, 13.9, 18.38, 18.44, 38.1, 38.4, 42.8, 
44.0, 45.8, 46.7, 72.2, 73.3, 78.4 (q, JC,F = 28 Hz), 80.4 (q, JC,F = 30 Hz), 114.0 (d, JC,F = 24 
Hz), 115.6 (d, JC,F = 23 Hz), 116.1 (d, JC,F = 21 Hz), 116.7 (d, JC,F = 21 Hz), 121.9, 123.6 (q, 
JC,F = 282 Hz), 124.0 (d, JC,F = 3 Hz), 124.9 (q, JC,F = 287 Hz), 129.9 (d, JC,F = 8 Hz), 130.4 (d, 
JC,F = 8 Hz), 136.2 (d, JC,F = 7 Hz), 140.2 (d, JC,F = 7 Hz), 162.6 (d, JC,F = 245 Hz), 163.0 (d, 
JC,F = 246 Hz), 202.9, 203.1. HRMS (ESI): calcd for C15H17O2F4 ([M + H]
+
) 305.1159, found 
305.1158. HPLC (Daicel Chiralpak AS, hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR 
(major diastereomer, major enantiomer) = 14.3 min, tR (major diastereomer, minor 
enantiomer) = 16.7 min. tR (minor diastereomer) = 19.3 min and 25.2 min. 
2-(4-Chlorophenyl)-6-phenyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21i) 
 
Synthesized by the general procedure; 24 h, 58.1 mg (82%), dr 21i-1:21i-2 = 1:4.2, 21i-2 er 
91:9.  
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 2.56 (ddd, J = 1.6 Hz, 3.2 Hz, 15.2 Hz, 1H × 
4.2/5.2, CHCHHC=O), 2.59 (dd, J = 11.6 Hz, 16.8 Hz, 1H × 1/5.2, CHCHHC=O), 2.72 (ddd, 
J = 0.7 Hz, 11.6 Hz, 15.2 Hz, 1H × 4.2/5.2, CHCHHC=O), 2.76 (ddd, J = 0.6 Hz, 2.8 Hz, 16.8 
Hz, 1H × 1/5.2, CHCHHC=O), 3.02 (d, J = 15.6 Hz, 1H × 1/5.2, CF3CCHHC=O), 3.18 (dd, J 
= 0.7 Hz, 14.7 Hz, 1H × 4.2/5.2, CF3CCHHC=O), 3.32 (dd, J = 0.6 Hz, 14.7 Hz, 1H × 4.2/5.2, 
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CF3CCHHC=O), 3.44 (dd, J = 0.6 Hz, 15.6 Hz, 1H × 1/5.2, CF3CCHHC=O), 4.74 (dd, J = 
3.2 Hz, 11.6 Hz, 1H × 4.2/5.2, OCH), 5.46 (dm, J = 11.6 Hz, 1H × 1/5.2, OCH), 7.35-7.57 (m, 
9H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 42.7, 43.7, 47.3, 48.6, 73.9, 75.5, 79.0 (q, JC,F = 29 
Hz), 80.9 (q, JC,F = 30 Hz), 123.6 (q, JC,F = 282 Hz), 124.9 (q, JC,F = 287 Hz), 125.7, 126.0, 
127.9, 128.6, 128.7, 128.8, 128.9, 129.1, 129.3, 129.8, 131.47, 131.55, 135.5, 136.2, 139.1, 
139.5, 202.0, 202.2. HRMS (ESI): calcd for C18H15O2ClF3 ([M + H]
+
) 355.0707, found 
355.0700. HPLC (Daicel Chiralpak IB, hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR 
(major diastereomer, major enantiomer) = 22.0 min, tR (major diastereomer, minor 
enantiomer) = 25.9 min. tR (minor diastereomer) = 35.6 min and 47.2 min. 
6-(4-Bromophenyl)-2-(4-chlorophenyl)-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one 
(21j) 
 
Synthesized by the general procedure; 24 h, 54.2 mg (63%), dr 21j-1:21j-2 = 1:4.1, 21j-2 er 
94:6. 
Colorless gum. 
1
H NMR (400 MHz, CDCl3): δ 2.45 (ddd, J = 1.6 Hz, 3.2 Hz, 15.0 Hz, 1H × 
4.1/5.1, CHCHHC=O), 2.46 (dd, J = 11.6 Hz, 16.4 Hz, 1H × 1/5.1, CHCHHC=O), 2.58 (ddd, 
J = 0.8 Hz, 11.6 Hz, 15.0 Hz, 1H × 4.1/5.1, CHCHHC=O), 2.66 (ddd, J = 0.8 Hz, 2.8 Hz, 16.4 
Hz, 1H × 1/5.1, CHCHHC=O), 2.93 (d, J = 15.6 Hz, 1H × 1/5.1, CF3CCHHC=O), 3.09 (dd, J 
= 0.8 Hz, 14.8 Hz, 1H × 4.1/5.1, CF3CCHHC=O), 3.24 (dd, J = 0.8 Hz, 14.8 Hz, 1H × 4.1/5.1, 
CF3CCHHC=O), 3.35 (dd, J = 0.8 Hz, 15.6 Hz, 1H × 1/5.1, CF3CCHHC=O), 4.61 (dd, J = 
3.2 Hz, 11.6 Hz, 1H × 4.1/5.1, OCH), 5.34 (dd, J = 2.8 Hz, 11.6 Hz, 1H × 1/5.1, OCH), 7.17-
7.52 (m, 8H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 42.7, 43.6, 47.1, 48.4, 73.3, 74.9, 79.1 (q, 
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JC,F = 29 Hz), 81.0 (q, JC,F = 30 Hz), 122.55, 122.64, 123.5 (q, JC,F = 282 Hz), 124.8 (q, JC,F = 
287 Hz), 127.3, 127.6, 127.8, 128.8, 129.4, 129.7, 131.2, 132.0, 132.1, 135.6, 136.3, 138.1, 
138.5, 201.4, 201.7. HRMS (ESI): calcd for C18H14O2BrClF3 ([M + H]
+
) 432.9812, found 
432.9797. HPLC (Daicel Chiralpak IB, hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR 
(major diastereomer, minor enantiomer) = 30.3 min, tR (major diastereomer, major 
enantiomer) = 34.1 min. 
 A 1 mmol-scale reaction to afford 21j-2. To a solution of 4-(4-bromophenyl)but-3-
en-2-one (20j) (1.05g, 5.0 mmol) and 4-chlorophenyl trifluomethyl ketone (10b) (208.6 mg, 
1.0 mmol) in toluene (super dehydrated, 2.0 mL), (2S,4R)-4-(tert-
butyldiphenylsilyloxy)pyrrolidine-2-carboxylic acid (XXI) (37.0 mg, 0.1 mmol,) and 
DABCO (XV) (22.4 mg, 0.2 mmol) were added at room temperature (25 
o
C), and the mixture 
was stirred at the same temperature for 24 h. The dr was determined by 
1
H NMR analysis 
before purification to be 1:4.1 (21j-1:21j-2). The mixture was purified by flash column 
chromatography (hexane/CH2Cl2 = 3:1 to 2:1) to give 21j-2 (255.0 mg, 61%, er 92:8). 
 
Colorless gum; er 92:8. 
1
H NMR (400 MHz, CDCl3): δ 2.45 (ddd, J = 1.6 Hz, 3.2 Hz, 15.0 Hz, 
1H, CHCHHC=O), 2.58 (ddd, J = 0.8 Hz, 11.6 Hz, 15.0 Hz, 1H, CHCHHC=O), 3.08 (dd, J = 
0.8 Hz, 14.6 Hz, 1H, CF3CCHHC=O), 3.24 (dd, J = 0.8 Hz, 14.6 Hz, 1H, CF3CCHHC=O), 
4.61 (dd, J = 3.2 Hz, 11.6 Hz, 1H, OCH), 7.17-7.20 (m, 2H, ArH), 7.33-7.39 (m, 4H, ArH), 
7.45-7.48 (m, 2H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 42.7, 48.4, 73.3, 81.0 (q, JC,F = 30 
Hz), 122.6, 123.6 (q, JC,F = 282 Hz), 127.3, 129.4, 129.7, 131.3, 132.0, 136.3, 138.2, 201.5. 
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6-(But-3-en-1-yl)-2-(4-chlorophenyl)-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one 
(21k) 
 
Synthesized by the general procedure; 29 h, 31.2 mg (47%), dr 21k-1:21k-2 = 1:1.7, 21k-2 er 
96:4. 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 1.60-1.94 (m, 2H, CH2CH2CH=CH2), 2.11-2.52 
(m, 4H, CH2CH2CH=CH2, CHCH2C=O), 2.86 (d, J = 15.6 Hz, 1H × 1/2.7, CF3CCHHC=O), 
3.02 (dd, J = 0.5 Hz, 14.6 Hz, 1H × 1.7/2.7, CF3CCHHC=O), 3.20 (d, J = 14.6 Hz, 1H × 
1.7/2.7, CF3CCHHC=O), 3.29 (d, J = 15.6 Hz, 1H × 1/2.7, CF3CCHHC=O), 3.67-3.37 (m, 1H 
× 1.7/2.7, OCH), 4.40-4.46 (m, 1H × 1/2.7, OCH), 4.95-5.14 (m, 2H, CH2CH=CH2), 5.74-
5.91 (m, 1H, CH2CH=CH2), 7.36-7.51 (m, 4H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 29.2, 
29.3, 35.2, 35.5, 42.7, 43.8, 45.7, 46.7, 71.7, 72.8, 78.5 (q, JC,F = 28 Hz), 80.6 (q, JC,F = 30 
Hz), 115.5, 115.7, 123.6 (q, JC,F = 282 Hz), 124.9 (q, JC,F = 287 Hz), 127.8, 128.6, 129.1, 
129.8, 131.8, 135.3, 136.0, 137.2, 137.3, 202.6, 202.8. HRMS (ESI): calcd for C16H17O2ClF3 
([M + H]
+
) 333.0864, found 333.0858. HPLC (Daicel Chiralpak AS, hexane/i-PrOH = 99:1, 
0.6 mL/min, λ = 220 nm): tR (major diastereomer, major enantiomer) = 16.6 min, tR (major 
diastereomer, minor enantiomer) = 19.9 min. tR (minor diastereomer) = 29.5 min and 55.9 
min. 
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2-(4-Chlorophenyl)-6-hexyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one (21l) 
 
Synthesized by the general procedure; 26 h, 39.3 (51%), dr 21l-1:21l-2 = 1:2.3, 21l-2 er 95:5. 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.86-1.80 (m, 13H, (CH2)5CH3), 2.17-2.29 (m, 
1H, CHCHHC=O), 2.38 (dd, J = 11.6 Hz, 14.9 Hz, 1H × 2.3/3.3, CHCHHC=O), 2.49 (dd, J = 
2.8 Hz, 16.6 Hz, 1H × 1/3.3, CHCHHC=O), 2.85 (d, J = 15.6 Hz, 1H × 1/3.3, 
CF3CCHHC=O), 3.01 (dd, J = 0.6 Hz, 14.6 Hz, 1H × 2.3/3.3, CF3CCHHC=O), 3.19 (d, J = 
14.6 Hz, 1H × 2.3/3.3, CF3CCHHC=O), 3.29 (d, J = 15.6 Hz, 1H × 1/3.3, CF3CCHHC=O), 
3.63-3.70 (m, 1H × 2.3/3.3, OCH), 4.37-4.41 (m, 1H × 1/3.3, OCH), 7.33-7.51 (m, 4H, ArH). 
13
C NMR (100 MHz, CDCl3): δ =14.0, 22.6, 25.05, 25.06, 29.0, 29.1, 31.66, 31.68, 36.0, 36.3, 
42.7, 43.8, 45.7, 46.8, 72.3, 73.6, 78.5 (q, JC,F = 28 Hz), 80.5 (q, JC,F = 30 Hz), 123.6 (q, JC,F = 
282 Hz), 124.9 (q, JC,F = 287 Hz), 127.8, 128.6, 129.1, 129.8, 132.0, 135.9, 202.9, 203.1. 
HRMS (ESI): calcd for C18H23O2ClF3 ([M + H]
+
) 363.1333, found 363.1326. HPLC (Daicel 
Chiralpak IB, hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR (major diastereomer, minor 
enantiomer) = 10.8 min, tR (major diastereomer, major enantiomer) = 11.5 min. tR (minor 
diastereomer) = 12.9 min and 17.1 min. 
 
 
 
 
 
 
Chapter 6                                                                                                                                                               155   
 
 
Analysis of the Stability of the Products under the Catalytic Conditions  
 
 To a mixture of racemic 21a and racemic 22a (21a-1:21a-2:22a = 3:1:1.6, 44.8 mg, 
21a 0.10 mmol, 22a 0.04 mmol) in toluene (super dehydrated, 0.2 mL), proline derivative 
XXI (0.01 mmol, 3.7 mg) and DABCO (XV) (0.02 mmol, 2.3 mg) were added at room 
temperature (25 
o
C). At 30 min, 20 h, 44 h, and 115 h, an aliquot was taken from the mixture, 
diluted with CDCl3, and analyzed by 
1
H NMR. No decomposition of the compounds and no 
changes in the ratios were detected.  
 
Transformations of the Oxa-Hetero-Diels-Alder Reaction Products 
 
 Transformation of 21a to 23. To a solution of 21a (21a-1:21a-2 = 1:1.9, 21a-2 er 
96:4, 32.1 mg, 0.10 mmol) in MeOH (1.0 mL), PhCH2ONH2 (12.3 mg, 0.10 mmol) was 
added at room temperature (25 
o
C). The mixture was stirred at 60 
o
C for 24 h (consumption of 
21a was analyzed by TLC). After being cooled to room temperature, the mixture was purified 
by flash column chromatography (hexane/EtOAc = 15:1 to 10:1) to give 23 (major 
diastereomer from 21a-2, 25.9 mg, 61%). 
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2-(4-Chlorophenyl)-6-propyl-2-(trifluoromethyl)dihydro-2H-pyran-4(3H)-one O-benzyl 
oxime (23) 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.93 (t, J = 7.2 Hz, 3H, CH3), 1.34-1.73 (m, 4H, 
CH2CH2CH3), 1.93 (dd, J = 11.6 Hz, 15.2 Hz, 1H, CHCHHC=N), 2.87 (d, J = 14.8 Hz, 1H, 
CF3CCHHC=N), 3.00 (ddd, J = 0.4 Hz, 2.8 Hz, 15.2 Hz, 1H, CHCHHC=N), 3.11 (d, J = 14.8 
Hz, 1H, CF3CCHHC=N), 3.38-3.45 (m, 1H, OCH), 5.05 (s, 2H, CH2Ph), 7.21-7.41 (m, 9H, 
ArH). 
13
C NMR (100 MHz, CDCl3): δ 14.0, 18.6, 31.5, 32.6, 38.1, 70.6, 75.6, 79.4 (q, JC,F = 
29 Hz ), 123.9 (q, JC,F = 282 Hz), 127.71, 127.73, 128.3, 128.7, 130.1, 132.4, 135.2, 137.8, 
152.2. HRMS (ESI): calcd for C22H24O2NClF3 ([M + H]
+
) 426.1430, found 426.1442.   
 
 
 Transformation of 21a to 24. A mixture of 21a (21a-1:21a-2 = 1:1.9, 21a-2 er 96:4, 
32.1 mg, 0.10 mmol), allylbromide (86 L, 1.0 mmol), and In (15.3 mg, 0.13 mmol) in DMF 
(0.8 mL)-H2O (0.1 mL) was stirred at room temperature (25 
o
C) for 20 h. The mixture was 
added to aqueous saturated NH4Cl and extracted with CH2Cl2 (x 3). Organic layers were 
combined, washed with brine, dried with MgSO4, concentrated, and purified by flash column 
chromatography (hexane/EtOAc = 20:1 to 10:1) to give 24-1 (26.4 mg, 73%, a mixture of two 
diastereomers, 24-1a from 21a-1, 24-1b from 21a-2, 24-1a:24-1b = 1:4.7) and 24-2 (from 
21a-1, 4.1 mg, 11%, single diastereomer). 
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 A mixture of racemic 21a (21a-1:21a-2 = 2.5:1, 32.1 mg, 0.10 mmol), allylbromide 
(86 L, 1.0 mmol), and In (15.3 mg, 0.13 mmol) in DMF (0.8 mL)-H2O (0.1 mL) was stirred 
at room temperature (25 
o
C) for 20 h. The mixture was added to aqueous saturated NH4Cl and 
extracted with CH2Cl2 (x 3). Organic layers were combined, washed with brine, dried with 
MgSO4, concentrated, and purified by flash column chromatography (hexane/EtOAc = 20:1 
to 10:1) to give 24-1 (18.8 mg, 52%, a mixture of two diastereomers, 24-1a from 21a-1, 24-
1b from 21a-2, 24-1a:24-1b = 1:1) and 24-2 (from 21a-1, 10.1 mg, 28%, single diastereomer). 
Compound 24-1 
Rf = 0.38 (hexane/ EtOAc = 10:1). 
Colorless oil. 24-1a:24-1b = 1:4.7. 
1
H NMR (400 MHz, CDCl3): δ 0.95-1.00 (m, 3H, CH3), 
1.39-1.72 {m, (4H, CH2CH2CH3), (2H × 4.7/5.7, OCHCH2COH), (1H × 1/5.7, 
OCHCHHCOH)}, 1.90 (dd, J = 3.4 Hz, 14.5 Hz, 1H × 1/5.7, OCHCHHCOH), 1.99 (d, J = 
14.4 Hz, 1H × 4.7/5.7, CCF3CHHCOH), 2.22-2.32 (m, 2H, CH2CH=CH2), 2.37 (s, 2H × 1/5.7, 
CCF3CH2COH), 2.49 (d, J = 14.4 Hz, 1H × 4.7/5.7, CCF3CHHCOH), 3.75-3.81 (m, 1H × 
4.7/5.7, OCH), 3.92-3.99 (m, 1H × 1/5.7, OCH), 5.13-5.26 (m, 2H, CH=CH2), 5.78-5.92 (m, 
1H, CH=CH2), 7.34-7.39 (m, 2H, ArH), 7.48 (d, J = 8.6 Hz, 2H × 4.7/5.7, ArH), 7.57 (d, J = 
8.4 Hz, 2H × 1/5.7, ArH). 
13
C NMR (100 MHz, CDCl3): * donates 24-1b, δ 13.8, *14.2, 18.5, 
*18.7, *35.6, 37.3, *38.0, 38.4, *41.9, 43.2, 47.9, *48.6, *67.7, *69.2, 69.5, 71.3, 77.0 (q, JC,F 
= 28 Hz), *78.1 (q, JC,F = 28 Hz), 119.8, *120.4, *124.4 (q, JC,F = 282 Hz), 125.3 (q, JC,F = 
286 Hz), 128.2, *128.3, 128.4, *129.7, *131.8, 132.3, *133.8, 134.5, *134.7, 137.9. 
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Compound 24-2 
Rf = 0.31 (hexane/ EtOAc = 10:1). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.99 (t, J = 7.2 Hz, 3H, CH3), 1.35 (dd, J = 11.8 
Hz, 14.1 Hz, 1H, OCHCHHCOH), 1.46-1.74 (m, 5H, CH2CH2CH3, OCHCHHCOH), 1.93-
2.04 (m, 2H, CH2CH=CH2), 2.08 (dd, J = 0.6 Hz, 14.5 Hz, 1H, CCF3CHHCOH), 2.54 (dd, J 
= 0.9 Hz, 14.5 Hz, 1H, CCF3CHHCOH), 4.29-4.33 (m, 1H, OCH), 5.05-5.11 (m, 1H, 
CH=CHH), 5.19-5.22 (m, 1H, CH=CHH), 5.72-5.83 (m, 1H, CH=CH2), 7.32-7.35 (m, 2H, 
ArH), 7.50 (d, J = 8.4 Hz, 2H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 14.0, 18.6, 38.2, 39.4, 
42.5, 48.3, 68.4, 70.0, 76.2 (q, JC,F = 28 Hz ), 120.6, 125.5 (q, JC,F = 287 Hz), 127.7, 128.2, 
132.0, 134.3 ,139.1.  
 
 
 Transformation of 21a to 25. To a solution of 21a (21a-1:21a-2 = 1:1.9, 21a-2 er 
96:4, 32.1 mg, 0.10 mmol) in CH2Cl2 (1.5 mL), benzylamine (32.7 μL, 0.30 mmol) and 
NaBH(OAc)3 (64 mg, 0.30 mmol) were added at room temperature (25 
o
C), and the mixture 
was stirred at the same temperature for 45 h (consumption of 21a was analyzed by TLC). 
After addition of aqueous NaOH (1 N, 0.6 mL), the mixture was extracted with CH2Cl2 (x 3). 
Organic layers were combined, washed with brine, dried over MgSO4, filtered, concentrated, 
and purified by flash column chromatography (hexane/EtOAc = 20:1 to 6:1) gave 25-1 (from 
21a-2, 23.9 mg, 58%, single diastereomer, er 95:5) and 21-2 (from 21a-1, 7.8 mg, 19%, single 
diastereomer).  
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Compound 25-1 
Rf = 0.29 (hexane/ EtOAc = 10:1).  
Colorless oil. []D
24
 +31.7 (c = 1.93, CHCl3, er 95:5 determined by the HPLC analysis). 
1
H 
NMR (400 MHz, CDCl3): δ 0.95 (t, J = 7.2 Hz, 3H, CH3), 1.31-1.72 (m, 6H, CH2CH2CH3, 
CH2CH2CH3, CHCH2CHNH), 2.33-2.36 (m, 1H, CCF3CHHCH), 2.45 (dd, J = 5.2 Hz, 14.4 
Hz, 1H, CCF3CHHCH), 3.23-3.26 (m, 1H, CHNHCH2Ph), 3.67 (s, 2H, CH2Ph), 3.74-3.81 (m, 
1H, OCH), 7.06-7.07 (m, 2H, ArH), 7.22-7.38 (m, 5H, ArH), 7.49 (d, J = 8.8 Hz, 2H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 14.2, 18.6, 30.6, 35.1, 38.4, 48.8, 50.9, 67.2, 77.6 (q, JC,F = 
28 Hz ), 124.6 (q, JC,F = 282 Hz ), 127.2, 127.8, 128.4, 128.9, 134.6 ,135.4. HRMS (ESI) 
calcd for C22H26ONClF3 ([M + H]
+
) 412.1650, found 412.1644. HPLC (Daicel Chiralpak IA, 
hexane/i-PrOH = 99:1, 0.6 mL/min, λ = 220 nm): tR (major enantiomer) = 8.0 min, tR (minor 
enantiomer) = 12.1 min. 
 Relative stereochemistry of 25-1 was determined by 
1
H NMR and NOESY 
experiments as shown below. 
 
Compound 25-2 
Rf = 0.24 (hexane/ EtOAc = 10:1). 
Colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 0.98 (t, J = 7.2 Hz, 3H, CH3), 1.06 (dt, J = 12.8 
Hz, 11.6 Hz, 1H, CHCHHCHNHBn), 1.43-1.69 (m, 5H, CH2CH2CH3, CF3CHHCHNH), 
2.01-2.06 (m, 1H, CHCHHCH), 2.87 (ddd, J = 1.6 Hz, 4.4 Hz, 13.8 Hz, 1H, CCF3CHHCH), 
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3.19-3.24 (m, 1H, CHNH), 3.86 (d, J = 15.5 Hz, 1H, CHHPh), 3.89 (d, J = 15.5 Hz, 1H, 
CHHPh ), 4.00-4.05 (m, 1H, OCH), 7.27-7.35 (m, 7H, ArH), 7.49 (m, 2H, ArH). 
13
C NMR 
(100 MHz, CDCl3): δ 13.9, 18.6, 37.4, 37.6, 38.8, 50.0, 50.6, 73.0, 76.7 (q, JC,F = 27 Hz ), 
125.9 (q, JC,F = 290 Hz ), 127.3, 127.6, 128.0, 128.2, 128.6, 134.3, 139.0. HRMS (ESI) calcd 
for C22H26ONClF3 ([M + H]
+
) 412.1650, found 412.1637. 
 Relative stereochemistry of 25-2 was determined by 
1
H NMR and NOESY 
experiments as shown below. 
 
 
 
 Transformation of 21j to 26. To a solution of 21j (21j-1:21j-2 = 1:25, 21j-2 er 92:8, 
70.0 mg, 0.161 mmol) in CH2Cl2 (2.5 mL), 4-bromobenzylamine (93.0 mg, 0.50 mmol) and 
NaBH(OAc)3 (106.8 mg, 0.50 mmol) were added at room temperature (25 
o
C) and the 
mixture was stirred at the same temperature for 45 h (consumption of 21j was analyzed by 
TLC). After addition of aqueous NaOH (1 N, 1.5 mL), the mixture was extracted with CH2Cl2 
(x 3). Organic layers were combined, washed with brine, dried over MgSO4, filtered, 
concentrated, and purified by flash column chromatography (hexane/EtOAc = 10:1) to give 
26 (97.1 mg, 87%, er 92:8, single diastereomer).  
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N-(4-Bromobenzyl)-6-(4-bromophenyl)-2-(4-chlorophenyl)-2 
(trifluoromethyl)tetrahydro-2H-pyran-4-amine (26) 
Colorless oil. []D
25
 –23.4 (c = 2.70, CHCl3, er 92:8 determined by the HPLC analysis). 
1
H NMR (400 MHz, CDCl3): δ 1.78-1.88 (m, 2H, CHCH2CHNH), 2.39 (dd, J = 4.0 Hz, 14.4 
Hz, 1H, CF3CCHHC=O), 2.57 (dd, J = 3.2 Hz, 14.4 Hz, 1H, CF3CCHHC=O), 3.34 (m 1H, 
CHNH), 3.60 (d, J = 14.0 Hz, 1H, CHHPh), 3.66 (d, J = 14.0 Hz, 1H, CHHPh), 4.87 (dd, J = 
3.6 Hz, 10.6 Hz, 1H, OCH), 6.86 (d, J = 8.0 Hz, 2H ArH), 7.23 (d, J = 8.4 Hz, 2H ArH), 7.36-
7.40 (m, 4H, ArH), 7.47-7.52 (m, 4H, ArH). 
13
C NMR (100 MHz, CDCl3): δ 30.5, 37.5, 49.4, 
50.6, 68.5, 78.3 (q, JC,F = 28 Hz ), 120.8, 121.6, 124.5 (q, JC,F = 282 Hz), 127.4, 128.6, 129.3, 
131.4, 131.6, 134.79, 134.80, 138.9, 140.6. HRMS (ESI) calcd for C25H22ONBr2ClF3 ([M + 
H]
+
) 601.9678, found 601.9703. HPLC (Daicel Chiralpak IA, hexane/i-PrOH = 99:1, 0.6 
mL/min, λ = 220 nm): tR (major enantiomer) = 18.6 min, tR (minor enantiomer) = 23.0 min. 
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